Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	3.3107153559596297e-62	3.3107153559596297e-62	0.799861000607755	0.090090185679713	0.0001655040560957	0.17905428302499976	204
hsa05165	Human papillomavirus infection	1	4.050846751295165e-72	4.050846751295165e-72	0.7043581584413251	0.04483487686253795	1.651443342960368e-09	0.10915558588965041	209
hsa05164	Influenza A	1	7.231307550739112e-71	7.231307550739112e-71	0.7928981445558452	0.0782001660333497	5.008945974417511e-05	0.16497184374657364	202
hsa04613	Neutrophil extracellular trap formation	1	4.2151608028098916e-46	4.2151608028098916e-46	0.945052145136519	0.06499697908120862	6.493158432908479e-07	0.15239049438884805	210
hsa05163	Human cytomegalovirus infection	1	2.3355952612524574e-60	2.3355952612524574e-60	0.652910431590019	0.059387691525146356	5.730971722434382e-07	0.1348311302212533	217
hsa04625	C-type lectin receptor signaling pathway	1	6.300905905634698e-71	6.300905905634698e-71	0.6736900022167941	0.07046396390342442	2.6123406772704232e-05	0.1468327705682604	192
hsa05020	Prion disease	7	7.826218126806749e-30	1.338495574714571e-55	0.945052145136519	0.0578564197877551	7.073241252217884e-07	0.13847026514914182	205
hsa05224	Breast cancer	1	1.0972861228528864e-66	1.0972861228528864e-66	0.8560194816661827	0.08116332880947584	5.339642190932434e-08	0.17743092303128077	190
hsa04530	Tight junction	1	2.4924014854660547e-69	2.4924014854660547e-69	0.7816708577192549	0.15379922644521776	0.03234024355828405	0.2050960465394181	188
hsa05225	Hepatocellular carcinoma	2	2.0001647480276063e-31	1.9383562983755083e-38	0.89385019691749	0.08198248735209017	0.0003439470256018	0.16383616540271348	205
hsa05017	Spinocerebellar ataxia	1	4.88887630866162e-35	4.88887630866162e-35	0.652910431590019	0.07755400840201081	0.0094028271134812	0.13951095244807593	198
hsa05010	Alzheimer disease	1	1.7407821377748618e-55	1.7407821377748618e-55	0.945052145136519	0.05375478716110336	1.1850911671166248e-05	0.12741603076943828	213
hsa05200	Pathways in cancer	1	2.1963824282547284e-101	2.1963824282547284e-101	0.6871987250202681	0.061275010845965254	2.381376904175725e-07	0.14334382658685096	206
hsa05206	MicroRNAs in cancer	1	3.7903390706213376e-127	3.7903390706213376e-127	0.8661326318575439	0.20988208518789286	0.1069904964186367	0.2299232418977929	186
hsa04927	Cortisol synthesis and secretion	1	2.595312276525824e-34	2.595312276525824e-34	0.945052145136519	0.14878773694146655	0.0606937370650065	0.18283369758485826	237
hsa05170	Human immunodeficiency virus 1 infection	1	6.13896606565261e-60	6.13896606565261e-60	0.7043581584413251	0.061772940015480435	8.702827146749942e-06	0.13489257442903035	203
hsa04060	Cytokine-cytokine receptor interaction	1	1.05187162855752e-148	1.05187162855752e-148	0.8640389506066377	0.12670094987773448	0.0008436750737966	0.21947417862629062	184
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	7.829555757572299e-79	7.829555757572299e-79	0.7043581584413251	0.07385481833983165	8.676404055904668e-05	0.15473539638110034	206
hsa04210	Apoptosis	1	7.384902792136834e-68	7.384902792136834e-68	0.5010690274785042	0.06116257450125466	5.294919969511161e-05	0.11787053589143175	217
hsa05168	Herpes simplex virus 1 infection	1	2.392979329816736e-77	2.392979329816736e-77	0.89385019691749	0.08440875860331705	2.8412310027813878e-05	0.17282870705172354	194
hsa04071	Sphingolipid signaling pathway	6	6.369974479612296e-28	9.028120004867832e-61	0.5811340386463366	0.06686372469311494	1.4981823919039822e-05	0.14148704142281643	210
hsa05166	Human T-cell leukemia virus 1 infection	1	1.4892557176921237e-78	1.4892557176921237e-78	0.7790917039515327	0.045027729775033144	1.1438974603415073e-05	0.1124435976061454	208
hsa05161	Hepatitis B	1	3.337092426078769e-83	3.337092426078769e-83	0.8919968202060229	0.05352806742137389	8.201116302039678e-08	0.1383064249272002	198
hsa05160	Hepatitis C	1	5.76416306814465e-46	5.76416306814465e-46	0.89385019691749	0.09187941460892755	0.0001604349074534	0.18481487306780953	187
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	4.2713829890417614e-76	4.2713829890417614e-76	0.7015647054836872	0.050538489880769366	6.031922149243079e-08	0.12853978805958727	205
hsa05169	Epstein-Barr virus infection	2	6.061302784016378e-79	6.061302784016378e-79	0.7928981445558452	0.053091724903954376	2.632851926661135e-07	0.14393493638912638	195
hsa05012	Parkinson disease	4	4.199151222199867e-25	1.950585684082761e-46	0.7833046657784437	0.05924017251319164	1.1368042106980964e-05	0.13519530864108686	235
hsa05014	Amyotrophic lateral sclerosis	2	1.5418550994586697e-43	5.4629825037276655e-48	0.8560194816661827	0.09045340635816257	0.0035303032489315	0.15876309636883523	199
hsa05226	Gastric cancer	2	3.569408163935953e-47	1.106468807012411e-78	0.89385019691749	0.060660173369800216	2.187758113445115e-06	0.131359701261053	203
hsa05415	Diabetic cardiomyopathy	2	4.204144808634628e-35	3.365839395784888e-37	0.5865979353911017	0.04627380478222065	4.559205597434762e-06	0.10262830932347136	228
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	3.858102091853023e-46	3.858102091853023e-46	0.5699903529074454	0.051898336451924924	4.3089349717518385e-08	0.12048259198068864	201
hsa05203	Viral carcinogenesis	2	1.9161318007542965e-61	9.132783395030224e-69	0.57831161455909	0.04203172742018352	3.0262152735744163e-07	0.11654879292751058	204
hsa04979	Cholesterol metabolism	1	2.4436092999412928e-70	2.4436092999412928e-70	0.908880644520742	0.4514227243414972	0.5835703543636465	0.27034452644617163	176
hsa05202	Transcriptional misregulation in cancer	1	3.786117621392158e-115	3.786117621392158e-115	0.7043581584413251	0.06793444573816607	5.363389089770566e-05	0.14697065809897777	200
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	3.3107153559596297e-62	3.3107153559596297e-62	0.799861000607755	0.090090185679713	0.0001655040560957	0.17905428302499976	204
hsa05165	Human papillomavirus infection	1	4.050846751295165e-72	4.050846751295165e-72	0.7043581584413251	0.04483487686253795	1.651443342960368e-09	0.10915558588965041	209
hsa05164	Influenza A	1	7.231307550739112e-71	7.231307550739112e-71	0.7928981445558452	0.0782001660333497	5.008945974417511e-05	0.16497184374657364	202
hsa04613	Neutrophil extracellular trap formation	1	4.2151608028098916e-46	4.2151608028098916e-46	0.945052145136519	0.06499697908120862	6.493158432908479e-07	0.15239049438884805	210
hsa05163	Human cytomegalovirus infection	1	2.3355952612524574e-60	2.3355952612524574e-60	0.652910431590019	0.059387691525146356	5.730971722434382e-07	0.1348311302212533	217
hsa04625	C-type lectin receptor signaling pathway	1	6.300905905634698e-71	6.300905905634698e-71	0.6736900022167941	0.07046396390342442	2.6123406772704232e-05	0.1468327705682604	192
hsa05020	Prion disease	7	7.826218126806749e-30	1.338495574714571e-55	0.945052145136519	0.0578564197877551	7.073241252217884e-07	0.13847026514914182	205
hsa05224	Breast cancer	1	1.0972861228528864e-66	1.0972861228528864e-66	0.8560194816661827	0.08116332880947584	5.339642190932434e-08	0.17743092303128077	190
hsa04530	Tight junction	1	2.4924014854660547e-69	2.4924014854660547e-69	0.7816708577192549	0.15379922644521776	0.03234024355828405	0.2050960465394181	188
hsa05225	Hepatocellular carcinoma	2	2.0001647480276063e-31	1.9383562983755083e-38	0.89385019691749	0.08198248735209017	0.0003439470256018	0.16383616540271348	205
hsa05017	Spinocerebellar ataxia	1	4.88887630866162e-35	4.88887630866162e-35	0.652910431590019	0.07755400840201081	0.0094028271134812	0.13951095244807593	198
hsa05010	Alzheimer disease	1	1.7407821377748618e-55	1.7407821377748618e-55	0.945052145136519	0.05375478716110336	1.1850911671166248e-05	0.12741603076943828	213
hsa05200	Pathways in cancer	1	2.1963824282547284e-101	2.1963824282547284e-101	0.6871987250202681	0.061275010845965254	2.381376904175725e-07	0.14334382658685096	206
hsa05206	MicroRNAs in cancer	1	3.7903390706213376e-127	3.7903390706213376e-127	0.8661326318575439	0.20988208518789286	0.1069904964186367	0.2299232418977929	186
hsa04927	Cortisol synthesis and secretion	1	2.595312276525824e-34	2.595312276525824e-34	0.945052145136519	0.14878773694146655	0.0606937370650065	0.18283369758485826	237
hsa05170	Human immunodeficiency virus 1 infection	1	6.13896606565261e-60	6.13896606565261e-60	0.7043581584413251	0.061772940015480435	8.702827146749942e-06	0.13489257442903035	203
hsa04060	Cytokine-cytokine receptor interaction	1	1.05187162855752e-148	1.05187162855752e-148	0.8640389506066377	0.12670094987773448	0.0008436750737966	0.21947417862629062	184
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	7.829555757572299e-79	7.829555757572299e-79	0.7043581584413251	0.07385481833983165	8.676404055904668e-05	0.15473539638110034	206
hsa04210	Apoptosis	1	7.384902792136834e-68	7.384902792136834e-68	0.5010690274785042	0.06116257450125466	5.294919969511161e-05	0.11787053589143175	217
hsa05168	Herpes simplex virus 1 infection	1	2.392979329816736e-77	2.392979329816736e-77	0.89385019691749	0.08440875860331705	2.8412310027813878e-05	0.17282870705172354	194
hsa04071	Sphingolipid signaling pathway	6	6.369974479612296e-28	9.028120004867832e-61	0.5811340386463366	0.06686372469311494	1.4981823919039822e-05	0.14148704142281643	210
hsa05166	Human T-cell leukemia virus 1 infection	1	1.4892557176921237e-78	1.4892557176921237e-78	0.7790917039515327	0.045027729775033144	1.1438974603415073e-05	0.1124435976061454	208
hsa05161	Hepatitis B	1	3.337092426078769e-83	3.337092426078769e-83	0.8919968202060229	0.05352806742137389	8.201116302039678e-08	0.1383064249272002	198
hsa05160	Hepatitis C	1	5.76416306814465e-46	5.76416306814465e-46	0.89385019691749	0.09187941460892755	0.0001604349074534	0.18481487306780953	187
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	4.2713829890417614e-76	4.2713829890417614e-76	0.7015647054836872	0.050538489880769366	6.031922149243079e-08	0.12853978805958727	205
hsa05169	Epstein-Barr virus infection	2	6.061302784016378e-79	6.061302784016378e-79	0.7928981445558452	0.053091724903954376	2.632851926661135e-07	0.14393493638912638	195
hsa05012	Parkinson disease	4	4.199151222199867e-25	1.950585684082761e-46	0.7833046657784437	0.05924017251319164	1.1368042106980964e-05	0.13519530864108686	235
hsa05014	Amyotrophic lateral sclerosis	2	1.5418550994586697e-43	5.4629825037276655e-48	0.8560194816661827	0.09045340635816257	0.0035303032489315	0.15876309636883523	199
hsa05226	Gastric cancer	2	3.569408163935953e-47	1.106468807012411e-78	0.89385019691749	0.060660173369800216	2.187758113445115e-06	0.131359701261053	203
hsa05415	Diabetic cardiomyopathy	2	4.204144808634628e-35	3.365839395784888e-37	0.5865979353911017	0.04627380478222065	4.559205597434762e-06	0.10262830932347136	228
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	3.858102091853023e-46	3.858102091853023e-46	0.5699903529074454	0.051898336451924924	4.3089349717518385e-08	0.12048259198068864	201
hsa05203	Viral carcinogenesis	2	1.9161318007542965e-61	9.132783395030224e-69	0.57831161455909	0.04203172742018352	3.0262152735744163e-07	0.11654879292751058	204
hsa04979	Cholesterol metabolism	1	2.4436092999412928e-70	2.4436092999412928e-70	0.908880644520742	0.4514227243414972	0.5835703543636465	0.27034452644617163	176
hsa05202	Transcriptional misregulation in cancer	1	3.786117621392158e-115	3.786117621392158e-115	0.7043581584413251	0.06793444573816607	5.363389089770566e-05	0.14697065809897777	200
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	3.3107153559596297e-62	3.3107153559596297e-62	0.799861000607755	0.090090185679713	0.0001655040560957	0.17905428302499976	204
hsa05165	Human papillomavirus infection	1	4.050846751295165e-72	4.050846751295165e-72	0.7043581584413251	0.04483487686253795	1.651443342960368e-09	0.10915558588965041	209
hsa05164	Influenza A	1	7.231307550739112e-71	7.231307550739112e-71	0.7928981445558452	0.0782001660333497	5.008945974417511e-05	0.16497184374657364	202
hsa04613	Neutrophil extracellular trap formation	1	4.2151608028098916e-46	4.2151608028098916e-46	0.945052145136519	0.06499697908120862	6.493158432908479e-07	0.15239049438884805	210
hsa05163	Human cytomegalovirus infection	1	2.3355952612524574e-60	2.3355952612524574e-60	0.652910431590019	0.059387691525146356	5.730971722434382e-07	0.1348311302212533	217
hsa04625	C-type lectin receptor signaling pathway	1	6.300905905634698e-71	6.300905905634698e-71	0.6736900022167941	0.07046396390342442	2.6123406772704232e-05	0.1468327705682604	192
hsa05020	Prion disease	7	7.826218126806749e-30	1.338495574714571e-55	0.945052145136519	0.0578564197877551	7.073241252217884e-07	0.13847026514914182	205
hsa05224	Breast cancer	1	1.0972861228528864e-66	1.0972861228528864e-66	0.8560194816661827	0.08116332880947584	5.339642190932434e-08	0.17743092303128077	190
hsa04530	Tight junction	1	2.4924014854660547e-69	2.4924014854660547e-69	0.7816708577192549	0.15379922644521776	0.03234024355828405	0.2050960465394181	188
hsa05225	Hepatocellular carcinoma	2	2.0001647480276063e-31	1.9383562983755083e-38	0.89385019691749	0.08198248735209017	0.0003439470256018	0.16383616540271348	205
hsa05017	Spinocerebellar ataxia	1	4.88887630866162e-35	4.88887630866162e-35	0.652910431590019	0.07755400840201081	0.0094028271134812	0.13951095244807593	198
hsa05010	Alzheimer disease	1	1.7407821377748618e-55	1.7407821377748618e-55	0.945052145136519	0.05375478716110336	1.1850911671166248e-05	0.12741603076943828	213
hsa05200	Pathways in cancer	1	2.1963824282547284e-101	2.1963824282547284e-101	0.6871987250202681	0.061275010845965254	2.381376904175725e-07	0.14334382658685096	206
hsa05206	MicroRNAs in cancer	1	3.7903390706213376e-127	3.7903390706213376e-127	0.8661326318575439	0.20988208518789286	0.1069904964186367	0.2299232418977929	186
hsa04927	Cortisol synthesis and secretion	1	2.595312276525824e-34	2.595312276525824e-34	0.945052145136519	0.14878773694146655	0.0606937370650065	0.18283369758485826	237
hsa05170	Human immunodeficiency virus 1 infection	1	6.13896606565261e-60	6.13896606565261e-60	0.7043581584413251	0.061772940015480435	8.702827146749942e-06	0.13489257442903035	203
hsa04060	Cytokine-cytokine receptor interaction	1	1.05187162855752e-148	1.05187162855752e-148	0.8640389506066377	0.12670094987773448	0.0008436750737966	0.21947417862629062	184
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	7.829555757572299e-79	7.829555757572299e-79	0.7043581584413251	0.07385481833983165	8.676404055904668e-05	0.15473539638110034	206
hsa04210	Apoptosis	1	7.384902792136834e-68	7.384902792136834e-68	0.5010690274785042	0.06116257450125466	5.294919969511161e-05	0.11787053589143175	217
hsa05168	Herpes simplex virus 1 infection	1	2.392979329816736e-77	2.392979329816736e-77	0.89385019691749	0.08440875860331705	2.8412310027813878e-05	0.17282870705172354	194
hsa04071	Sphingolipid signaling pathway	6	6.369974479612296e-28	9.028120004867832e-61	0.5811340386463366	0.06686372469311494	1.4981823919039822e-05	0.14148704142281643	210
hsa05166	Human T-cell leukemia virus 1 infection	1	1.4892557176921237e-78	1.4892557176921237e-78	0.7790917039515327	0.045027729775033144	1.1438974603415073e-05	0.1124435976061454	208
hsa05161	Hepatitis B	1	3.337092426078769e-83	3.337092426078769e-83	0.8919968202060229	0.05352806742137389	8.201116302039678e-08	0.1383064249272002	198
hsa05160	Hepatitis C	1	5.76416306814465e-46	5.76416306814465e-46	0.89385019691749	0.09187941460892755	0.0001604349074534	0.18481487306780953	187
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	4.2713829890417614e-76	4.2713829890417614e-76	0.7015647054836872	0.050538489880769366	6.031922149243079e-08	0.12853978805958727	205
hsa05169	Epstein-Barr virus infection	2	6.061302784016378e-79	6.061302784016378e-79	0.7928981445558452	0.053091724903954376	2.632851926661135e-07	0.14393493638912638	195
hsa05012	Parkinson disease	4	4.199151222199867e-25	1.950585684082761e-46	0.7833046657784437	0.05924017251319164	1.1368042106980964e-05	0.13519530864108686	235
hsa05014	Amyotrophic lateral sclerosis	2	1.5418550994586697e-43	5.4629825037276655e-48	0.8560194816661827	0.09045340635816257	0.0035303032489315	0.15876309636883523	199
hsa05226	Gastric cancer	2	3.569408163935953e-47	1.106468807012411e-78	0.89385019691749	0.060660173369800216	2.187758113445115e-06	0.131359701261053	203
hsa05415	Diabetic cardiomyopathy	2	4.204144808634628e-35	3.365839395784888e-37	0.5865979353911017	0.04627380478222065	4.559205597434762e-06	0.10262830932347136	228
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	3.858102091853023e-46	3.858102091853023e-46	0.5699903529074454	0.051898336451924924	4.3089349717518385e-08	0.12048259198068864	201
hsa05203	Viral carcinogenesis	2	1.9161318007542965e-61	9.132783395030224e-69	0.57831161455909	0.04203172742018352	3.0262152735744163e-07	0.11654879292751058	204
hsa04979	Cholesterol metabolism	1	2.4436092999412928e-70	2.4436092999412928e-70	0.908880644520742	0.4514227243414972	0.5835703543636465	0.27034452644617163	176
hsa05202	Transcriptional misregulation in cancer	1	3.786117621392158e-115	3.786117621392158e-115	0.7043581584413251	0.06793444573816607	5.363389089770566e-05	0.14697065809897777	200
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	3.3107153559596297e-62	3.3107153559596297e-62	0.799861000607755	0.090090185679713	0.0001655040560957	0.17905428302499976	204
hsa05165	Human papillomavirus infection	1	4.050846751295165e-72	4.050846751295165e-72	0.7043581584413251	0.04483487686253795	1.651443342960368e-09	0.10915558588965041	209
hsa05164	Influenza A	1	7.231307550739112e-71	7.231307550739112e-71	0.7928981445558452	0.0782001660333497	5.008945974417511e-05	0.16497184374657364	202
hsa04613	Neutrophil extracellular trap formation	1	4.2151608028098916e-46	4.2151608028098916e-46	0.945052145136519	0.06499697908120862	6.493158432908479e-07	0.15239049438884805	210
hsa05163	Human cytomegalovirus infection	1	2.3355952612524574e-60	2.3355952612524574e-60	0.652910431590019	0.059387691525146356	5.730971722434382e-07	0.1348311302212533	217
hsa04625	C-type lectin receptor signaling pathway	1	6.300905905634698e-71	6.300905905634698e-71	0.6736900022167941	0.07046396390342442	2.6123406772704232e-05	0.1468327705682604	192
hsa05020	Prion disease	7	7.826218126806749e-30	1.338495574714571e-55	0.945052145136519	0.0578564197877551	7.073241252217884e-07	0.13847026514914182	205
hsa05224	Breast cancer	1	1.0972861228528864e-66	1.0972861228528864e-66	0.8560194816661827	0.08116332880947584	5.339642190932434e-08	0.17743092303128077	190
hsa04530	Tight junction	1	2.4924014854660547e-69	2.4924014854660547e-69	0.7816708577192549	0.15379922644521776	0.03234024355828405	0.2050960465394181	188
hsa05225	Hepatocellular carcinoma	2	2.0001647480276063e-31	1.9383562983755083e-38	0.89385019691749	0.08198248735209017	0.0003439470256018	0.16383616540271348	205
hsa05017	Spinocerebellar ataxia	1	4.88887630866162e-35	4.88887630866162e-35	0.652910431590019	0.07755400840201081	0.0094028271134812	0.13951095244807593	198
hsa05010	Alzheimer disease	1	1.7407821377748618e-55	1.7407821377748618e-55	0.945052145136519	0.05375478716110336	1.1850911671166248e-05	0.12741603076943828	213
hsa05200	Pathways in cancer	1	2.1963824282547284e-101	2.1963824282547284e-101	0.6871987250202681	0.061275010845965254	2.381376904175725e-07	0.14334382658685096	206
hsa05206	MicroRNAs in cancer	1	3.7903390706213376e-127	3.7903390706213376e-127	0.8661326318575439	0.20988208518789286	0.1069904964186367	0.2299232418977929	186
hsa04927	Cortisol synthesis and secretion	1	2.595312276525824e-34	2.595312276525824e-34	0.945052145136519	0.14878773694146655	0.0606937370650065	0.18283369758485826	237
hsa05170	Human immunodeficiency virus 1 infection	1	6.13896606565261e-60	6.13896606565261e-60	0.7043581584413251	0.061772940015480435	8.702827146749942e-06	0.13489257442903035	203
hsa04060	Cytokine-cytokine receptor interaction	1	1.05187162855752e-148	1.05187162855752e-148	0.8640389506066377	0.12670094987773448	0.0008436750737966	0.21947417862629062	184
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	7.829555757572299e-79	7.829555757572299e-79	0.7043581584413251	0.07385481833983165	8.676404055904668e-05	0.15473539638110034	206
hsa04210	Apoptosis	1	7.384902792136834e-68	7.384902792136834e-68	0.5010690274785042	0.06116257450125466	5.294919969511161e-05	0.11787053589143175	217
hsa05168	Herpes simplex virus 1 infection	1	2.392979329816736e-77	2.392979329816736e-77	0.89385019691749	0.08440875860331705	2.8412310027813878e-05	0.17282870705172354	194
hsa04071	Sphingolipid signaling pathway	6	6.369974479612296e-28	9.028120004867832e-61	0.5811340386463366	0.06686372469311494	1.4981823919039822e-05	0.14148704142281643	210
hsa05166	Human T-cell leukemia virus 1 infection	1	1.4892557176921237e-78	1.4892557176921237e-78	0.7790917039515327	0.045027729775033144	1.1438974603415073e-05	0.1124435976061454	208
hsa05161	Hepatitis B	1	3.337092426078769e-83	3.337092426078769e-83	0.8919968202060229	0.05352806742137389	8.201116302039678e-08	0.1383064249272002	198
hsa05160	Hepatitis C	1	5.76416306814465e-46	5.76416306814465e-46	0.89385019691749	0.09187941460892755	0.0001604349074534	0.18481487306780953	187
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	4.2713829890417614e-76	4.2713829890417614e-76	0.7015647054836872	0.050538489880769366	6.031922149243079e-08	0.12853978805958727	205
hsa05169	Epstein-Barr virus infection	2	6.061302784016378e-79	6.061302784016378e-79	0.7928981445558452	0.053091724903954376	2.632851926661135e-07	0.14393493638912638	195
hsa05012	Parkinson disease	4	4.199151222199867e-25	1.950585684082761e-46	0.7833046657784437	0.05924017251319164	1.1368042106980964e-05	0.13519530864108686	235
hsa05014	Amyotrophic lateral sclerosis	2	1.5418550994586697e-43	5.4629825037276655e-48	0.8560194816661827	0.09045340635816257	0.0035303032489315	0.15876309636883523	199
hsa05226	Gastric cancer	2	3.569408163935953e-47	1.106468807012411e-78	0.89385019691749	0.060660173369800216	2.187758113445115e-06	0.131359701261053	203
hsa05415	Diabetic cardiomyopathy	2	4.204144808634628e-35	3.365839395784888e-37	0.5865979353911017	0.04627380478222065	4.559205597434762e-06	0.10262830932347136	228
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	3.858102091853023e-46	3.858102091853023e-46	0.5699903529074454	0.051898336451924924	4.3089349717518385e-08	0.12048259198068864	201
hsa05203	Viral carcinogenesis	2	1.9161318007542965e-61	9.132783395030224e-69	0.57831161455909	0.04203172742018352	3.0262152735744163e-07	0.11654879292751058	204
hsa04979	Cholesterol metabolism	1	2.4436092999412928e-70	2.4436092999412928e-70	0.908880644520742	0.4514227243414972	0.5835703543636465	0.27034452644617163	176
hsa05202	Transcriptional misregulation in cancer	1	3.786117621392158e-115	3.786117621392158e-115	0.7043581584413251	0.06793444573816607	5.363389089770566e-05	0.14697065809897777	200
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	3.3107153559596297e-62	3.3107153559596297e-62	0.799861000607755	0.090090185679713	0.0001655040560957	0.17905428302499976	204
hsa05165	Human papillomavirus infection	1	4.050846751295165e-72	4.050846751295165e-72	0.7043581584413251	0.04483487686253795	1.651443342960368e-09	0.10915558588965041	209
hsa05164	Influenza A	1	7.231307550739112e-71	7.231307550739112e-71	0.7928981445558452	0.0782001660333497	5.008945974417511e-05	0.16497184374657364	202
hsa04613	Neutrophil extracellular trap formation	1	4.2151608028098916e-46	4.2151608028098916e-46	0.945052145136519	0.06499697908120862	6.493158432908479e-07	0.15239049438884805	210
hsa05163	Human cytomegalovirus infection	1	2.3355952612524574e-60	2.3355952612524574e-60	0.652910431590019	0.059387691525146356	5.730971722434382e-07	0.1348311302212533	217
hsa04625	C-type lectin receptor signaling pathway	1	6.300905905634698e-71	6.300905905634698e-71	0.6736900022167941	0.07046396390342442	2.6123406772704232e-05	0.1468327705682604	192
hsa05020	Prion disease	7	7.826218126806749e-30	1.338495574714571e-55	0.945052145136519	0.0578564197877551	7.073241252217884e-07	0.13847026514914182	205
hsa05224	Breast cancer	1	1.0972861228528864e-66	1.0972861228528864e-66	0.8560194816661827	0.08116332880947584	5.339642190932434e-08	0.17743092303128077	190
hsa04530	Tight junction	1	2.4924014854660547e-69	2.4924014854660547e-69	0.7816708577192549	0.15379922644521776	0.03234024355828405	0.2050960465394181	188
hsa05225	Hepatocellular carcinoma	2	2.0001647480276063e-31	1.9383562983755083e-38	0.89385019691749	0.08198248735209017	0.0003439470256018	0.16383616540271348	205
hsa05017	Spinocerebellar ataxia	1	4.88887630866162e-35	4.88887630866162e-35	0.652910431590019	0.07755400840201081	0.0094028271134812	0.13951095244807593	198
hsa05010	Alzheimer disease	1	1.7407821377748618e-55	1.7407821377748618e-55	0.945052145136519	0.05375478716110336	1.1850911671166248e-05	0.12741603076943828	213
hsa05200	Pathways in cancer	1	2.1963824282547284e-101	2.1963824282547284e-101	0.6871987250202681	0.061275010845965254	2.381376904175725e-07	0.14334382658685096	206
hsa05206	MicroRNAs in cancer	1	3.7903390706213376e-127	3.7903390706213376e-127	0.8661326318575439	0.20988208518789286	0.1069904964186367	0.2299232418977929	186
hsa04927	Cortisol synthesis and secretion	1	2.595312276525824e-34	2.595312276525824e-34	0.945052145136519	0.14878773694146655	0.0606937370650065	0.18283369758485826	237
hsa05170	Human immunodeficiency virus 1 infection	1	6.13896606565261e-60	6.13896606565261e-60	0.7043581584413251	0.061772940015480435	8.702827146749942e-06	0.13489257442903035	203
hsa04060	Cytokine-cytokine receptor interaction	1	1.05187162855752e-148	1.05187162855752e-148	0.8640389506066377	0.12670094987773448	0.0008436750737966	0.21947417862629062	184
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	7.829555757572299e-79	7.829555757572299e-79	0.7043581584413251	0.07385481833983165	8.676404055904668e-05	0.15473539638110034	206
hsa04210	Apoptosis	1	7.384902792136834e-68	7.384902792136834e-68	0.5010690274785042	0.06116257450125466	5.294919969511161e-05	0.11787053589143175	217
hsa05168	Herpes simplex virus 1 infection	1	2.392979329816736e-77	2.392979329816736e-77	0.89385019691749	0.08440875860331705	2.8412310027813878e-05	0.17282870705172354	194
hsa04071	Sphingolipid signaling pathway	6	6.369974479612296e-28	9.028120004867832e-61	0.5811340386463366	0.06686372469311494	1.4981823919039822e-05	0.14148704142281643	210
hsa05166	Human T-cell leukemia virus 1 infection	1	1.4892557176921237e-78	1.4892557176921237e-78	0.7790917039515327	0.045027729775033144	1.1438974603415073e-05	0.1124435976061454	208
hsa05161	Hepatitis B	1	3.337092426078769e-83	3.337092426078769e-83	0.8919968202060229	0.05352806742137389	8.201116302039678e-08	0.1383064249272002	198
hsa05160	Hepatitis C	1	5.76416306814465e-46	5.76416306814465e-46	0.89385019691749	0.09187941460892755	0.0001604349074534	0.18481487306780953	187
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	4.2713829890417614e-76	4.2713829890417614e-76	0.7015647054836872	0.050538489880769366	6.031922149243079e-08	0.12853978805958727	205
hsa05169	Epstein-Barr virus infection	2	6.061302784016378e-79	6.061302784016378e-79	0.7928981445558452	0.053091724903954376	2.632851926661135e-07	0.14393493638912638	195
hsa05012	Parkinson disease	4	4.199151222199867e-25	1.950585684082761e-46	0.7833046657784437	0.05924017251319164	1.1368042106980964e-05	0.13519530864108686	235
hsa05014	Amyotrophic lateral sclerosis	2	1.5418550994586697e-43	5.4629825037276655e-48	0.8560194816661827	0.09045340635816257	0.0035303032489315	0.15876309636883523	199
hsa05226	Gastric cancer	2	3.569408163935953e-47	1.106468807012411e-78	0.89385019691749	0.060660173369800216	2.187758113445115e-06	0.131359701261053	203
hsa05415	Diabetic cardiomyopathy	2	4.204144808634628e-35	3.365839395784888e-37	0.5865979353911017	0.04627380478222065	4.559205597434762e-06	0.10262830932347136	228
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	3.858102091853023e-46	3.858102091853023e-46	0.5699903529074454	0.051898336451924924	4.3089349717518385e-08	0.12048259198068864	201
hsa05203	Viral carcinogenesis	2	1.9161318007542965e-61	9.132783395030224e-69	0.57831161455909	0.04203172742018352	3.0262152735744163e-07	0.11654879292751058	204
hsa04979	Cholesterol metabolism	1	2.4436092999412928e-70	2.4436092999412928e-70	0.908880644520742	0.4514227243414972	0.5835703543636465	0.27034452644617163	176
hsa05202	Transcriptional misregulation in cancer	1	3.786117621392158e-115	3.786117621392158e-115	0.7043581584413251	0.06793444573816607	5.363389089770566e-05	0.14697065809897777	200
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	3.3107153559596297e-62	3.3107153559596297e-62	0.799861000607755	0.090090185679713	0.0001655040560957	0.17905428302499976	204
hsa05165	Human papillomavirus infection	1	4.050846751295165e-72	4.050846751295165e-72	0.7043581584413251	0.04483487686253795	1.651443342960368e-09	0.10915558588965041	209
hsa05164	Influenza A	1	7.231307550739112e-71	7.231307550739112e-71	0.7928981445558452	0.0782001660333497	5.008945974417511e-05	0.16497184374657364	202
hsa04613	Neutrophil extracellular trap formation	1	4.2151608028098916e-46	4.2151608028098916e-46	0.945052145136519	0.06499697908120862	6.493158432908479e-07	0.15239049438884805	210
hsa05163	Human cytomegalovirus infection	1	2.3355952612524574e-60	2.3355952612524574e-60	0.652910431590019	0.059387691525146356	5.730971722434382e-07	0.1348311302212533	217
hsa04625	C-type lectin receptor signaling pathway	1	6.300905905634698e-71	6.300905905634698e-71	0.6736900022167941	0.07046396390342442	2.6123406772704232e-05	0.1468327705682604	192
hsa05020	Prion disease	7	7.826218126806749e-30	1.338495574714571e-55	0.945052145136519	0.0578564197877551	7.073241252217884e-07	0.13847026514914182	205
hsa05224	Breast cancer	1	1.0972861228528864e-66	1.0972861228528864e-66	0.8560194816661827	0.08116332880947584	5.339642190932434e-08	0.17743092303128077	190
hsa04530	Tight junction	1	2.4924014854660547e-69	2.4924014854660547e-69	0.7816708577192549	0.15379922644521776	0.03234024355828405	0.2050960465394181	188
hsa05225	Hepatocellular carcinoma	2	2.0001647480276063e-31	1.9383562983755083e-38	0.89385019691749	0.08198248735209017	0.0003439470256018	0.16383616540271348	205
hsa05017	Spinocerebellar ataxia	1	4.88887630866162e-35	4.88887630866162e-35	0.652910431590019	0.07755400840201081	0.0094028271134812	0.13951095244807593	198
hsa05010	Alzheimer disease	1	1.7407821377748618e-55	1.7407821377748618e-55	0.945052145136519	0.05375478716110336	1.1850911671166248e-05	0.12741603076943828	213
hsa05200	Pathways in cancer	1	2.1963824282547284e-101	2.1963824282547284e-101	0.6871987250202681	0.061275010845965254	2.381376904175725e-07	0.14334382658685096	206
hsa05206	MicroRNAs in cancer	1	3.7903390706213376e-127	3.7903390706213376e-127	0.8661326318575439	0.20988208518789286	0.1069904964186367	0.2299232418977929	186
hsa04927	Cortisol synthesis and secretion	1	2.595312276525824e-34	2.595312276525824e-34	0.945052145136519	0.14878773694146655	0.0606937370650065	0.18283369758485826	237
hsa05170	Human immunodeficiency virus 1 infection	1	6.13896606565261e-60	6.13896606565261e-60	0.7043581584413251	0.061772940015480435	8.702827146749942e-06	0.13489257442903035	203
hsa04060	Cytokine-cytokine receptor interaction	1	1.05187162855752e-148	1.05187162855752e-148	0.8640389506066377	0.12670094987773448	0.0008436750737966	0.21947417862629062	184
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	7.829555757572299e-79	7.829555757572299e-79	0.7043581584413251	0.07385481833983165	8.676404055904668e-05	0.15473539638110034	206
hsa04210	Apoptosis	1	7.384902792136834e-68	7.384902792136834e-68	0.5010690274785042	0.06116257450125466	5.294919969511161e-05	0.11787053589143175	217
hsa05168	Herpes simplex virus 1 infection	1	2.392979329816736e-77	2.392979329816736e-77	0.89385019691749	0.08440875860331705	2.8412310027813878e-05	0.17282870705172354	194
hsa04071	Sphingolipid signaling pathway	6	6.369974479612296e-28	9.028120004867832e-61	0.5811340386463366	0.06686372469311494	1.4981823919039822e-05	0.14148704142281643	210
hsa05166	Human T-cell leukemia virus 1 infection	1	1.4892557176921237e-78	1.4892557176921237e-78	0.7790917039515327	0.045027729775033144	1.1438974603415073e-05	0.1124435976061454	208
hsa05161	Hepatitis B	1	3.337092426078769e-83	3.337092426078769e-83	0.8919968202060229	0.05352806742137389	8.201116302039678e-08	0.1383064249272002	198
hsa05160	Hepatitis C	1	5.76416306814465e-46	5.76416306814465e-46	0.89385019691749	0.09187941460892755	0.0001604349074534	0.18481487306780953	187
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	4.2713829890417614e-76	4.2713829890417614e-76	0.7015647054836872	0.050538489880769366	6.031922149243079e-08	0.12853978805958727	205
hsa05169	Epstein-Barr virus infection	2	6.061302784016378e-79	6.061302784016378e-79	0.7928981445558452	0.053091724903954376	2.632851926661135e-07	0.14393493638912638	195
hsa05012	Parkinson disease	4	4.199151222199867e-25	1.950585684082761e-46	0.7833046657784437	0.05924017251319164	1.1368042106980964e-05	0.13519530864108686	235
hsa05014	Amyotrophic lateral sclerosis	2	1.5418550994586697e-43	5.4629825037276655e-48	0.8560194816661827	0.09045340635816257	0.0035303032489315	0.15876309636883523	199
hsa05226	Gastric cancer	2	3.569408163935953e-47	1.106468807012411e-78	0.89385019691749	0.060660173369800216	2.187758113445115e-06	0.131359701261053	203
hsa05415	Diabetic cardiomyopathy	2	4.204144808634628e-35	3.365839395784888e-37	0.5865979353911017	0.04627380478222065	4.559205597434762e-06	0.10262830932347136	228
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	3.858102091853023e-46	3.858102091853023e-46	0.5699903529074454	0.051898336451924924	4.3089349717518385e-08	0.12048259198068864	201
hsa05203	Viral carcinogenesis	2	1.9161318007542965e-61	9.132783395030224e-69	0.57831161455909	0.04203172742018352	3.0262152735744163e-07	0.11654879292751058	204
hsa04979	Cholesterol metabolism	1	2.4436092999412928e-70	2.4436092999412928e-70	0.908880644520742	0.4514227243414972	0.5835703543636465	0.27034452644617163	176
hsa05202	Transcriptional misregulation in cancer	1	3.786117621392158e-115	3.786117621392158e-115	0.7043581584413251	0.06793444573816607	5.363389089770566e-05	0.14697065809897777	200
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	3.3107153559596297e-62	3.3107153559596297e-62	0.799861000607755	0.090090185679713	0.0001655040560957	0.17905428302499976	204
hsa05165	Human papillomavirus infection	1	4.050846751295165e-72	4.050846751295165e-72	0.7043581584413251	0.04483487686253795	1.651443342960368e-09	0.10915558588965041	209
hsa05164	Influenza A	1	7.231307550739112e-71	7.231307550739112e-71	0.7928981445558452	0.0782001660333497	5.008945974417511e-05	0.16497184374657364	202
hsa04613	Neutrophil extracellular trap formation	1	4.2151608028098916e-46	4.2151608028098916e-46	0.945052145136519	0.06499697908120862	6.493158432908479e-07	0.15239049438884805	210
hsa05163	Human cytomegalovirus infection	1	2.3355952612524574e-60	2.3355952612524574e-60	0.652910431590019	0.059387691525146356	5.730971722434382e-07	0.1348311302212533	217
hsa04625	C-type lectin receptor signaling pathway	1	6.300905905634698e-71	6.300905905634698e-71	0.6736900022167941	0.07046396390342442	2.6123406772704232e-05	0.1468327705682604	192
hsa05020	Prion disease	7	7.826218126806749e-30	1.338495574714571e-55	0.945052145136519	0.0578564197877551	7.073241252217884e-07	0.13847026514914182	205
hsa05224	Breast cancer	1	1.0972861228528864e-66	1.0972861228528864e-66	0.8560194816661827	0.08116332880947584	5.339642190932434e-08	0.17743092303128077	190
hsa04530	Tight junction	1	2.4924014854660547e-69	2.4924014854660547e-69	0.7816708577192549	0.15379922644521776	0.03234024355828405	0.2050960465394181	188
hsa05225	Hepatocellular carcinoma	2	2.0001647480276063e-31	1.9383562983755083e-38	0.89385019691749	0.08198248735209017	0.0003439470256018	0.16383616540271348	205
hsa05017	Spinocerebellar ataxia	1	4.88887630866162e-35	4.88887630866162e-35	0.652910431590019	0.07755400840201081	0.0094028271134812	0.13951095244807593	198
hsa05010	Alzheimer disease	1	1.7407821377748618e-55	1.7407821377748618e-55	0.945052145136519	0.05375478716110336	1.1850911671166248e-05	0.12741603076943828	213
hsa05200	Pathways in cancer	1	2.1963824282547284e-101	2.1963824282547284e-101	0.6871987250202681	0.061275010845965254	2.381376904175725e-07	0.14334382658685096	206
hsa05206	MicroRNAs in cancer	1	3.7903390706213376e-127	3.7903390706213376e-127	0.8661326318575439	0.20988208518789286	0.1069904964186367	0.2299232418977929	186
hsa04927	Cortisol synthesis and secretion	1	2.595312276525824e-34	2.595312276525824e-34	0.945052145136519	0.14878773694146655	0.0606937370650065	0.18283369758485826	237
hsa05170	Human immunodeficiency virus 1 infection	1	6.13896606565261e-60	6.13896606565261e-60	0.7043581584413251	0.061772940015480435	8.702827146749942e-06	0.13489257442903035	203
hsa04060	Cytokine-cytokine receptor interaction	1	1.05187162855752e-148	1.05187162855752e-148	0.8640389506066377	0.12670094987773448	0.0008436750737966	0.21947417862629062	184
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	7.829555757572299e-79	7.829555757572299e-79	0.7043581584413251	0.07385481833983165	8.676404055904668e-05	0.15473539638110034	206
hsa04210	Apoptosis	1	7.384902792136834e-68	7.384902792136834e-68	0.5010690274785042	0.06116257450125466	5.294919969511161e-05	0.11787053589143175	217
hsa05168	Herpes simplex virus 1 infection	1	2.392979329816736e-77	2.392979329816736e-77	0.89385019691749	0.08440875860331705	2.8412310027813878e-05	0.17282870705172354	194
hsa04071	Sphingolipid signaling pathway	6	6.369974479612296e-28	9.028120004867832e-61	0.5811340386463366	0.06686372469311494	1.4981823919039822e-05	0.14148704142281643	210
hsa05166	Human T-cell leukemia virus 1 infection	1	1.4892557176921237e-78	1.4892557176921237e-78	0.7790917039515327	0.045027729775033144	1.1438974603415073e-05	0.1124435976061454	208
hsa05161	Hepatitis B	1	3.337092426078769e-83	3.337092426078769e-83	0.8919968202060229	0.05352806742137389	8.201116302039678e-08	0.1383064249272002	198
hsa05160	Hepatitis C	1	5.76416306814465e-46	5.76416306814465e-46	0.89385019691749	0.09187941460892755	0.0001604349074534	0.18481487306780953	187
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	4.2713829890417614e-76	4.2713829890417614e-76	0.7015647054836872	0.050538489880769366	6.031922149243079e-08	0.12853978805958727	205
hsa05169	Epstein-Barr virus infection	2	6.061302784016378e-79	6.061302784016378e-79	0.7928981445558452	0.053091724903954376	2.632851926661135e-07	0.14393493638912638	195
hsa05012	Parkinson disease	4	4.199151222199867e-25	1.950585684082761e-46	0.7833046657784437	0.05924017251319164	1.1368042106980964e-05	0.13519530864108686	235
hsa05014	Amyotrophic lateral sclerosis	2	1.5418550994586697e-43	5.4629825037276655e-48	0.8560194816661827	0.09045340635816257	0.0035303032489315	0.15876309636883523	199
hsa05226	Gastric cancer	2	3.569408163935953e-47	1.106468807012411e-78	0.89385019691749	0.060660173369800216	2.187758113445115e-06	0.131359701261053	203
hsa05415	Diabetic cardiomyopathy	2	4.204144808634628e-35	3.365839395784888e-37	0.5865979353911017	0.04627380478222065	4.559205597434762e-06	0.10262830932347136	228
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	3.858102091853023e-46	3.858102091853023e-46	0.5699903529074454	0.051898336451924924	4.3089349717518385e-08	0.12048259198068864	201
hsa05203	Viral carcinogenesis	2	1.9161318007542965e-61	9.132783395030224e-69	0.57831161455909	0.04203172742018352	3.0262152735744163e-07	0.11654879292751058	204
hsa04979	Cholesterol metabolism	1	2.4436092999412928e-70	2.4436092999412928e-70	0.908880644520742	0.4514227243414972	0.5835703543636465	0.27034452644617163	176
hsa05202	Transcriptional misregulation in cancer	1	3.786117621392158e-115	3.786117621392158e-115	0.7043581584413251	0.06793444573816607	5.363389089770566e-05	0.14697065809897777	200
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	3.3107153559596297e-62	3.3107153559596297e-62	0.799861000607755	0.090090185679713	0.0001655040560957	0.17905428302499976	204
hsa05165	Human papillomavirus infection	1	4.050846751295165e-72	4.050846751295165e-72	0.7043581584413251	0.04483487686253795	1.651443342960368e-09	0.10915558588965041	209
hsa05164	Influenza A	1	7.231307550739112e-71	7.231307550739112e-71	0.7928981445558452	0.0782001660333497	5.008945974417511e-05	0.16497184374657364	202
hsa04613	Neutrophil extracellular trap formation	1	4.2151608028098916e-46	4.2151608028098916e-46	0.945052145136519	0.06499697908120862	6.493158432908479e-07	0.15239049438884805	210
hsa05163	Human cytomegalovirus infection	1	2.3355952612524574e-60	2.3355952612524574e-60	0.652910431590019	0.059387691525146356	5.730971722434382e-07	0.1348311302212533	217
hsa04625	C-type lectin receptor signaling pathway	1	6.300905905634698e-71	6.300905905634698e-71	0.6736900022167941	0.07046396390342442	2.6123406772704232e-05	0.1468327705682604	192
hsa05020	Prion disease	7	7.826218126806749e-30	1.338495574714571e-55	0.945052145136519	0.0578564197877551	7.073241252217884e-07	0.13847026514914182	205
hsa05224	Breast cancer	1	1.0972861228528864e-66	1.0972861228528864e-66	0.8560194816661827	0.08116332880947584	5.339642190932434e-08	0.17743092303128077	190
hsa04530	Tight junction	1	2.4924014854660547e-69	2.4924014854660547e-69	0.7816708577192549	0.15379922644521776	0.03234024355828405	0.2050960465394181	188
hsa05225	Hepatocellular carcinoma	2	2.0001647480276063e-31	1.9383562983755083e-38	0.89385019691749	0.08198248735209017	0.0003439470256018	0.16383616540271348	205
hsa05017	Spinocerebellar ataxia	1	4.88887630866162e-35	4.88887630866162e-35	0.652910431590019	0.07755400840201081	0.0094028271134812	0.13951095244807593	198
hsa05010	Alzheimer disease	1	1.7407821377748618e-55	1.7407821377748618e-55	0.945052145136519	0.05375478716110336	1.1850911671166248e-05	0.12741603076943828	213
hsa05200	Pathways in cancer	1	2.1963824282547284e-101	2.1963824282547284e-101	0.6871987250202681	0.061275010845965254	2.381376904175725e-07	0.14334382658685096	206
hsa05206	MicroRNAs in cancer	1	3.7903390706213376e-127	3.7903390706213376e-127	0.8661326318575439	0.20988208518789286	0.1069904964186367	0.2299232418977929	186
hsa04927	Cortisol synthesis and secretion	1	2.595312276525824e-34	2.595312276525824e-34	0.945052145136519	0.14878773694146655	0.0606937370650065	0.18283369758485826	237
hsa05170	Human immunodeficiency virus 1 infection	1	6.13896606565261e-60	6.13896606565261e-60	0.7043581584413251	0.061772940015480435	8.702827146749942e-06	0.13489257442903035	203
hsa04060	Cytokine-cytokine receptor interaction	1	1.05187162855752e-148	1.05187162855752e-148	0.8640389506066377	0.12670094987773448	0.0008436750737966	0.21947417862629062	184
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	7.829555757572299e-79	7.829555757572299e-79	0.7043581584413251	0.07385481833983165	8.676404055904668e-05	0.15473539638110034	206
hsa04210	Apoptosis	1	7.384902792136834e-68	7.384902792136834e-68	0.5010690274785042	0.06116257450125466	5.294919969511161e-05	0.11787053589143175	217
hsa05168	Herpes simplex virus 1 infection	1	2.392979329816736e-77	2.392979329816736e-77	0.89385019691749	0.08440875860331705	2.8412310027813878e-05	0.17282870705172354	194
hsa04071	Sphingolipid signaling pathway	6	6.369974479612296e-28	9.028120004867832e-61	0.5811340386463366	0.06686372469311494	1.4981823919039822e-05	0.14148704142281643	210
hsa05166	Human T-cell leukemia virus 1 infection	1	1.4892557176921237e-78	1.4892557176921237e-78	0.7790917039515327	0.045027729775033144	1.1438974603415073e-05	0.1124435976061454	208
hsa05161	Hepatitis B	1	3.337092426078769e-83	3.337092426078769e-83	0.8919968202060229	0.05352806742137389	8.201116302039678e-08	0.1383064249272002	198
hsa05160	Hepatitis C	1	5.76416306814465e-46	5.76416306814465e-46	0.89385019691749	0.09187941460892755	0.0001604349074534	0.18481487306780953	187
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	4.2713829890417614e-76	4.2713829890417614e-76	0.7015647054836872	0.050538489880769366	6.031922149243079e-08	0.12853978805958727	205
hsa05169	Epstein-Barr virus infection	2	6.061302784016378e-79	6.061302784016378e-79	0.7928981445558452	0.053091724903954376	2.632851926661135e-07	0.14393493638912638	195
hsa05012	Parkinson disease	4	4.199151222199867e-25	1.950585684082761e-46	0.7833046657784437	0.05924017251319164	1.1368042106980964e-05	0.13519530864108686	235
hsa05014	Amyotrophic lateral sclerosis	2	1.5418550994586697e-43	5.4629825037276655e-48	0.8560194816661827	0.09045340635816257	0.0035303032489315	0.15876309636883523	199
hsa05226	Gastric cancer	2	3.569408163935953e-47	1.106468807012411e-78	0.89385019691749	0.060660173369800216	2.187758113445115e-06	0.131359701261053	203
hsa05415	Diabetic cardiomyopathy	2	4.204144808634628e-35	3.365839395784888e-37	0.5865979353911017	0.04627380478222065	4.559205597434762e-06	0.10262830932347136	228
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	3.858102091853023e-46	3.858102091853023e-46	0.5699903529074454	0.051898336451924924	4.3089349717518385e-08	0.12048259198068864	201
hsa05203	Viral carcinogenesis	2	1.9161318007542965e-61	9.132783395030224e-69	0.57831161455909	0.04203172742018352	3.0262152735744163e-07	0.11654879292751058	204
hsa04979	Cholesterol metabolism	1	2.4436092999412928e-70	2.4436092999412928e-70	0.908880644520742	0.4514227243414972	0.5835703543636465	0.27034452644617163	176
hsa05202	Transcriptional misregulation in cancer	1	3.786117621392158e-115	3.786117621392158e-115	0.7043581584413251	0.06793444573816607	5.363389089770566e-05	0.14697065809897777	200
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	3.3107153559596297e-62	3.3107153559596297e-62	0.799861000607755	0.090090185679713	0.0001655040560957	0.17905428302499976	204
hsa05165	Human papillomavirus infection	1	4.050846751295165e-72	4.050846751295165e-72	0.7043581584413251	0.04483487686253795	1.651443342960368e-09	0.10915558588965041	209
hsa05164	Influenza A	1	7.231307550739112e-71	7.231307550739112e-71	0.7928981445558452	0.0782001660333497	5.008945974417511e-05	0.16497184374657364	202
hsa04613	Neutrophil extracellular trap formation	1	4.2151608028098916e-46	4.2151608028098916e-46	0.945052145136519	0.06499697908120862	6.493158432908479e-07	0.15239049438884805	210
hsa05163	Human cytomegalovirus infection	1	2.3355952612524574e-60	2.3355952612524574e-60	0.652910431590019	0.059387691525146356	5.730971722434382e-07	0.1348311302212533	217
hsa04625	C-type lectin receptor signaling pathway	1	6.300905905634698e-71	6.300905905634698e-71	0.6736900022167941	0.07046396390342442	2.6123406772704232e-05	0.1468327705682604	192
hsa05020	Prion disease	7	7.826218126806749e-30	1.338495574714571e-55	0.945052145136519	0.0578564197877551	7.073241252217884e-07	0.13847026514914182	205
hsa05224	Breast cancer	1	1.0972861228528864e-66	1.0972861228528864e-66	0.8560194816661827	0.08116332880947584	5.339642190932434e-08	0.17743092303128077	190
hsa04530	Tight junction	1	2.4924014854660547e-69	2.4924014854660547e-69	0.7816708577192549	0.15379922644521776	0.03234024355828405	0.2050960465394181	188
hsa05225	Hepatocellular carcinoma	2	2.0001647480276063e-31	1.9383562983755083e-38	0.89385019691749	0.08198248735209017	0.0003439470256018	0.16383616540271348	205
hsa05017	Spinocerebellar ataxia	1	4.88887630866162e-35	4.88887630866162e-35	0.652910431590019	0.07755400840201081	0.0094028271134812	0.13951095244807593	198
hsa05010	Alzheimer disease	1	1.7407821377748618e-55	1.7407821377748618e-55	0.945052145136519	0.05375478716110336	1.1850911671166248e-05	0.12741603076943828	213
hsa05200	Pathways in cancer	1	2.1963824282547284e-101	2.1963824282547284e-101	0.6871987250202681	0.061275010845965254	2.381376904175725e-07	0.14334382658685096	206
hsa05206	MicroRNAs in cancer	1	3.7903390706213376e-127	3.7903390706213376e-127	0.8661326318575439	0.20988208518789286	0.1069904964186367	0.2299232418977929	186
hsa04927	Cortisol synthesis and secretion	1	2.595312276525824e-34	2.595312276525824e-34	0.945052145136519	0.14878773694146655	0.0606937370650065	0.18283369758485826	237
hsa05170	Human immunodeficiency virus 1 infection	1	6.13896606565261e-60	6.13896606565261e-60	0.7043581584413251	0.061772940015480435	8.702827146749942e-06	0.13489257442903035	203
hsa04060	Cytokine-cytokine receptor interaction	1	1.05187162855752e-148	1.05187162855752e-148	0.8640389506066377	0.12670094987773448	0.0008436750737966	0.21947417862629062	184
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	7.829555757572299e-79	7.829555757572299e-79	0.7043581584413251	0.07385481833983165	8.676404055904668e-05	0.15473539638110034	206
hsa04210	Apoptosis	1	7.384902792136834e-68	7.384902792136834e-68	0.5010690274785042	0.06116257450125466	5.294919969511161e-05	0.11787053589143175	217
hsa05168	Herpes simplex virus 1 infection	1	2.392979329816736e-77	2.392979329816736e-77	0.89385019691749	0.08440875860331705	2.8412310027813878e-05	0.17282870705172354	194
hsa04071	Sphingolipid signaling pathway	6	6.369974479612296e-28	9.028120004867832e-61	0.5811340386463366	0.06686372469311494	1.4981823919039822e-05	0.14148704142281643	210
hsa05166	Human T-cell leukemia virus 1 infection	1	1.4892557176921237e-78	1.4892557176921237e-78	0.7790917039515327	0.045027729775033144	1.1438974603415073e-05	0.1124435976061454	208
hsa05161	Hepatitis B	1	3.337092426078769e-83	3.337092426078769e-83	0.8919968202060229	0.05352806742137389	8.201116302039678e-08	0.1383064249272002	198
hsa05160	Hepatitis C	1	5.76416306814465e-46	5.76416306814465e-46	0.89385019691749	0.09187941460892755	0.0001604349074534	0.18481487306780953	187
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	4.2713829890417614e-76	4.2713829890417614e-76	0.7015647054836872	0.050538489880769366	6.031922149243079e-08	0.12853978805958727	205
hsa05169	Epstein-Barr virus infection	2	6.061302784016378e-79	6.061302784016378e-79	0.7928981445558452	0.053091724903954376	2.632851926661135e-07	0.14393493638912638	195
hsa05012	Parkinson disease	4	4.199151222199867e-25	1.950585684082761e-46	0.7833046657784437	0.05924017251319164	1.1368042106980964e-05	0.13519530864108686	235
hsa05014	Amyotrophic lateral sclerosis	2	1.5418550994586697e-43	5.4629825037276655e-48	0.8560194816661827	0.09045340635816257	0.0035303032489315	0.15876309636883523	199
hsa05226	Gastric cancer	2	3.569408163935953e-47	1.106468807012411e-78	0.89385019691749	0.060660173369800216	2.187758113445115e-06	0.131359701261053	203
hsa05415	Diabetic cardiomyopathy	2	4.204144808634628e-35	3.365839395784888e-37	0.5865979353911017	0.04627380478222065	4.559205597434762e-06	0.10262830932347136	228
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	3.858102091853023e-46	3.858102091853023e-46	0.5699903529074454	0.051898336451924924	4.3089349717518385e-08	0.12048259198068864	201
hsa05203	Viral carcinogenesis	2	1.9161318007542965e-61	9.132783395030224e-69	0.57831161455909	0.04203172742018352	3.0262152735744163e-07	0.11654879292751058	204
hsa04979	Cholesterol metabolism	1	2.4436092999412928e-70	2.4436092999412928e-70	0.908880644520742	0.4514227243414972	0.5835703543636465	0.27034452644617163	176
hsa05202	Transcriptional misregulation in cancer	1	3.786117621392158e-115	3.786117621392158e-115	0.7043581584413251	0.06793444573816607	5.363389089770566e-05	0.14697065809897777	200
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	3.3107153559596297e-62	3.3107153559596297e-62	0.799861000607755	0.090090185679713	0.0001655040560957	0.17905428302499976	204
hsa05165	Human papillomavirus infection	1	4.050846751295165e-72	4.050846751295165e-72	0.7043581584413251	0.04483487686253795	1.651443342960368e-09	0.10915558588965041	209
hsa05164	Influenza A	1	7.231307550739112e-71	7.231307550739112e-71	0.7928981445558452	0.0782001660333497	5.008945974417511e-05	0.16497184374657364	202
hsa04613	Neutrophil extracellular trap formation	1	4.2151608028098916e-46	4.2151608028098916e-46	0.945052145136519	0.06499697908120862	6.493158432908479e-07	0.15239049438884805	210
hsa05163	Human cytomegalovirus infection	1	2.3355952612524574e-60	2.3355952612524574e-60	0.652910431590019	0.059387691525146356	5.730971722434382e-07	0.1348311302212533	217
hsa04625	C-type lectin receptor signaling pathway	1	6.300905905634698e-71	6.300905905634698e-71	0.6736900022167941	0.07046396390342442	2.6123406772704232e-05	0.1468327705682604	192
hsa05020	Prion disease	7	7.826218126806749e-30	1.338495574714571e-55	0.945052145136519	0.0578564197877551	7.073241252217884e-07	0.13847026514914182	205
hsa05224	Breast cancer	1	1.0972861228528864e-66	1.0972861228528864e-66	0.8560194816661827	0.08116332880947584	5.339642190932434e-08	0.17743092303128077	190
hsa04530	Tight junction	1	2.4924014854660547e-69	2.4924014854660547e-69	0.7816708577192549	0.15379922644521776	0.03234024355828405	0.2050960465394181	188
hsa05225	Hepatocellular carcinoma	2	2.0001647480276063e-31	1.9383562983755083e-38	0.89385019691749	0.08198248735209017	0.0003439470256018	0.16383616540271348	205
hsa05017	Spinocerebellar ataxia	1	4.88887630866162e-35	4.88887630866162e-35	0.652910431590019	0.07755400840201081	0.0094028271134812	0.13951095244807593	198
hsa05010	Alzheimer disease	1	1.7407821377748618e-55	1.7407821377748618e-55	0.945052145136519	0.05375478716110336	1.1850911671166248e-05	0.12741603076943828	213
hsa05200	Pathways in cancer	1	2.1963824282547284e-101	2.1963824282547284e-101	0.6871987250202681	0.061275010845965254	2.381376904175725e-07	0.14334382658685096	206
hsa05206	MicroRNAs in cancer	1	3.7903390706213376e-127	3.7903390706213376e-127	0.8661326318575439	0.20988208518789286	0.1069904964186367	0.2299232418977929	186
hsa04927	Cortisol synthesis and secretion	1	2.595312276525824e-34	2.595312276525824e-34	0.945052145136519	0.14878773694146655	0.0606937370650065	0.18283369758485826	237
hsa05170	Human immunodeficiency virus 1 infection	1	6.13896606565261e-60	6.13896606565261e-60	0.7043581584413251	0.061772940015480435	8.702827146749942e-06	0.13489257442903035	203
hsa04060	Cytokine-cytokine receptor interaction	1	1.05187162855752e-148	1.05187162855752e-148	0.8640389506066377	0.12670094987773448	0.0008436750737966	0.21947417862629062	184
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	7.829555757572299e-79	7.829555757572299e-79	0.7043581584413251	0.07385481833983165	8.676404055904668e-05	0.15473539638110034	206
hsa04210	Apoptosis	1	7.384902792136834e-68	7.384902792136834e-68	0.5010690274785042	0.06116257450125466	5.294919969511161e-05	0.11787053589143175	217
hsa05168	Herpes simplex virus 1 infection	1	2.392979329816736e-77	2.392979329816736e-77	0.89385019691749	0.08440875860331705	2.8412310027813878e-05	0.17282870705172354	194
hsa04071	Sphingolipid signaling pathway	6	6.369974479612296e-28	9.028120004867832e-61	0.5811340386463366	0.06686372469311494	1.4981823919039822e-05	0.14148704142281643	210
hsa05166	Human T-cell leukemia virus 1 infection	1	1.4892557176921237e-78	1.4892557176921237e-78	0.7790917039515327	0.045027729775033144	1.1438974603415073e-05	0.1124435976061454	208
hsa05161	Hepatitis B	1	3.337092426078769e-83	3.337092426078769e-83	0.8919968202060229	0.05352806742137389	8.201116302039678e-08	0.1383064249272002	198
hsa05160	Hepatitis C	1	5.76416306814465e-46	5.76416306814465e-46	0.89385019691749	0.09187941460892755	0.0001604349074534	0.18481487306780953	187
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	4.2713829890417614e-76	4.2713829890417614e-76	0.7015647054836872	0.050538489880769366	6.031922149243079e-08	0.12853978805958727	205
hsa05169	Epstein-Barr virus infection	2	6.061302784016378e-79	6.061302784016378e-79	0.7928981445558452	0.053091724903954376	2.632851926661135e-07	0.14393493638912638	195
hsa05012	Parkinson disease	4	4.199151222199867e-25	1.950585684082761e-46	0.7833046657784437	0.05924017251319164	1.1368042106980964e-05	0.13519530864108686	235
hsa05014	Amyotrophic lateral sclerosis	2	1.5418550994586697e-43	5.4629825037276655e-48	0.8560194816661827	0.09045340635816257	0.0035303032489315	0.15876309636883523	199
hsa05226	Gastric cancer	2	3.569408163935953e-47	1.106468807012411e-78	0.89385019691749	0.060660173369800216	2.187758113445115e-06	0.131359701261053	203
hsa05415	Diabetic cardiomyopathy	2	4.204144808634628e-35	3.365839395784888e-37	0.5865979353911017	0.04627380478222065	4.559205597434762e-06	0.10262830932347136	228
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	3.858102091853023e-46	3.858102091853023e-46	0.5699903529074454	0.051898336451924924	4.3089349717518385e-08	0.12048259198068864	201
hsa05203	Viral carcinogenesis	2	1.9161318007542965e-61	9.132783395030224e-69	0.57831161455909	0.04203172742018352	3.0262152735744163e-07	0.11654879292751058	204
hsa04979	Cholesterol metabolism	1	2.4436092999412928e-70	2.4436092999412928e-70	0.908880644520742	0.4514227243414972	0.5835703543636465	0.27034452644617163	176
hsa05202	Transcriptional misregulation in cancer	1	3.786117621392158e-115	3.786117621392158e-115	0.7043581584413251	0.06793444573816607	5.363389089770566e-05	0.14697065809897777	200
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	3.3107153559596297e-62	3.3107153559596297e-62	0.799861000607755	0.090090185679713	0.0001655040560957	0.17905428302499976	204
hsa05165	Human papillomavirus infection	1	4.050846751295165e-72	4.050846751295165e-72	0.7043581584413251	0.04483487686253795	1.651443342960368e-09	0.10915558588965041	209
hsa05164	Influenza A	1	7.231307550739112e-71	7.231307550739112e-71	0.7928981445558452	0.0782001660333497	5.008945974417511e-05	0.16497184374657364	202
hsa04613	Neutrophil extracellular trap formation	1	4.2151608028098916e-46	4.2151608028098916e-46	0.945052145136519	0.06499697908120862	6.493158432908479e-07	0.15239049438884805	210
hsa05163	Human cytomegalovirus infection	1	2.3355952612524574e-60	2.3355952612524574e-60	0.652910431590019	0.059387691525146356	5.730971722434382e-07	0.1348311302212533	217
hsa04625	C-type lectin receptor signaling pathway	1	6.300905905634698e-71	6.300905905634698e-71	0.6736900022167941	0.07046396390342442	2.6123406772704232e-05	0.1468327705682604	192
hsa05020	Prion disease	7	7.826218126806749e-30	1.338495574714571e-55	0.945052145136519	0.0578564197877551	7.073241252217884e-07	0.13847026514914182	205
hsa05224	Breast cancer	1	1.0972861228528864e-66	1.0972861228528864e-66	0.8560194816661827	0.08116332880947584	5.339642190932434e-08	0.17743092303128077	190
hsa04530	Tight junction	1	2.4924014854660547e-69	2.4924014854660547e-69	0.7816708577192549	0.15379922644521776	0.03234024355828405	0.2050960465394181	188
hsa05225	Hepatocellular carcinoma	2	2.0001647480276063e-31	1.9383562983755083e-38	0.89385019691749	0.08198248735209017	0.0003439470256018	0.16383616540271348	205
hsa05017	Spinocerebellar ataxia	1	4.88887630866162e-35	4.88887630866162e-35	0.652910431590019	0.07755400840201081	0.0094028271134812	0.13951095244807593	198
hsa05010	Alzheimer disease	1	1.7407821377748618e-55	1.7407821377748618e-55	0.945052145136519	0.05375478716110336	1.1850911671166248e-05	0.12741603076943828	213
hsa05200	Pathways in cancer	1	2.1963824282547284e-101	2.1963824282547284e-101	0.6871987250202681	0.061275010845965254	2.381376904175725e-07	0.14334382658685096	206
hsa05206	MicroRNAs in cancer	1	3.7903390706213376e-127	3.7903390706213376e-127	0.8661326318575439	0.20988208518789286	0.1069904964186367	0.2299232418977929	186
hsa04927	Cortisol synthesis and secretion	1	2.595312276525824e-34	2.595312276525824e-34	0.945052145136519	0.14878773694146655	0.0606937370650065	0.18283369758485826	237
hsa05170	Human immunodeficiency virus 1 infection	1	6.13896606565261e-60	6.13896606565261e-60	0.7043581584413251	0.061772940015480435	8.702827146749942e-06	0.13489257442903035	203
hsa04060	Cytokine-cytokine receptor interaction	1	1.05187162855752e-148	1.05187162855752e-148	0.8640389506066377	0.12670094987773448	0.0008436750737966	0.21947417862629062	184
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	7.829555757572299e-79	7.829555757572299e-79	0.7043581584413251	0.07385481833983165	8.676404055904668e-05	0.15473539638110034	206
hsa04210	Apoptosis	1	7.384902792136834e-68	7.384902792136834e-68	0.5010690274785042	0.06116257450125466	5.294919969511161e-05	0.11787053589143175	217
hsa05168	Herpes simplex virus 1 infection	1	2.392979329816736e-77	2.392979329816736e-77	0.89385019691749	0.08440875860331705	2.8412310027813878e-05	0.17282870705172354	194
hsa04071	Sphingolipid signaling pathway	6	6.369974479612296e-28	9.028120004867832e-61	0.5811340386463366	0.06686372469311494	1.4981823919039822e-05	0.14148704142281643	210
hsa05166	Human T-cell leukemia virus 1 infection	1	1.4892557176921237e-78	1.4892557176921237e-78	0.7790917039515327	0.045027729775033144	1.1438974603415073e-05	0.1124435976061454	208
hsa05161	Hepatitis B	1	3.337092426078769e-83	3.337092426078769e-83	0.8919968202060229	0.05352806742137389	8.201116302039678e-08	0.1383064249272002	198
hsa05160	Hepatitis C	1	5.76416306814465e-46	5.76416306814465e-46	0.89385019691749	0.09187941460892755	0.0001604349074534	0.18481487306780953	187
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	4.2713829890417614e-76	4.2713829890417614e-76	0.7015647054836872	0.050538489880769366	6.031922149243079e-08	0.12853978805958727	205
hsa05169	Epstein-Barr virus infection	2	6.061302784016378e-79	6.061302784016378e-79	0.7928981445558452	0.053091724903954376	2.632851926661135e-07	0.14393493638912638	195
hsa05012	Parkinson disease	4	4.199151222199867e-25	1.950585684082761e-46	0.7833046657784437	0.05924017251319164	1.1368042106980964e-05	0.13519530864108686	235
hsa05014	Amyotrophic lateral sclerosis	2	1.5418550994586697e-43	5.4629825037276655e-48	0.8560194816661827	0.09045340635816257	0.0035303032489315	0.15876309636883523	199
hsa05226	Gastric cancer	2	3.569408163935953e-47	1.106468807012411e-78	0.89385019691749	0.060660173369800216	2.187758113445115e-06	0.131359701261053	203
hsa05415	Diabetic cardiomyopathy	2	4.204144808634628e-35	3.365839395784888e-37	0.5865979353911017	0.04627380478222065	4.559205597434762e-06	0.10262830932347136	228
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	3.858102091853023e-46	3.858102091853023e-46	0.5699903529074454	0.051898336451924924	4.3089349717518385e-08	0.12048259198068864	201
hsa05203	Viral carcinogenesis	2	1.9161318007542965e-61	9.132783395030224e-69	0.57831161455909	0.04203172742018352	3.0262152735744163e-07	0.11654879292751058	204
hsa04979	Cholesterol metabolism	1	2.4436092999412928e-70	2.4436092999412928e-70	0.908880644520742	0.4514227243414972	0.5835703543636465	0.27034452644617163	176
hsa05202	Transcriptional misregulation in cancer	1	3.786117621392158e-115	3.786117621392158e-115	0.7043581584413251	0.06793444573816607	5.363389089770566e-05	0.14697065809897777	200
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	3.3107153559596297e-62	3.3107153559596297e-62	0.799861000607755	0.090090185679713	0.0001655040560957	0.17905428302499976	204
hsa05165	Human papillomavirus infection	1	4.050846751295165e-72	4.050846751295165e-72	0.7043581584413251	0.04483487686253795	1.651443342960368e-09	0.10915558588965041	209
hsa05164	Influenza A	1	7.231307550739112e-71	7.231307550739112e-71	0.7928981445558452	0.0782001660333497	5.008945974417511e-05	0.16497184374657364	202
hsa04613	Neutrophil extracellular trap formation	1	4.2151608028098916e-46	4.2151608028098916e-46	0.945052145136519	0.06499697908120862	6.493158432908479e-07	0.15239049438884805	210
hsa05163	Human cytomegalovirus infection	1	2.3355952612524574e-60	2.3355952612524574e-60	0.652910431590019	0.059387691525146356	5.730971722434382e-07	0.1348311302212533	217
hsa04625	C-type lectin receptor signaling pathway	1	6.300905905634698e-71	6.300905905634698e-71	0.6736900022167941	0.07046396390342442	2.6123406772704232e-05	0.1468327705682604	192
hsa05020	Prion disease	7	7.826218126806749e-30	1.338495574714571e-55	0.945052145136519	0.0578564197877551	7.073241252217884e-07	0.13847026514914182	205
hsa05224	Breast cancer	1	1.0972861228528864e-66	1.0972861228528864e-66	0.8560194816661827	0.08116332880947584	5.339642190932434e-08	0.17743092303128077	190
hsa04530	Tight junction	1	2.4924014854660547e-69	2.4924014854660547e-69	0.7816708577192549	0.15379922644521776	0.03234024355828405	0.2050960465394181	188
hsa05225	Hepatocellular carcinoma	2	2.0001647480276063e-31	1.9383562983755083e-38	0.89385019691749	0.08198248735209017	0.0003439470256018	0.16383616540271348	205
hsa05017	Spinocerebellar ataxia	1	4.88887630866162e-35	4.88887630866162e-35	0.652910431590019	0.07755400840201081	0.0094028271134812	0.13951095244807593	198
hsa05010	Alzheimer disease	1	1.7407821377748618e-55	1.7407821377748618e-55	0.945052145136519	0.05375478716110336	1.1850911671166248e-05	0.12741603076943828	213
hsa05200	Pathways in cancer	1	2.1963824282547284e-101	2.1963824282547284e-101	0.6871987250202681	0.061275010845965254	2.381376904175725e-07	0.14334382658685096	206
hsa05206	MicroRNAs in cancer	1	3.7903390706213376e-127	3.7903390706213376e-127	0.8661326318575439	0.20988208518789286	0.1069904964186367	0.2299232418977929	186
hsa04927	Cortisol synthesis and secretion	1	2.595312276525824e-34	2.595312276525824e-34	0.945052145136519	0.14878773694146655	0.0606937370650065	0.18283369758485826	237
hsa05170	Human immunodeficiency virus 1 infection	1	6.13896606565261e-60	6.13896606565261e-60	0.7043581584413251	0.061772940015480435	8.702827146749942e-06	0.13489257442903035	203
hsa04060	Cytokine-cytokine receptor interaction	1	1.05187162855752e-148	1.05187162855752e-148	0.8640389506066377	0.12670094987773448	0.0008436750737966	0.21947417862629062	184
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	7.829555757572299e-79	7.829555757572299e-79	0.7043581584413251	0.07385481833983165	8.676404055904668e-05	0.15473539638110034	206
hsa04210	Apoptosis	1	7.384902792136834e-68	7.384902792136834e-68	0.5010690274785042	0.06116257450125466	5.294919969511161e-05	0.11787053589143175	217
hsa05168	Herpes simplex virus 1 infection	1	2.392979329816736e-77	2.392979329816736e-77	0.89385019691749	0.08440875860331705	2.8412310027813878e-05	0.17282870705172354	194
hsa04071	Sphingolipid signaling pathway	6	6.369974479612296e-28	9.028120004867832e-61	0.5811340386463366	0.06686372469311494	1.4981823919039822e-05	0.14148704142281643	210
hsa05166	Human T-cell leukemia virus 1 infection	1	1.4892557176921237e-78	1.4892557176921237e-78	0.7790917039515327	0.045027729775033144	1.1438974603415073e-05	0.1124435976061454	208
hsa05161	Hepatitis B	1	3.337092426078769e-83	3.337092426078769e-83	0.8919968202060229	0.05352806742137389	8.201116302039678e-08	0.1383064249272002	198
hsa05160	Hepatitis C	1	5.76416306814465e-46	5.76416306814465e-46	0.89385019691749	0.09187941460892755	0.0001604349074534	0.18481487306780953	187
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	4.2713829890417614e-76	4.2713829890417614e-76	0.7015647054836872	0.050538489880769366	6.031922149243079e-08	0.12853978805958727	205
hsa05169	Epstein-Barr virus infection	2	6.061302784016378e-79	6.061302784016378e-79	0.7928981445558452	0.053091724903954376	2.632851926661135e-07	0.14393493638912638	195
hsa05012	Parkinson disease	4	4.199151222199867e-25	1.950585684082761e-46	0.7833046657784437	0.05924017251319164	1.1368042106980964e-05	0.13519530864108686	235
hsa05014	Amyotrophic lateral sclerosis	2	1.5418550994586697e-43	5.4629825037276655e-48	0.8560194816661827	0.09045340635816257	0.0035303032489315	0.15876309636883523	199
hsa05226	Gastric cancer	2	3.569408163935953e-47	1.106468807012411e-78	0.89385019691749	0.060660173369800216	2.187758113445115e-06	0.131359701261053	203
hsa05415	Diabetic cardiomyopathy	2	4.204144808634628e-35	3.365839395784888e-37	0.5865979353911017	0.04627380478222065	4.559205597434762e-06	0.10262830932347136	228
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	3.858102091853023e-46	3.858102091853023e-46	0.5699903529074454	0.051898336451924924	4.3089349717518385e-08	0.12048259198068864	201
hsa05203	Viral carcinogenesis	2	1.9161318007542965e-61	9.132783395030224e-69	0.57831161455909	0.04203172742018352	3.0262152735744163e-07	0.11654879292751058	204
hsa04979	Cholesterol metabolism	1	2.4436092999412928e-70	2.4436092999412928e-70	0.908880644520742	0.4514227243414972	0.5835703543636465	0.27034452644617163	176
hsa05202	Transcriptional misregulation in cancer	1	3.786117621392158e-115	3.786117621392158e-115	0.7043581584413251	0.06793444573816607	5.363389089770566e-05	0.14697065809897777	200
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	3.3107153559596297e-62	3.3107153559596297e-62	0.799861000607755	0.090090185679713	0.0001655040560957	0.17905428302499976	204
hsa05165	Human papillomavirus infection	1	4.050846751295165e-72	4.050846751295165e-72	0.7043581584413251	0.04483487686253795	1.651443342960368e-09	0.10915558588965041	209
hsa05164	Influenza A	1	7.231307550739112e-71	7.231307550739112e-71	0.7928981445558452	0.0782001660333497	5.008945974417511e-05	0.16497184374657364	202
hsa04613	Neutrophil extracellular trap formation	1	4.2151608028098916e-46	4.2151608028098916e-46	0.945052145136519	0.06499697908120862	6.493158432908479e-07	0.15239049438884805	210
hsa05163	Human cytomegalovirus infection	1	2.3355952612524574e-60	2.3355952612524574e-60	0.652910431590019	0.059387691525146356	5.730971722434382e-07	0.1348311302212533	217
hsa04625	C-type lectin receptor signaling pathway	1	6.300905905634698e-71	6.300905905634698e-71	0.6736900022167941	0.07046396390342442	2.6123406772704232e-05	0.1468327705682604	192
hsa05020	Prion disease	7	7.826218126806749e-30	1.338495574714571e-55	0.945052145136519	0.0578564197877551	7.073241252217884e-07	0.13847026514914182	205
hsa05224	Breast cancer	1	1.0972861228528864e-66	1.0972861228528864e-66	0.8560194816661827	0.08116332880947584	5.339642190932434e-08	0.17743092303128077	190
hsa04530	Tight junction	1	2.4924014854660547e-69	2.4924014854660547e-69	0.7816708577192549	0.15379922644521776	0.03234024355828405	0.2050960465394181	188
hsa05225	Hepatocellular carcinoma	2	2.0001647480276063e-31	1.9383562983755083e-38	0.89385019691749	0.08198248735209017	0.0003439470256018	0.16383616540271348	205
hsa05017	Spinocerebellar ataxia	1	4.88887630866162e-35	4.88887630866162e-35	0.652910431590019	0.07755400840201081	0.0094028271134812	0.13951095244807593	198
hsa05010	Alzheimer disease	1	1.7407821377748618e-55	1.7407821377748618e-55	0.945052145136519	0.05375478716110336	1.1850911671166248e-05	0.12741603076943828	213
hsa05200	Pathways in cancer	1	2.1963824282547284e-101	2.1963824282547284e-101	0.6871987250202681	0.061275010845965254	2.381376904175725e-07	0.14334382658685096	206
hsa05206	MicroRNAs in cancer	1	3.7903390706213376e-127	3.7903390706213376e-127	0.8661326318575439	0.20988208518789286	0.1069904964186367	0.2299232418977929	186
hsa04927	Cortisol synthesis and secretion	1	2.595312276525824e-34	2.595312276525824e-34	0.945052145136519	0.14878773694146655	0.0606937370650065	0.18283369758485826	237
hsa05170	Human immunodeficiency virus 1 infection	1	6.13896606565261e-60	6.13896606565261e-60	0.7043581584413251	0.061772940015480435	8.702827146749942e-06	0.13489257442903035	203
hsa04060	Cytokine-cytokine receptor interaction	1	1.05187162855752e-148	1.05187162855752e-148	0.8640389506066377	0.12670094987773448	0.0008436750737966	0.21947417862629062	184
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	7.829555757572299e-79	7.829555757572299e-79	0.7043581584413251	0.07385481833983165	8.676404055904668e-05	0.15473539638110034	206
hsa04210	Apoptosis	1	7.384902792136834e-68	7.384902792136834e-68	0.5010690274785042	0.06116257450125466	5.294919969511161e-05	0.11787053589143175	217
hsa05168	Herpes simplex virus 1 infection	1	2.392979329816736e-77	2.392979329816736e-77	0.89385019691749	0.08440875860331705	2.8412310027813878e-05	0.17282870705172354	194
hsa04071	Sphingolipid signaling pathway	6	6.369974479612296e-28	9.028120004867832e-61	0.5811340386463366	0.06686372469311494	1.4981823919039822e-05	0.14148704142281643	210
hsa05166	Human T-cell leukemia virus 1 infection	1	1.4892557176921237e-78	1.4892557176921237e-78	0.7790917039515327	0.045027729775033144	1.1438974603415073e-05	0.1124435976061454	208
hsa05161	Hepatitis B	1	3.337092426078769e-83	3.337092426078769e-83	0.8919968202060229	0.05352806742137389	8.201116302039678e-08	0.1383064249272002	198
hsa05160	Hepatitis C	1	5.76416306814465e-46	5.76416306814465e-46	0.89385019691749	0.09187941460892755	0.0001604349074534	0.18481487306780953	187
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	4.2713829890417614e-76	4.2713829890417614e-76	0.7015647054836872	0.050538489880769366	6.031922149243079e-08	0.12853978805958727	205
hsa05169	Epstein-Barr virus infection	2	6.061302784016378e-79	6.061302784016378e-79	0.7928981445558452	0.053091724903954376	2.632851926661135e-07	0.14393493638912638	195
hsa05012	Parkinson disease	4	4.199151222199867e-25	1.950585684082761e-46	0.7833046657784437	0.05924017251319164	1.1368042106980964e-05	0.13519530864108686	235
hsa05014	Amyotrophic lateral sclerosis	2	1.5418550994586697e-43	5.4629825037276655e-48	0.8560194816661827	0.09045340635816257	0.0035303032489315	0.15876309636883523	199
hsa05226	Gastric cancer	2	3.569408163935953e-47	1.106468807012411e-78	0.89385019691749	0.060660173369800216	2.187758113445115e-06	0.131359701261053	203
hsa05415	Diabetic cardiomyopathy	2	4.204144808634628e-35	3.365839395784888e-37	0.5865979353911017	0.04627380478222065	4.559205597434762e-06	0.10262830932347136	228
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	3.858102091853023e-46	3.858102091853023e-46	0.5699903529074454	0.051898336451924924	4.3089349717518385e-08	0.12048259198068864	201
hsa05203	Viral carcinogenesis	2	1.9161318007542965e-61	9.132783395030224e-69	0.57831161455909	0.04203172742018352	3.0262152735744163e-07	0.11654879292751058	204
hsa04979	Cholesterol metabolism	1	2.4436092999412928e-70	2.4436092999412928e-70	0.908880644520742	0.4514227243414972	0.5835703543636465	0.27034452644617163	176
hsa05202	Transcriptional misregulation in cancer	1	3.786117621392158e-115	3.786117621392158e-115	0.7043581584413251	0.06793444573816607	5.363389089770566e-05	0.14697065809897777	200
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	3.3107153559596297e-62	3.3107153559596297e-62	0.799861000607755	0.090090185679713	0.0001655040560957	0.17905428302499976	204
hsa05165	Human papillomavirus infection	1	4.050846751295165e-72	4.050846751295165e-72	0.7043581584413251	0.04483487686253795	1.651443342960368e-09	0.10915558588965041	209
hsa05164	Influenza A	1	7.231307550739112e-71	7.231307550739112e-71	0.7928981445558452	0.0782001660333497	5.008945974417511e-05	0.16497184374657364	202
hsa04613	Neutrophil extracellular trap formation	1	4.2151608028098916e-46	4.2151608028098916e-46	0.945052145136519	0.06499697908120862	6.493158432908479e-07	0.15239049438884805	210
hsa05163	Human cytomegalovirus infection	1	2.3355952612524574e-60	2.3355952612524574e-60	0.652910431590019	0.059387691525146356	5.730971722434382e-07	0.1348311302212533	217
hsa04625	C-type lectin receptor signaling pathway	1	6.300905905634698e-71	6.300905905634698e-71	0.6736900022167941	0.07046396390342442	2.6123406772704232e-05	0.1468327705682604	192
hsa05020	Prion disease	7	7.826218126806749e-30	1.338495574714571e-55	0.945052145136519	0.0578564197877551	7.073241252217884e-07	0.13847026514914182	205
hsa05224	Breast cancer	1	1.0972861228528864e-66	1.0972861228528864e-66	0.8560194816661827	0.08116332880947584	5.339642190932434e-08	0.17743092303128077	190
hsa04530	Tight junction	1	2.4924014854660547e-69	2.4924014854660547e-69	0.7816708577192549	0.15379922644521776	0.03234024355828405	0.2050960465394181	188
hsa05225	Hepatocellular carcinoma	2	2.0001647480276063e-31	1.9383562983755083e-38	0.89385019691749	0.08198248735209017	0.0003439470256018	0.16383616540271348	205
hsa05017	Spinocerebellar ataxia	1	4.88887630866162e-35	4.88887630866162e-35	0.652910431590019	0.07755400840201081	0.0094028271134812	0.13951095244807593	198
hsa05010	Alzheimer disease	1	1.7407821377748618e-55	1.7407821377748618e-55	0.945052145136519	0.05375478716110336	1.1850911671166248e-05	0.12741603076943828	213
hsa05200	Pathways in cancer	1	2.1963824282547284e-101	2.1963824282547284e-101	0.6871987250202681	0.061275010845965254	2.381376904175725e-07	0.14334382658685096	206
hsa05206	MicroRNAs in cancer	1	3.7903390706213376e-127	3.7903390706213376e-127	0.8661326318575439	0.20988208518789286	0.1069904964186367	0.2299232418977929	186
hsa04927	Cortisol synthesis and secretion	1	2.595312276525824e-34	2.595312276525824e-34	0.945052145136519	0.14878773694146655	0.0606937370650065	0.18283369758485826	237
hsa05170	Human immunodeficiency virus 1 infection	1	6.13896606565261e-60	6.13896606565261e-60	0.7043581584413251	0.061772940015480435	8.702827146749942e-06	0.13489257442903035	203
hsa04060	Cytokine-cytokine receptor interaction	1	1.05187162855752e-148	1.05187162855752e-148	0.8640389506066377	0.12670094987773448	0.0008436750737966	0.21947417862629062	184
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	7.829555757572299e-79	7.829555757572299e-79	0.7043581584413251	0.07385481833983165	8.676404055904668e-05	0.15473539638110034	206
hsa04210	Apoptosis	1	7.384902792136834e-68	7.384902792136834e-68	0.5010690274785042	0.06116257450125466	5.294919969511161e-05	0.11787053589143175	217
hsa05168	Herpes simplex virus 1 infection	1	2.392979329816736e-77	2.392979329816736e-77	0.89385019691749	0.08440875860331705	2.8412310027813878e-05	0.17282870705172354	194
hsa04071	Sphingolipid signaling pathway	6	6.369974479612296e-28	9.028120004867832e-61	0.5811340386463366	0.06686372469311494	1.4981823919039822e-05	0.14148704142281643	210
hsa05166	Human T-cell leukemia virus 1 infection	1	1.4892557176921237e-78	1.4892557176921237e-78	0.7790917039515327	0.045027729775033144	1.1438974603415073e-05	0.1124435976061454	208
hsa05161	Hepatitis B	1	3.337092426078769e-83	3.337092426078769e-83	0.8919968202060229	0.05352806742137389	8.201116302039678e-08	0.1383064249272002	198
hsa05160	Hepatitis C	1	5.76416306814465e-46	5.76416306814465e-46	0.89385019691749	0.09187941460892755	0.0001604349074534	0.18481487306780953	187
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	4.2713829890417614e-76	4.2713829890417614e-76	0.7015647054836872	0.050538489880769366	6.031922149243079e-08	0.12853978805958727	205
hsa05169	Epstein-Barr virus infection	2	6.061302784016378e-79	6.061302784016378e-79	0.7928981445558452	0.053091724903954376	2.632851926661135e-07	0.14393493638912638	195
hsa05012	Parkinson disease	4	4.199151222199867e-25	1.950585684082761e-46	0.7833046657784437	0.05924017251319164	1.1368042106980964e-05	0.13519530864108686	235
hsa05014	Amyotrophic lateral sclerosis	2	1.5418550994586697e-43	5.4629825037276655e-48	0.8560194816661827	0.09045340635816257	0.0035303032489315	0.15876309636883523	199
hsa05226	Gastric cancer	2	3.569408163935953e-47	1.106468807012411e-78	0.89385019691749	0.060660173369800216	2.187758113445115e-06	0.131359701261053	203
hsa05415	Diabetic cardiomyopathy	2	4.204144808634628e-35	3.365839395784888e-37	0.5865979353911017	0.04627380478222065	4.559205597434762e-06	0.10262830932347136	228
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	3.858102091853023e-46	3.858102091853023e-46	0.5699903529074454	0.051898336451924924	4.3089349717518385e-08	0.12048259198068864	201
hsa05203	Viral carcinogenesis	2	1.9161318007542965e-61	9.132783395030224e-69	0.57831161455909	0.04203172742018352	3.0262152735744163e-07	0.11654879292751058	204
hsa04979	Cholesterol metabolism	1	2.4436092999412928e-70	2.4436092999412928e-70	0.908880644520742	0.4514227243414972	0.5835703543636465	0.27034452644617163	176
hsa05202	Transcriptional misregulation in cancer	1	3.786117621392158e-115	3.786117621392158e-115	0.7043581584413251	0.06793444573816607	5.363389089770566e-05	0.14697065809897777	200
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	3.3107153559596297e-62	3.3107153559596297e-62	0.799861000607755	0.090090185679713	0.0001655040560957	0.17905428302499976	204
hsa05165	Human papillomavirus infection	1	4.050846751295165e-72	4.050846751295165e-72	0.7043581584413251	0.04483487686253795	1.651443342960368e-09	0.10915558588965041	209
hsa05164	Influenza A	1	7.231307550739112e-71	7.231307550739112e-71	0.7928981445558452	0.0782001660333497	5.008945974417511e-05	0.16497184374657364	202
hsa04613	Neutrophil extracellular trap formation	1	4.2151608028098916e-46	4.2151608028098916e-46	0.945052145136519	0.06499697908120862	6.493158432908479e-07	0.15239049438884805	210
hsa05163	Human cytomegalovirus infection	1	2.3355952612524574e-60	2.3355952612524574e-60	0.652910431590019	0.059387691525146356	5.730971722434382e-07	0.1348311302212533	217
hsa04625	C-type lectin receptor signaling pathway	1	6.300905905634698e-71	6.300905905634698e-71	0.6736900022167941	0.07046396390342442	2.6123406772704232e-05	0.1468327705682604	192
hsa05020	Prion disease	7	7.826218126806749e-30	1.338495574714571e-55	0.945052145136519	0.0578564197877551	7.073241252217884e-07	0.13847026514914182	205
hsa05224	Breast cancer	1	1.0972861228528864e-66	1.0972861228528864e-66	0.8560194816661827	0.08116332880947584	5.339642190932434e-08	0.17743092303128077	190
hsa04530	Tight junction	1	2.4924014854660547e-69	2.4924014854660547e-69	0.7816708577192549	0.15379922644521776	0.03234024355828405	0.2050960465394181	188
hsa05225	Hepatocellular carcinoma	2	2.0001647480276063e-31	1.9383562983755083e-38	0.89385019691749	0.08198248735209017	0.0003439470256018	0.16383616540271348	205
hsa05017	Spinocerebellar ataxia	1	4.88887630866162e-35	4.88887630866162e-35	0.652910431590019	0.07755400840201081	0.0094028271134812	0.13951095244807593	198
hsa05010	Alzheimer disease	1	1.7407821377748618e-55	1.7407821377748618e-55	0.945052145136519	0.05375478716110336	1.1850911671166248e-05	0.12741603076943828	213
hsa05200	Pathways in cancer	1	2.1963824282547284e-101	2.1963824282547284e-101	0.6871987250202681	0.061275010845965254	2.381376904175725e-07	0.14334382658685096	206
hsa05206	MicroRNAs in cancer	1	3.7903390706213376e-127	3.7903390706213376e-127	0.8661326318575439	0.20988208518789286	0.1069904964186367	0.2299232418977929	186
hsa04927	Cortisol synthesis and secretion	1	2.595312276525824e-34	2.595312276525824e-34	0.945052145136519	0.14878773694146655	0.0606937370650065	0.18283369758485826	237
hsa05170	Human immunodeficiency virus 1 infection	1	6.13896606565261e-60	6.13896606565261e-60	0.7043581584413251	0.061772940015480435	8.702827146749942e-06	0.13489257442903035	203
hsa04060	Cytokine-cytokine receptor interaction	1	1.05187162855752e-148	1.05187162855752e-148	0.8640389506066377	0.12670094987773448	0.0008436750737966	0.21947417862629062	184
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	7.829555757572299e-79	7.829555757572299e-79	0.7043581584413251	0.07385481833983165	8.676404055904668e-05	0.15473539638110034	206
hsa04210	Apoptosis	1	7.384902792136834e-68	7.384902792136834e-68	0.5010690274785042	0.06116257450125466	5.294919969511161e-05	0.11787053589143175	217
hsa05168	Herpes simplex virus 1 infection	1	2.392979329816736e-77	2.392979329816736e-77	0.89385019691749	0.08440875860331705	2.8412310027813878e-05	0.17282870705172354	194
hsa04071	Sphingolipid signaling pathway	6	6.369974479612296e-28	9.028120004867832e-61	0.5811340386463366	0.06686372469311494	1.4981823919039822e-05	0.14148704142281643	210
hsa05166	Human T-cell leukemia virus 1 infection	1	1.4892557176921237e-78	1.4892557176921237e-78	0.7790917039515327	0.045027729775033144	1.1438974603415073e-05	0.1124435976061454	208
hsa05161	Hepatitis B	1	3.337092426078769e-83	3.337092426078769e-83	0.8919968202060229	0.05352806742137389	8.201116302039678e-08	0.1383064249272002	198
hsa05160	Hepatitis C	1	5.76416306814465e-46	5.76416306814465e-46	0.89385019691749	0.09187941460892755	0.0001604349074534	0.18481487306780953	187
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	4.2713829890417614e-76	4.2713829890417614e-76	0.7015647054836872	0.050538489880769366	6.031922149243079e-08	0.12853978805958727	205
hsa05169	Epstein-Barr virus infection	2	6.061302784016378e-79	6.061302784016378e-79	0.7928981445558452	0.053091724903954376	2.632851926661135e-07	0.14393493638912638	195
hsa05012	Parkinson disease	4	4.199151222199867e-25	1.950585684082761e-46	0.7833046657784437	0.05924017251319164	1.1368042106980964e-05	0.13519530864108686	235
hsa05014	Amyotrophic lateral sclerosis	2	1.5418550994586697e-43	5.4629825037276655e-48	0.8560194816661827	0.09045340635816257	0.0035303032489315	0.15876309636883523	199
hsa05226	Gastric cancer	2	3.569408163935953e-47	1.106468807012411e-78	0.89385019691749	0.060660173369800216	2.187758113445115e-06	0.131359701261053	203
hsa05415	Diabetic cardiomyopathy	2	4.204144808634628e-35	3.365839395784888e-37	0.5865979353911017	0.04627380478222065	4.559205597434762e-06	0.10262830932347136	228
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	3.858102091853023e-46	3.858102091853023e-46	0.5699903529074454	0.051898336451924924	4.3089349717518385e-08	0.12048259198068864	201
hsa05203	Viral carcinogenesis	2	1.9161318007542965e-61	9.132783395030224e-69	0.57831161455909	0.04203172742018352	3.0262152735744163e-07	0.11654879292751058	204
hsa04979	Cholesterol metabolism	1	2.4436092999412928e-70	2.4436092999412928e-70	0.908880644520742	0.4514227243414972	0.5835703543636465	0.27034452644617163	176
hsa05202	Transcriptional misregulation in cancer	1	3.786117621392158e-115	3.786117621392158e-115	0.7043581584413251	0.06793444573816607	5.363389089770566e-05	0.14697065809897777	200
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	3.3107153559596297e-62	3.3107153559596297e-62	0.799861000607755	0.090090185679713	0.0001655040560957	0.17905428302499976	204
hsa05165	Human papillomavirus infection	1	4.050846751295165e-72	4.050846751295165e-72	0.7043581584413251	0.04483487686253795	1.651443342960368e-09	0.10915558588965041	209
hsa05164	Influenza A	1	7.231307550739112e-71	7.231307550739112e-71	0.7928981445558452	0.0782001660333497	5.008945974417511e-05	0.16497184374657364	202
hsa04613	Neutrophil extracellular trap formation	1	4.2151608028098916e-46	4.2151608028098916e-46	0.945052145136519	0.06499697908120862	6.493158432908479e-07	0.15239049438884805	210
hsa05163	Human cytomegalovirus infection	1	2.3355952612524574e-60	2.3355952612524574e-60	0.652910431590019	0.059387691525146356	5.730971722434382e-07	0.1348311302212533	217
hsa04625	C-type lectin receptor signaling pathway	1	6.300905905634698e-71	6.300905905634698e-71	0.6736900022167941	0.07046396390342442	2.6123406772704232e-05	0.1468327705682604	192
hsa05020	Prion disease	7	7.826218126806749e-30	1.338495574714571e-55	0.945052145136519	0.0578564197877551	7.073241252217884e-07	0.13847026514914182	205
hsa05224	Breast cancer	1	1.0972861228528864e-66	1.0972861228528864e-66	0.8560194816661827	0.08116332880947584	5.339642190932434e-08	0.17743092303128077	190
hsa04530	Tight junction	1	2.4924014854660547e-69	2.4924014854660547e-69	0.7816708577192549	0.15379922644521776	0.03234024355828405	0.2050960465394181	188
hsa05225	Hepatocellular carcinoma	2	2.0001647480276063e-31	1.9383562983755083e-38	0.89385019691749	0.08198248735209017	0.0003439470256018	0.16383616540271348	205
hsa05017	Spinocerebellar ataxia	1	4.88887630866162e-35	4.88887630866162e-35	0.652910431590019	0.07755400840201081	0.0094028271134812	0.13951095244807593	198
hsa05010	Alzheimer disease	1	1.7407821377748618e-55	1.7407821377748618e-55	0.945052145136519	0.05375478716110336	1.1850911671166248e-05	0.12741603076943828	213
hsa05200	Pathways in cancer	1	2.1963824282547284e-101	2.1963824282547284e-101	0.6871987250202681	0.061275010845965254	2.381376904175725e-07	0.14334382658685096	206
hsa05206	MicroRNAs in cancer	1	3.7903390706213376e-127	3.7903390706213376e-127	0.8661326318575439	0.20988208518789286	0.1069904964186367	0.2299232418977929	186
hsa04927	Cortisol synthesis and secretion	1	2.595312276525824e-34	2.595312276525824e-34	0.945052145136519	0.14878773694146655	0.0606937370650065	0.18283369758485826	237
hsa05170	Human immunodeficiency virus 1 infection	1	6.13896606565261e-60	6.13896606565261e-60	0.7043581584413251	0.061772940015480435	8.702827146749942e-06	0.13489257442903035	203
hsa04060	Cytokine-cytokine receptor interaction	1	1.05187162855752e-148	1.05187162855752e-148	0.8640389506066377	0.12670094987773448	0.0008436750737966	0.21947417862629062	184
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	7.829555757572299e-79	7.829555757572299e-79	0.7043581584413251	0.07385481833983165	8.676404055904668e-05	0.15473539638110034	206
hsa04210	Apoptosis	1	7.384902792136834e-68	7.384902792136834e-68	0.5010690274785042	0.06116257450125466	5.294919969511161e-05	0.11787053589143175	217
hsa05168	Herpes simplex virus 1 infection	1	2.392979329816736e-77	2.392979329816736e-77	0.89385019691749	0.08440875860331705	2.8412310027813878e-05	0.17282870705172354	194
hsa04071	Sphingolipid signaling pathway	6	6.369974479612296e-28	9.028120004867832e-61	0.5811340386463366	0.06686372469311494	1.4981823919039822e-05	0.14148704142281643	210
hsa05166	Human T-cell leukemia virus 1 infection	1	1.4892557176921237e-78	1.4892557176921237e-78	0.7790917039515327	0.045027729775033144	1.1438974603415073e-05	0.1124435976061454	208
hsa05161	Hepatitis B	1	3.337092426078769e-83	3.337092426078769e-83	0.8919968202060229	0.05352806742137389	8.201116302039678e-08	0.1383064249272002	198
hsa05160	Hepatitis C	1	5.76416306814465e-46	5.76416306814465e-46	0.89385019691749	0.09187941460892755	0.0001604349074534	0.18481487306780953	187
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	4.2713829890417614e-76	4.2713829890417614e-76	0.7015647054836872	0.050538489880769366	6.031922149243079e-08	0.12853978805958727	205
hsa05169	Epstein-Barr virus infection	2	6.061302784016378e-79	6.061302784016378e-79	0.7928981445558452	0.053091724903954376	2.632851926661135e-07	0.14393493638912638	195
hsa05012	Parkinson disease	4	4.199151222199867e-25	1.950585684082761e-46	0.7833046657784437	0.05924017251319164	1.1368042106980964e-05	0.13519530864108686	235
hsa05014	Amyotrophic lateral sclerosis	2	1.5418550994586697e-43	5.4629825037276655e-48	0.8560194816661827	0.09045340635816257	0.0035303032489315	0.15876309636883523	199
hsa05226	Gastric cancer	2	3.569408163935953e-47	1.106468807012411e-78	0.89385019691749	0.060660173369800216	2.187758113445115e-06	0.131359701261053	203
hsa05415	Diabetic cardiomyopathy	2	4.204144808634628e-35	3.365839395784888e-37	0.5865979353911017	0.04627380478222065	4.559205597434762e-06	0.10262830932347136	228
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	3.858102091853023e-46	3.858102091853023e-46	0.5699903529074454	0.051898336451924924	4.3089349717518385e-08	0.12048259198068864	201
hsa05203	Viral carcinogenesis	2	1.9161318007542965e-61	9.132783395030224e-69	0.57831161455909	0.04203172742018352	3.0262152735744163e-07	0.11654879292751058	204
hsa04979	Cholesterol metabolism	1	2.4436092999412928e-70	2.4436092999412928e-70	0.908880644520742	0.4514227243414972	0.5835703543636465	0.27034452644617163	176
hsa05202	Transcriptional misregulation in cancer	1	3.786117621392158e-115	3.786117621392158e-115	0.7043581584413251	0.06793444573816607	5.363389089770566e-05	0.14697065809897777	200
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	3.3107153559596297e-62	3.3107153559596297e-62	0.799861000607755	0.090090185679713	0.0001655040560957	0.17905428302499976	204
hsa05165	Human papillomavirus infection	1	4.050846751295165e-72	4.050846751295165e-72	0.7043581584413251	0.04483487686253795	1.651443342960368e-09	0.10915558588965041	209
hsa05164	Influenza A	1	7.231307550739112e-71	7.231307550739112e-71	0.7928981445558452	0.0782001660333497	5.008945974417511e-05	0.16497184374657364	202
hsa04613	Neutrophil extracellular trap formation	1	4.2151608028098916e-46	4.2151608028098916e-46	0.945052145136519	0.06499697908120862	6.493158432908479e-07	0.15239049438884805	210
hsa05163	Human cytomegalovirus infection	1	2.3355952612524574e-60	2.3355952612524574e-60	0.652910431590019	0.059387691525146356	5.730971722434382e-07	0.1348311302212533	217
hsa04625	C-type lectin receptor signaling pathway	1	6.300905905634698e-71	6.300905905634698e-71	0.6736900022167941	0.07046396390342442	2.6123406772704232e-05	0.1468327705682604	192
hsa05020	Prion disease	7	7.826218126806749e-30	1.338495574714571e-55	0.945052145136519	0.0578564197877551	7.073241252217884e-07	0.13847026514914182	205
hsa05224	Breast cancer	1	1.0972861228528864e-66	1.0972861228528864e-66	0.8560194816661827	0.08116332880947584	5.339642190932434e-08	0.17743092303128077	190
hsa04530	Tight junction	1	2.4924014854660547e-69	2.4924014854660547e-69	0.7816708577192549	0.15379922644521776	0.03234024355828405	0.2050960465394181	188
hsa05225	Hepatocellular carcinoma	2	2.0001647480276063e-31	1.9383562983755083e-38	0.89385019691749	0.08198248735209017	0.0003439470256018	0.16383616540271348	205
hsa05017	Spinocerebellar ataxia	1	4.88887630866162e-35	4.88887630866162e-35	0.652910431590019	0.07755400840201081	0.0094028271134812	0.13951095244807593	198
hsa05010	Alzheimer disease	1	1.7407821377748618e-55	1.7407821377748618e-55	0.945052145136519	0.05375478716110336	1.1850911671166248e-05	0.12741603076943828	213
hsa05200	Pathways in cancer	1	2.1963824282547284e-101	2.1963824282547284e-101	0.6871987250202681	0.061275010845965254	2.381376904175725e-07	0.14334382658685096	206
hsa05206	MicroRNAs in cancer	1	3.7903390706213376e-127	3.7903390706213376e-127	0.8661326318575439	0.20988208518789286	0.1069904964186367	0.2299232418977929	186
hsa04927	Cortisol synthesis and secretion	1	2.595312276525824e-34	2.595312276525824e-34	0.945052145136519	0.14878773694146655	0.0606937370650065	0.18283369758485826	237
hsa05170	Human immunodeficiency virus 1 infection	1	6.13896606565261e-60	6.13896606565261e-60	0.7043581584413251	0.061772940015480435	8.702827146749942e-06	0.13489257442903035	203
hsa04060	Cytokine-cytokine receptor interaction	1	1.05187162855752e-148	1.05187162855752e-148	0.8640389506066377	0.12670094987773448	0.0008436750737966	0.21947417862629062	184
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	7.829555757572299e-79	7.829555757572299e-79	0.7043581584413251	0.07385481833983165	8.676404055904668e-05	0.15473539638110034	206
hsa04210	Apoptosis	1	7.384902792136834e-68	7.384902792136834e-68	0.5010690274785042	0.06116257450125466	5.294919969511161e-05	0.11787053589143175	217
hsa05168	Herpes simplex virus 1 infection	1	2.392979329816736e-77	2.392979329816736e-77	0.89385019691749	0.08440875860331705	2.8412310027813878e-05	0.17282870705172354	194
hsa04071	Sphingolipid signaling pathway	6	6.369974479612296e-28	9.028120004867832e-61	0.5811340386463366	0.06686372469311494	1.4981823919039822e-05	0.14148704142281643	210
hsa05166	Human T-cell leukemia virus 1 infection	1	1.4892557176921237e-78	1.4892557176921237e-78	0.7790917039515327	0.045027729775033144	1.1438974603415073e-05	0.1124435976061454	208
hsa05161	Hepatitis B	1	3.337092426078769e-83	3.337092426078769e-83	0.8919968202060229	0.05352806742137389	8.201116302039678e-08	0.1383064249272002	198
hsa05160	Hepatitis C	1	5.76416306814465e-46	5.76416306814465e-46	0.89385019691749	0.09187941460892755	0.0001604349074534	0.18481487306780953	187
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	4.2713829890417614e-76	4.2713829890417614e-76	0.7015647054836872	0.050538489880769366	6.031922149243079e-08	0.12853978805958727	205
hsa05169	Epstein-Barr virus infection	2	6.061302784016378e-79	6.061302784016378e-79	0.7928981445558452	0.053091724903954376	2.632851926661135e-07	0.14393493638912638	195
hsa05012	Parkinson disease	4	4.199151222199867e-25	1.950585684082761e-46	0.7833046657784437	0.05924017251319164	1.1368042106980964e-05	0.13519530864108686	235
hsa05014	Amyotrophic lateral sclerosis	2	1.5418550994586697e-43	5.4629825037276655e-48	0.8560194816661827	0.09045340635816257	0.0035303032489315	0.15876309636883523	199
hsa05226	Gastric cancer	2	3.569408163935953e-47	1.106468807012411e-78	0.89385019691749	0.060660173369800216	2.187758113445115e-06	0.131359701261053	203
hsa05415	Diabetic cardiomyopathy	2	4.204144808634628e-35	3.365839395784888e-37	0.5865979353911017	0.04627380478222065	4.559205597434762e-06	0.10262830932347136	228
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	3.858102091853023e-46	3.858102091853023e-46	0.5699903529074454	0.051898336451924924	4.3089349717518385e-08	0.12048259198068864	201
hsa05203	Viral carcinogenesis	2	1.9161318007542965e-61	9.132783395030224e-69	0.57831161455909	0.04203172742018352	3.0262152735744163e-07	0.11654879292751058	204
hsa04979	Cholesterol metabolism	1	2.4436092999412928e-70	2.4436092999412928e-70	0.908880644520742	0.4514227243414972	0.5835703543636465	0.27034452644617163	176
hsa05202	Transcriptional misregulation in cancer	1	3.786117621392158e-115	3.786117621392158e-115	0.7043581584413251	0.06793444573816607	5.363389089770566e-05	0.14697065809897777	200
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	3.3107153559596297e-62	3.3107153559596297e-62	0.799861000607755	0.090090185679713	0.0001655040560957	0.17905428302499976	204
hsa05165	Human papillomavirus infection	1	4.050846751295165e-72	4.050846751295165e-72	0.7043581584413251	0.04483487686253795	1.651443342960368e-09	0.10915558588965041	209
hsa05164	Influenza A	1	7.231307550739112e-71	7.231307550739112e-71	0.7928981445558452	0.0782001660333497	5.008945974417511e-05	0.16497184374657364	202
hsa04613	Neutrophil extracellular trap formation	1	4.2151608028098916e-46	4.2151608028098916e-46	0.945052145136519	0.06499697908120862	6.493158432908479e-07	0.15239049438884805	210
hsa05163	Human cytomegalovirus infection	1	2.3355952612524574e-60	2.3355952612524574e-60	0.652910431590019	0.059387691525146356	5.730971722434382e-07	0.1348311302212533	217
hsa04625	C-type lectin receptor signaling pathway	1	6.300905905634698e-71	6.300905905634698e-71	0.6736900022167941	0.07046396390342442	2.6123406772704232e-05	0.1468327705682604	192
hsa05020	Prion disease	7	7.826218126806749e-30	1.338495574714571e-55	0.945052145136519	0.0578564197877551	7.073241252217884e-07	0.13847026514914182	205
hsa05224	Breast cancer	1	1.0972861228528864e-66	1.0972861228528864e-66	0.8560194816661827	0.08116332880947584	5.339642190932434e-08	0.17743092303128077	190
hsa04530	Tight junction	1	2.4924014854660547e-69	2.4924014854660547e-69	0.7816708577192549	0.15379922644521776	0.03234024355828405	0.2050960465394181	188
hsa05225	Hepatocellular carcinoma	2	2.0001647480276063e-31	1.9383562983755083e-38	0.89385019691749	0.08198248735209017	0.0003439470256018	0.16383616540271348	205
hsa05017	Spinocerebellar ataxia	1	4.88887630866162e-35	4.88887630866162e-35	0.652910431590019	0.07755400840201081	0.0094028271134812	0.13951095244807593	198
hsa05010	Alzheimer disease	1	1.7407821377748618e-55	1.7407821377748618e-55	0.945052145136519	0.05375478716110336	1.1850911671166248e-05	0.12741603076943828	213
hsa05200	Pathways in cancer	1	2.1963824282547284e-101	2.1963824282547284e-101	0.6871987250202681	0.061275010845965254	2.381376904175725e-07	0.14334382658685096	206
hsa05206	MicroRNAs in cancer	1	3.7903390706213376e-127	3.7903390706213376e-127	0.8661326318575439	0.20988208518789286	0.1069904964186367	0.2299232418977929	186
hsa04927	Cortisol synthesis and secretion	1	2.595312276525824e-34	2.595312276525824e-34	0.945052145136519	0.14878773694146655	0.0606937370650065	0.18283369758485826	237
hsa05170	Human immunodeficiency virus 1 infection	1	6.13896606565261e-60	6.13896606565261e-60	0.7043581584413251	0.061772940015480435	8.702827146749942e-06	0.13489257442903035	203
hsa04060	Cytokine-cytokine receptor interaction	1	1.05187162855752e-148	1.05187162855752e-148	0.8640389506066377	0.12670094987773448	0.0008436750737966	0.21947417862629062	184
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	7.829555757572299e-79	7.829555757572299e-79	0.7043581584413251	0.07385481833983165	8.676404055904668e-05	0.15473539638110034	206
hsa04210	Apoptosis	1	7.384902792136834e-68	7.384902792136834e-68	0.5010690274785042	0.06116257450125466	5.294919969511161e-05	0.11787053589143175	217
hsa05168	Herpes simplex virus 1 infection	1	2.392979329816736e-77	2.392979329816736e-77	0.89385019691749	0.08440875860331705	2.8412310027813878e-05	0.17282870705172354	194
hsa04071	Sphingolipid signaling pathway	6	6.369974479612296e-28	9.028120004867832e-61	0.5811340386463366	0.06686372469311494	1.4981823919039822e-05	0.14148704142281643	210
hsa05166	Human T-cell leukemia virus 1 infection	1	1.4892557176921237e-78	1.4892557176921237e-78	0.7790917039515327	0.045027729775033144	1.1438974603415073e-05	0.1124435976061454	208
hsa05161	Hepatitis B	1	3.337092426078769e-83	3.337092426078769e-83	0.8919968202060229	0.05352806742137389	8.201116302039678e-08	0.1383064249272002	198
hsa05160	Hepatitis C	1	5.76416306814465e-46	5.76416306814465e-46	0.89385019691749	0.09187941460892755	0.0001604349074534	0.18481487306780953	187
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	4.2713829890417614e-76	4.2713829890417614e-76	0.7015647054836872	0.050538489880769366	6.031922149243079e-08	0.12853978805958727	205
hsa05169	Epstein-Barr virus infection	2	6.061302784016378e-79	6.061302784016378e-79	0.7928981445558452	0.053091724903954376	2.632851926661135e-07	0.14393493638912638	195
hsa05012	Parkinson disease	4	4.199151222199867e-25	1.950585684082761e-46	0.7833046657784437	0.05924017251319164	1.1368042106980964e-05	0.13519530864108686	235
hsa05014	Amyotrophic lateral sclerosis	2	1.5418550994586697e-43	5.4629825037276655e-48	0.8560194816661827	0.09045340635816257	0.0035303032489315	0.15876309636883523	199
hsa05226	Gastric cancer	2	3.569408163935953e-47	1.106468807012411e-78	0.89385019691749	0.060660173369800216	2.187758113445115e-06	0.131359701261053	203
hsa05415	Diabetic cardiomyopathy	2	4.204144808634628e-35	3.365839395784888e-37	0.5865979353911017	0.04627380478222065	4.559205597434762e-06	0.10262830932347136	228
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	3.858102091853023e-46	3.858102091853023e-46	0.5699903529074454	0.051898336451924924	4.3089349717518385e-08	0.12048259198068864	201
hsa05203	Viral carcinogenesis	2	1.9161318007542965e-61	9.132783395030224e-69	0.57831161455909	0.04203172742018352	3.0262152735744163e-07	0.11654879292751058	204
hsa04979	Cholesterol metabolism	1	2.4436092999412928e-70	2.4436092999412928e-70	0.908880644520742	0.4514227243414972	0.5835703543636465	0.27034452644617163	176
hsa05202	Transcriptional misregulation in cancer	1	3.786117621392158e-115	3.786117621392158e-115	0.7043581584413251	0.06793444573816607	5.363389089770566e-05	0.14697065809897777	200
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	3.3107153559596297e-62	3.3107153559596297e-62	0.799861000607755	0.090090185679713	0.0001655040560957	0.17905428302499976	204
hsa05165	Human papillomavirus infection	1	4.050846751295165e-72	4.050846751295165e-72	0.7043581584413251	0.04483487686253795	1.651443342960368e-09	0.10915558588965041	209
hsa05164	Influenza A	1	7.231307550739112e-71	7.231307550739112e-71	0.7928981445558452	0.0782001660333497	5.008945974417511e-05	0.16497184374657364	202
hsa04613	Neutrophil extracellular trap formation	1	4.2151608028098916e-46	4.2151608028098916e-46	0.945052145136519	0.06499697908120862	6.493158432908479e-07	0.15239049438884805	210
hsa05163	Human cytomegalovirus infection	1	2.3355952612524574e-60	2.3355952612524574e-60	0.652910431590019	0.059387691525146356	5.730971722434382e-07	0.1348311302212533	217
hsa04625	C-type lectin receptor signaling pathway	1	6.300905905634698e-71	6.300905905634698e-71	0.6736900022167941	0.07046396390342442	2.6123406772704232e-05	0.1468327705682604	192
hsa05020	Prion disease	7	7.826218126806749e-30	1.338495574714571e-55	0.945052145136519	0.0578564197877551	7.073241252217884e-07	0.13847026514914182	205
hsa05224	Breast cancer	1	1.0972861228528864e-66	1.0972861228528864e-66	0.8560194816661827	0.08116332880947584	5.339642190932434e-08	0.17743092303128077	190
hsa04530	Tight junction	1	2.4924014854660547e-69	2.4924014854660547e-69	0.7816708577192549	0.15379922644521776	0.03234024355828405	0.2050960465394181	188
hsa05225	Hepatocellular carcinoma	2	2.0001647480276063e-31	1.9383562983755083e-38	0.89385019691749	0.08198248735209017	0.0003439470256018	0.16383616540271348	205
hsa05017	Spinocerebellar ataxia	1	4.88887630866162e-35	4.88887630866162e-35	0.652910431590019	0.07755400840201081	0.0094028271134812	0.13951095244807593	198
hsa05010	Alzheimer disease	1	1.7407821377748618e-55	1.7407821377748618e-55	0.945052145136519	0.05375478716110336	1.1850911671166248e-05	0.12741603076943828	213
hsa05200	Pathways in cancer	1	2.1963824282547284e-101	2.1963824282547284e-101	0.6871987250202681	0.061275010845965254	2.381376904175725e-07	0.14334382658685096	206
hsa05206	MicroRNAs in cancer	1	3.7903390706213376e-127	3.7903390706213376e-127	0.8661326318575439	0.20988208518789286	0.1069904964186367	0.2299232418977929	186
hsa04927	Cortisol synthesis and secretion	1	2.595312276525824e-34	2.595312276525824e-34	0.945052145136519	0.14878773694146655	0.0606937370650065	0.18283369758485826	237
hsa05170	Human immunodeficiency virus 1 infection	1	6.13896606565261e-60	6.13896606565261e-60	0.7043581584413251	0.061772940015480435	8.702827146749942e-06	0.13489257442903035	203
hsa04060	Cytokine-cytokine receptor interaction	1	1.05187162855752e-148	1.05187162855752e-148	0.8640389506066377	0.12670094987773448	0.0008436750737966	0.21947417862629062	184
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	7.829555757572299e-79	7.829555757572299e-79	0.7043581584413251	0.07385481833983165	8.676404055904668e-05	0.15473539638110034	206
hsa04210	Apoptosis	1	7.384902792136834e-68	7.384902792136834e-68	0.5010690274785042	0.06116257450125466	5.294919969511161e-05	0.11787053589143175	217
hsa05168	Herpes simplex virus 1 infection	1	2.392979329816736e-77	2.392979329816736e-77	0.89385019691749	0.08440875860331705	2.8412310027813878e-05	0.17282870705172354	194
hsa04071	Sphingolipid signaling pathway	6	6.369974479612296e-28	9.028120004867832e-61	0.5811340386463366	0.06686372469311494	1.4981823919039822e-05	0.14148704142281643	210
hsa05166	Human T-cell leukemia virus 1 infection	1	1.4892557176921237e-78	1.4892557176921237e-78	0.7790917039515327	0.045027729775033144	1.1438974603415073e-05	0.1124435976061454	208
hsa05161	Hepatitis B	1	3.337092426078769e-83	3.337092426078769e-83	0.8919968202060229	0.05352806742137389	8.201116302039678e-08	0.1383064249272002	198
hsa05160	Hepatitis C	1	5.76416306814465e-46	5.76416306814465e-46	0.89385019691749	0.09187941460892755	0.0001604349074534	0.18481487306780953	187
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	4.2713829890417614e-76	4.2713829890417614e-76	0.7015647054836872	0.050538489880769366	6.031922149243079e-08	0.12853978805958727	205
hsa05169	Epstein-Barr virus infection	2	6.061302784016378e-79	6.061302784016378e-79	0.7928981445558452	0.053091724903954376	2.632851926661135e-07	0.14393493638912638	195
hsa05012	Parkinson disease	4	4.199151222199867e-25	1.950585684082761e-46	0.7833046657784437	0.05924017251319164	1.1368042106980964e-05	0.13519530864108686	235
hsa05014	Amyotrophic lateral sclerosis	2	1.5418550994586697e-43	5.4629825037276655e-48	0.8560194816661827	0.09045340635816257	0.0035303032489315	0.15876309636883523	199
hsa05226	Gastric cancer	2	3.569408163935953e-47	1.106468807012411e-78	0.89385019691749	0.060660173369800216	2.187758113445115e-06	0.131359701261053	203
hsa05415	Diabetic cardiomyopathy	2	4.204144808634628e-35	3.365839395784888e-37	0.5865979353911017	0.04627380478222065	4.559205597434762e-06	0.10262830932347136	228
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	3.858102091853023e-46	3.858102091853023e-46	0.5699903529074454	0.051898336451924924	4.3089349717518385e-08	0.12048259198068864	201
hsa05203	Viral carcinogenesis	2	1.9161318007542965e-61	9.132783395030224e-69	0.57831161455909	0.04203172742018352	3.0262152735744163e-07	0.11654879292751058	204
hsa04979	Cholesterol metabolism	1	2.4436092999412928e-70	2.4436092999412928e-70	0.908880644520742	0.4514227243414972	0.5835703543636465	0.27034452644617163	176
hsa05202	Transcriptional misregulation in cancer	1	3.786117621392158e-115	3.786117621392158e-115	0.7043581584413251	0.06793444573816607	5.363389089770566e-05	0.14697065809897777	200
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	3.3107153559596297e-62	3.3107153559596297e-62	0.799861000607755	0.090090185679713	0.0001655040560957	0.17905428302499976	204
hsa05165	Human papillomavirus infection	1	4.050846751295165e-72	4.050846751295165e-72	0.7043581584413251	0.04483487686253795	1.651443342960368e-09	0.10915558588965041	209
hsa05164	Influenza A	1	7.231307550739112e-71	7.231307550739112e-71	0.7928981445558452	0.0782001660333497	5.008945974417511e-05	0.16497184374657364	202
hsa04613	Neutrophil extracellular trap formation	1	4.2151608028098916e-46	4.2151608028098916e-46	0.945052145136519	0.06499697908120862	6.493158432908479e-07	0.15239049438884805	210
hsa05163	Human cytomegalovirus infection	1	2.3355952612524574e-60	2.3355952612524574e-60	0.652910431590019	0.059387691525146356	5.730971722434382e-07	0.1348311302212533	217
hsa04625	C-type lectin receptor signaling pathway	1	6.300905905634698e-71	6.300905905634698e-71	0.6736900022167941	0.07046396390342442	2.6123406772704232e-05	0.1468327705682604	192
hsa05020	Prion disease	7	7.826218126806749e-30	1.338495574714571e-55	0.945052145136519	0.0578564197877551	7.073241252217884e-07	0.13847026514914182	205
hsa05224	Breast cancer	1	1.0972861228528864e-66	1.0972861228528864e-66	0.8560194816661827	0.08116332880947584	5.339642190932434e-08	0.17743092303128077	190
hsa04530	Tight junction	1	2.4924014854660547e-69	2.4924014854660547e-69	0.7816708577192549	0.15379922644521776	0.03234024355828405	0.2050960465394181	188
hsa05225	Hepatocellular carcinoma	2	2.0001647480276063e-31	1.9383562983755083e-38	0.89385019691749	0.08198248735209017	0.0003439470256018	0.16383616540271348	205
hsa05017	Spinocerebellar ataxia	1	4.88887630866162e-35	4.88887630866162e-35	0.652910431590019	0.07755400840201081	0.0094028271134812	0.13951095244807593	198
hsa05010	Alzheimer disease	1	1.7407821377748618e-55	1.7407821377748618e-55	0.945052145136519	0.05375478716110336	1.1850911671166248e-05	0.12741603076943828	213
hsa05200	Pathways in cancer	1	2.1963824282547284e-101	2.1963824282547284e-101	0.6871987250202681	0.061275010845965254	2.381376904175725e-07	0.14334382658685096	206
hsa05206	MicroRNAs in cancer	1	3.7903390706213376e-127	3.7903390706213376e-127	0.8661326318575439	0.20988208518789286	0.1069904964186367	0.2299232418977929	186
hsa04927	Cortisol synthesis and secretion	1	2.595312276525824e-34	2.595312276525824e-34	0.945052145136519	0.14878773694146655	0.0606937370650065	0.18283369758485826	237
hsa05170	Human immunodeficiency virus 1 infection	1	6.13896606565261e-60	6.13896606565261e-60	0.7043581584413251	0.061772940015480435	8.702827146749942e-06	0.13489257442903035	203
hsa04060	Cytokine-cytokine receptor interaction	1	1.05187162855752e-148	1.05187162855752e-148	0.8640389506066377	0.12670094987773448	0.0008436750737966	0.21947417862629062	184
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	7.829555757572299e-79	7.829555757572299e-79	0.7043581584413251	0.07385481833983165	8.676404055904668e-05	0.15473539638110034	206
hsa04210	Apoptosis	1	7.384902792136834e-68	7.384902792136834e-68	0.5010690274785042	0.06116257450125466	5.294919969511161e-05	0.11787053589143175	217
hsa05168	Herpes simplex virus 1 infection	1	2.392979329816736e-77	2.392979329816736e-77	0.89385019691749	0.08440875860331705	2.8412310027813878e-05	0.17282870705172354	194
hsa04071	Sphingolipid signaling pathway	6	6.369974479612296e-28	9.028120004867832e-61	0.5811340386463366	0.06686372469311494	1.4981823919039822e-05	0.14148704142281643	210
hsa05166	Human T-cell leukemia virus 1 infection	1	1.4892557176921237e-78	1.4892557176921237e-78	0.7790917039515327	0.045027729775033144	1.1438974603415073e-05	0.1124435976061454	208
hsa05161	Hepatitis B	1	3.337092426078769e-83	3.337092426078769e-83	0.8919968202060229	0.05352806742137389	8.201116302039678e-08	0.1383064249272002	198
hsa05160	Hepatitis C	1	5.76416306814465e-46	5.76416306814465e-46	0.89385019691749	0.09187941460892755	0.0001604349074534	0.18481487306780953	187
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	4.2713829890417614e-76	4.2713829890417614e-76	0.7015647054836872	0.050538489880769366	6.031922149243079e-08	0.12853978805958727	205
hsa05169	Epstein-Barr virus infection	2	6.061302784016378e-79	6.061302784016378e-79	0.7928981445558452	0.053091724903954376	2.632851926661135e-07	0.14393493638912638	195
hsa05012	Parkinson disease	4	4.199151222199867e-25	1.950585684082761e-46	0.7833046657784437	0.05924017251319164	1.1368042106980964e-05	0.13519530864108686	235
hsa05014	Amyotrophic lateral sclerosis	2	1.5418550994586697e-43	5.4629825037276655e-48	0.8560194816661827	0.09045340635816257	0.0035303032489315	0.15876309636883523	199
hsa05226	Gastric cancer	2	3.569408163935953e-47	1.106468807012411e-78	0.89385019691749	0.060660173369800216	2.187758113445115e-06	0.131359701261053	203
hsa05415	Diabetic cardiomyopathy	2	4.204144808634628e-35	3.365839395784888e-37	0.5865979353911017	0.04627380478222065	4.559205597434762e-06	0.10262830932347136	228
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	3.858102091853023e-46	3.858102091853023e-46	0.5699903529074454	0.051898336451924924	4.3089349717518385e-08	0.12048259198068864	201
hsa05203	Viral carcinogenesis	2	1.9161318007542965e-61	9.132783395030224e-69	0.57831161455909	0.04203172742018352	3.0262152735744163e-07	0.11654879292751058	204
hsa04979	Cholesterol metabolism	1	2.4436092999412928e-70	2.4436092999412928e-70	0.908880644520742	0.4514227243414972	0.5835703543636465	0.27034452644617163	176
hsa05202	Transcriptional misregulation in cancer	1	3.786117621392158e-115	3.786117621392158e-115	0.7043581584413251	0.06793444573816607	5.363389089770566e-05	0.14697065809897777	200
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	3.3107153559596297e-62	3.3107153559596297e-62	0.799861000607755	0.090090185679713	0.0001655040560957	0.17905428302499976	204
hsa05165	Human papillomavirus infection	1	4.050846751295165e-72	4.050846751295165e-72	0.7043581584413251	0.04483487686253795	1.651443342960368e-09	0.10915558588965041	209
hsa05164	Influenza A	1	7.231307550739112e-71	7.231307550739112e-71	0.7928981445558452	0.0782001660333497	5.008945974417511e-05	0.16497184374657364	202
hsa04613	Neutrophil extracellular trap formation	1	4.2151608028098916e-46	4.2151608028098916e-46	0.945052145136519	0.06499697908120862	6.493158432908479e-07	0.15239049438884805	210
hsa05163	Human cytomegalovirus infection	1	2.3355952612524574e-60	2.3355952612524574e-60	0.652910431590019	0.059387691525146356	5.730971722434382e-07	0.1348311302212533	217
hsa04625	C-type lectin receptor signaling pathway	1	6.300905905634698e-71	6.300905905634698e-71	0.6736900022167941	0.07046396390342442	2.6123406772704232e-05	0.1468327705682604	192
hsa05020	Prion disease	7	7.826218126806749e-30	1.338495574714571e-55	0.945052145136519	0.0578564197877551	7.073241252217884e-07	0.13847026514914182	205
hsa05224	Breast cancer	1	1.0972861228528864e-66	1.0972861228528864e-66	0.8560194816661827	0.08116332880947584	5.339642190932434e-08	0.17743092303128077	190
hsa04530	Tight junction	1	2.4924014854660547e-69	2.4924014854660547e-69	0.7816708577192549	0.15379922644521776	0.03234024355828405	0.2050960465394181	188
hsa05225	Hepatocellular carcinoma	2	2.0001647480276063e-31	1.9383562983755083e-38	0.89385019691749	0.08198248735209017	0.0003439470256018	0.16383616540271348	205
hsa05017	Spinocerebellar ataxia	1	4.88887630866162e-35	4.88887630866162e-35	0.652910431590019	0.07755400840201081	0.0094028271134812	0.13951095244807593	198
hsa05010	Alzheimer disease	1	1.7407821377748618e-55	1.7407821377748618e-55	0.945052145136519	0.05375478716110336	1.1850911671166248e-05	0.12741603076943828	213
hsa05200	Pathways in cancer	1	2.1963824282547284e-101	2.1963824282547284e-101	0.6871987250202681	0.061275010845965254	2.381376904175725e-07	0.14334382658685096	206
hsa05206	MicroRNAs in cancer	1	3.7903390706213376e-127	3.7903390706213376e-127	0.8661326318575439	0.20988208518789286	0.1069904964186367	0.2299232418977929	186
hsa04927	Cortisol synthesis and secretion	1	2.595312276525824e-34	2.595312276525824e-34	0.945052145136519	0.14878773694146655	0.0606937370650065	0.18283369758485826	237
hsa05170	Human immunodeficiency virus 1 infection	1	6.13896606565261e-60	6.13896606565261e-60	0.7043581584413251	0.061772940015480435	8.702827146749942e-06	0.13489257442903035	203
hsa04060	Cytokine-cytokine receptor interaction	1	1.05187162855752e-148	1.05187162855752e-148	0.8640389506066377	0.12670094987773448	0.0008436750737966	0.21947417862629062	184
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	7.829555757572299e-79	7.829555757572299e-79	0.7043581584413251	0.07385481833983165	8.676404055904668e-05	0.15473539638110034	206
hsa04210	Apoptosis	1	7.384902792136834e-68	7.384902792136834e-68	0.5010690274785042	0.06116257450125466	5.294919969511161e-05	0.11787053589143175	217
hsa05168	Herpes simplex virus 1 infection	1	2.392979329816736e-77	2.392979329816736e-77	0.89385019691749	0.08440875860331705	2.8412310027813878e-05	0.17282870705172354	194
hsa04071	Sphingolipid signaling pathway	6	6.369974479612296e-28	9.028120004867832e-61	0.5811340386463366	0.06686372469311494	1.4981823919039822e-05	0.14148704142281643	210
hsa05166	Human T-cell leukemia virus 1 infection	1	1.4892557176921237e-78	1.4892557176921237e-78	0.7790917039515327	0.045027729775033144	1.1438974603415073e-05	0.1124435976061454	208
hsa05161	Hepatitis B	1	3.337092426078769e-83	3.337092426078769e-83	0.8919968202060229	0.05352806742137389	8.201116302039678e-08	0.1383064249272002	198
hsa05160	Hepatitis C	1	5.76416306814465e-46	5.76416306814465e-46	0.89385019691749	0.09187941460892755	0.0001604349074534	0.18481487306780953	187
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	4.2713829890417614e-76	4.2713829890417614e-76	0.7015647054836872	0.050538489880769366	6.031922149243079e-08	0.12853978805958727	205
hsa05169	Epstein-Barr virus infection	2	6.061302784016378e-79	6.061302784016378e-79	0.7928981445558452	0.053091724903954376	2.632851926661135e-07	0.14393493638912638	195
hsa05012	Parkinson disease	4	4.199151222199867e-25	1.950585684082761e-46	0.7833046657784437	0.05924017251319164	1.1368042106980964e-05	0.13519530864108686	235
hsa05014	Amyotrophic lateral sclerosis	2	1.5418550994586697e-43	5.4629825037276655e-48	0.8560194816661827	0.09045340635816257	0.0035303032489315	0.15876309636883523	199
hsa05226	Gastric cancer	2	3.569408163935953e-47	1.106468807012411e-78	0.89385019691749	0.060660173369800216	2.187758113445115e-06	0.131359701261053	203
hsa05415	Diabetic cardiomyopathy	2	4.204144808634628e-35	3.365839395784888e-37	0.5865979353911017	0.04627380478222065	4.559205597434762e-06	0.10262830932347136	228
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	3.858102091853023e-46	3.858102091853023e-46	0.5699903529074454	0.051898336451924924	4.3089349717518385e-08	0.12048259198068864	201
hsa05203	Viral carcinogenesis	2	1.9161318007542965e-61	9.132783395030224e-69	0.57831161455909	0.04203172742018352	3.0262152735744163e-07	0.11654879292751058	204
hsa04979	Cholesterol metabolism	1	2.4436092999412928e-70	2.4436092999412928e-70	0.908880644520742	0.4514227243414972	0.5835703543636465	0.27034452644617163	176
hsa05202	Transcriptional misregulation in cancer	1	3.786117621392158e-115	3.786117621392158e-115	0.7043581584413251	0.06793444573816607	5.363389089770566e-05	0.14697065809897777	200
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	3.3107153559596297e-62	3.3107153559596297e-62	0.799861000607755	0.090090185679713	0.0001655040560957	0.17905428302499976	204
hsa05165	Human papillomavirus infection	1	4.050846751295165e-72	4.050846751295165e-72	0.7043581584413251	0.04483487686253795	1.651443342960368e-09	0.10915558588965041	209
hsa05164	Influenza A	1	7.231307550739112e-71	7.231307550739112e-71	0.7928981445558452	0.0782001660333497	5.008945974417511e-05	0.16497184374657364	202
hsa04613	Neutrophil extracellular trap formation	1	4.2151608028098916e-46	4.2151608028098916e-46	0.945052145136519	0.06499697908120862	6.493158432908479e-07	0.15239049438884805	210
hsa05163	Human cytomegalovirus infection	1	2.3355952612524574e-60	2.3355952612524574e-60	0.652910431590019	0.059387691525146356	5.730971722434382e-07	0.1348311302212533	217
hsa04625	C-type lectin receptor signaling pathway	1	6.300905905634698e-71	6.300905905634698e-71	0.6736900022167941	0.07046396390342442	2.6123406772704232e-05	0.1468327705682604	192
hsa05020	Prion disease	7	7.826218126806749e-30	1.338495574714571e-55	0.945052145136519	0.0578564197877551	7.073241252217884e-07	0.13847026514914182	205
hsa05224	Breast cancer	1	1.0972861228528864e-66	1.0972861228528864e-66	0.8560194816661827	0.08116332880947584	5.339642190932434e-08	0.17743092303128077	190
hsa04530	Tight junction	1	2.4924014854660547e-69	2.4924014854660547e-69	0.7816708577192549	0.15379922644521776	0.03234024355828405	0.2050960465394181	188
hsa05225	Hepatocellular carcinoma	2	2.0001647480276063e-31	1.9383562983755083e-38	0.89385019691749	0.08198248735209017	0.0003439470256018	0.16383616540271348	205
hsa05017	Spinocerebellar ataxia	1	4.88887630866162e-35	4.88887630866162e-35	0.652910431590019	0.07755400840201081	0.0094028271134812	0.13951095244807593	198
hsa05010	Alzheimer disease	1	1.7407821377748618e-55	1.7407821377748618e-55	0.945052145136519	0.05375478716110336	1.1850911671166248e-05	0.12741603076943828	213
hsa05200	Pathways in cancer	1	2.1963824282547284e-101	2.1963824282547284e-101	0.6871987250202681	0.061275010845965254	2.381376904175725e-07	0.14334382658685096	206
hsa05206	MicroRNAs in cancer	1	3.7903390706213376e-127	3.7903390706213376e-127	0.8661326318575439	0.20988208518789286	0.1069904964186367	0.2299232418977929	186
hsa04927	Cortisol synthesis and secretion	1	2.595312276525824e-34	2.595312276525824e-34	0.945052145136519	0.14878773694146655	0.0606937370650065	0.18283369758485826	237
hsa05170	Human immunodeficiency virus 1 infection	1	6.13896606565261e-60	6.13896606565261e-60	0.7043581584413251	0.061772940015480435	8.702827146749942e-06	0.13489257442903035	203
hsa04060	Cytokine-cytokine receptor interaction	1	1.05187162855752e-148	1.05187162855752e-148	0.8640389506066377	0.12670094987773448	0.0008436750737966	0.21947417862629062	184
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	7.829555757572299e-79	7.829555757572299e-79	0.7043581584413251	0.07385481833983165	8.676404055904668e-05	0.15473539638110034	206
hsa04210	Apoptosis	1	7.384902792136834e-68	7.384902792136834e-68	0.5010690274785042	0.06116257450125466	5.294919969511161e-05	0.11787053589143175	217
hsa05168	Herpes simplex virus 1 infection	1	2.392979329816736e-77	2.392979329816736e-77	0.89385019691749	0.08440875860331705	2.8412310027813878e-05	0.17282870705172354	194
hsa04071	Sphingolipid signaling pathway	6	6.369974479612296e-28	9.028120004867832e-61	0.5811340386463366	0.06686372469311494	1.4981823919039822e-05	0.14148704142281643	210
hsa05166	Human T-cell leukemia virus 1 infection	1	1.4892557176921237e-78	1.4892557176921237e-78	0.7790917039515327	0.045027729775033144	1.1438974603415073e-05	0.1124435976061454	208
hsa05161	Hepatitis B	1	3.337092426078769e-83	3.337092426078769e-83	0.8919968202060229	0.05352806742137389	8.201116302039678e-08	0.1383064249272002	198
hsa05160	Hepatitis C	1	5.76416306814465e-46	5.76416306814465e-46	0.89385019691749	0.09187941460892755	0.0001604349074534	0.18481487306780953	187
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	4.2713829890417614e-76	4.2713829890417614e-76	0.7015647054836872	0.050538489880769366	6.031922149243079e-08	0.12853978805958727	205
hsa05169	Epstein-Barr virus infection	2	6.061302784016378e-79	6.061302784016378e-79	0.7928981445558452	0.053091724903954376	2.632851926661135e-07	0.14393493638912638	195
hsa05012	Parkinson disease	4	4.199151222199867e-25	1.950585684082761e-46	0.7833046657784437	0.05924017251319164	1.1368042106980964e-05	0.13519530864108686	235
hsa05014	Amyotrophic lateral sclerosis	2	1.5418550994586697e-43	5.4629825037276655e-48	0.8560194816661827	0.09045340635816257	0.0035303032489315	0.15876309636883523	199
hsa05226	Gastric cancer	2	3.569408163935953e-47	1.106468807012411e-78	0.89385019691749	0.060660173369800216	2.187758113445115e-06	0.131359701261053	203
hsa05415	Diabetic cardiomyopathy	2	4.204144808634628e-35	3.365839395784888e-37	0.5865979353911017	0.04627380478222065	4.559205597434762e-06	0.10262830932347136	228
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	3.858102091853023e-46	3.858102091853023e-46	0.5699903529074454	0.051898336451924924	4.3089349717518385e-08	0.12048259198068864	201
hsa05203	Viral carcinogenesis	2	1.9161318007542965e-61	9.132783395030224e-69	0.57831161455909	0.04203172742018352	3.0262152735744163e-07	0.11654879292751058	204
hsa04979	Cholesterol metabolism	1	2.4436092999412928e-70	2.4436092999412928e-70	0.908880644520742	0.4514227243414972	0.5835703543636465	0.27034452644617163	176
hsa05202	Transcriptional misregulation in cancer	1	3.786117621392158e-115	3.786117621392158e-115	0.7043581584413251	0.06793444573816607	5.363389089770566e-05	0.14697065809897777	200
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	3.3107153559596297e-62	3.3107153559596297e-62	0.799861000607755	0.090090185679713	0.0001655040560957	0.17905428302499976	204
hsa05165	Human papillomavirus infection	1	4.050846751295165e-72	4.050846751295165e-72	0.7043581584413251	0.04483487686253795	1.651443342960368e-09	0.10915558588965041	209
hsa05164	Influenza A	1	7.231307550739112e-71	7.231307550739112e-71	0.7928981445558452	0.0782001660333497	5.008945974417511e-05	0.16497184374657364	202
hsa04613	Neutrophil extracellular trap formation	1	4.2151608028098916e-46	4.2151608028098916e-46	0.945052145136519	0.06499697908120862	6.493158432908479e-07	0.15239049438884805	210
hsa05163	Human cytomegalovirus infection	1	2.3355952612524574e-60	2.3355952612524574e-60	0.652910431590019	0.059387691525146356	5.730971722434382e-07	0.1348311302212533	217
hsa04625	C-type lectin receptor signaling pathway	1	6.300905905634698e-71	6.300905905634698e-71	0.6736900022167941	0.07046396390342442	2.6123406772704232e-05	0.1468327705682604	192
hsa05020	Prion disease	7	7.826218126806749e-30	1.338495574714571e-55	0.945052145136519	0.0578564197877551	7.073241252217884e-07	0.13847026514914182	205
hsa05224	Breast cancer	1	1.0972861228528864e-66	1.0972861228528864e-66	0.8560194816661827	0.08116332880947584	5.339642190932434e-08	0.17743092303128077	190
hsa04530	Tight junction	1	2.4924014854660547e-69	2.4924014854660547e-69	0.7816708577192549	0.15379922644521776	0.03234024355828405	0.2050960465394181	188
hsa05225	Hepatocellular carcinoma	2	2.0001647480276063e-31	1.9383562983755083e-38	0.89385019691749	0.08198248735209017	0.0003439470256018	0.16383616540271348	205
hsa05017	Spinocerebellar ataxia	1	4.88887630866162e-35	4.88887630866162e-35	0.652910431590019	0.07755400840201081	0.0094028271134812	0.13951095244807593	198
hsa05010	Alzheimer disease	1	1.7407821377748618e-55	1.7407821377748618e-55	0.945052145136519	0.05375478716110336	1.1850911671166248e-05	0.12741603076943828	213
hsa05200	Pathways in cancer	1	2.1963824282547284e-101	2.1963824282547284e-101	0.6871987250202681	0.061275010845965254	2.381376904175725e-07	0.14334382658685096	206
hsa05206	MicroRNAs in cancer	1	3.7903390706213376e-127	3.7903390706213376e-127	0.8661326318575439	0.20988208518789286	0.1069904964186367	0.2299232418977929	186
hsa04927	Cortisol synthesis and secretion	1	2.595312276525824e-34	2.595312276525824e-34	0.945052145136519	0.14878773694146655	0.0606937370650065	0.18283369758485826	237
hsa05170	Human immunodeficiency virus 1 infection	1	6.13896606565261e-60	6.13896606565261e-60	0.7043581584413251	0.061772940015480435	8.702827146749942e-06	0.13489257442903035	203
hsa04060	Cytokine-cytokine receptor interaction	1	1.05187162855752e-148	1.05187162855752e-148	0.8640389506066377	0.12670094987773448	0.0008436750737966	0.21947417862629062	184
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	7.829555757572299e-79	7.829555757572299e-79	0.7043581584413251	0.07385481833983165	8.676404055904668e-05	0.15473539638110034	206
hsa04210	Apoptosis	1	7.384902792136834e-68	7.384902792136834e-68	0.5010690274785042	0.06116257450125466	5.294919969511161e-05	0.11787053589143175	217
hsa05168	Herpes simplex virus 1 infection	1	2.392979329816736e-77	2.392979329816736e-77	0.89385019691749	0.08440875860331705	2.8412310027813878e-05	0.17282870705172354	194
hsa04071	Sphingolipid signaling pathway	6	6.369974479612296e-28	9.028120004867832e-61	0.5811340386463366	0.06686372469311494	1.4981823919039822e-05	0.14148704142281643	210
hsa05166	Human T-cell leukemia virus 1 infection	1	1.4892557176921237e-78	1.4892557176921237e-78	0.7790917039515327	0.045027729775033144	1.1438974603415073e-05	0.1124435976061454	208
hsa05161	Hepatitis B	1	3.337092426078769e-83	3.337092426078769e-83	0.8919968202060229	0.05352806742137389	8.201116302039678e-08	0.1383064249272002	198
hsa05160	Hepatitis C	1	5.76416306814465e-46	5.76416306814465e-46	0.89385019691749	0.09187941460892755	0.0001604349074534	0.18481487306780953	187
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	4.2713829890417614e-76	4.2713829890417614e-76	0.7015647054836872	0.050538489880769366	6.031922149243079e-08	0.12853978805958727	205
hsa05169	Epstein-Barr virus infection	2	6.061302784016378e-79	6.061302784016378e-79	0.7928981445558452	0.053091724903954376	2.632851926661135e-07	0.14393493638912638	195
hsa05012	Parkinson disease	4	4.199151222199867e-25	1.950585684082761e-46	0.7833046657784437	0.05924017251319164	1.1368042106980964e-05	0.13519530864108686	235
hsa05014	Amyotrophic lateral sclerosis	2	1.5418550994586697e-43	5.4629825037276655e-48	0.8560194816661827	0.09045340635816257	0.0035303032489315	0.15876309636883523	199
hsa05226	Gastric cancer	2	3.569408163935953e-47	1.106468807012411e-78	0.89385019691749	0.060660173369800216	2.187758113445115e-06	0.131359701261053	203
hsa05415	Diabetic cardiomyopathy	2	4.204144808634628e-35	3.365839395784888e-37	0.5865979353911017	0.04627380478222065	4.559205597434762e-06	0.10262830932347136	228
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	3.858102091853023e-46	3.858102091853023e-46	0.5699903529074454	0.051898336451924924	4.3089349717518385e-08	0.12048259198068864	201
hsa05203	Viral carcinogenesis	2	1.9161318007542965e-61	9.132783395030224e-69	0.57831161455909	0.04203172742018352	3.0262152735744163e-07	0.11654879292751058	204
hsa04979	Cholesterol metabolism	1	2.4436092999412928e-70	2.4436092999412928e-70	0.908880644520742	0.4514227243414972	0.5835703543636465	0.27034452644617163	176
hsa05202	Transcriptional misregulation in cancer	1	3.786117621392158e-115	3.786117621392158e-115	0.7043581584413251	0.06793444573816607	5.363389089770566e-05	0.14697065809897777	200
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	3.3107153559596297e-62	3.3107153559596297e-62	0.799861000607755	0.090090185679713	0.0001655040560957	0.17905428302499976	204
hsa05165	Human papillomavirus infection	1	4.050846751295165e-72	4.050846751295165e-72	0.7043581584413251	0.04483487686253795	1.651443342960368e-09	0.10915558588965041	209
hsa05164	Influenza A	1	7.231307550739112e-71	7.231307550739112e-71	0.7928981445558452	0.0782001660333497	5.008945974417511e-05	0.16497184374657364	202
hsa04613	Neutrophil extracellular trap formation	1	4.2151608028098916e-46	4.2151608028098916e-46	0.945052145136519	0.06499697908120862	6.493158432908479e-07	0.15239049438884805	210
hsa05163	Human cytomegalovirus infection	1	2.3355952612524574e-60	2.3355952612524574e-60	0.652910431590019	0.059387691525146356	5.730971722434382e-07	0.1348311302212533	217
hsa04625	C-type lectin receptor signaling pathway	1	6.300905905634698e-71	6.300905905634698e-71	0.6736900022167941	0.07046396390342442	2.6123406772704232e-05	0.1468327705682604	192
hsa05020	Prion disease	7	7.826218126806749e-30	1.338495574714571e-55	0.945052145136519	0.0578564197877551	7.073241252217884e-07	0.13847026514914182	205
hsa05224	Breast cancer	1	1.0972861228528864e-66	1.0972861228528864e-66	0.8560194816661827	0.08116332880947584	5.339642190932434e-08	0.17743092303128077	190
hsa04530	Tight junction	1	2.4924014854660547e-69	2.4924014854660547e-69	0.7816708577192549	0.15379922644521776	0.03234024355828405	0.2050960465394181	188
hsa05225	Hepatocellular carcinoma	2	2.0001647480276063e-31	1.9383562983755083e-38	0.89385019691749	0.08198248735209017	0.0003439470256018	0.16383616540271348	205
hsa05017	Spinocerebellar ataxia	1	4.88887630866162e-35	4.88887630866162e-35	0.652910431590019	0.07755400840201081	0.0094028271134812	0.13951095244807593	198
hsa05010	Alzheimer disease	1	1.7407821377748618e-55	1.7407821377748618e-55	0.945052145136519	0.05375478716110336	1.1850911671166248e-05	0.12741603076943828	213
hsa05200	Pathways in cancer	1	2.1963824282547284e-101	2.1963824282547284e-101	0.6871987250202681	0.061275010845965254	2.381376904175725e-07	0.14334382658685096	206
hsa05206	MicroRNAs in cancer	1	3.7903390706213376e-127	3.7903390706213376e-127	0.8661326318575439	0.20988208518789286	0.1069904964186367	0.2299232418977929	186
hsa04927	Cortisol synthesis and secretion	1	2.595312276525824e-34	2.595312276525824e-34	0.945052145136519	0.14878773694146655	0.0606937370650065	0.18283369758485826	237
hsa05170	Human immunodeficiency virus 1 infection	1	6.13896606565261e-60	6.13896606565261e-60	0.7043581584413251	0.061772940015480435	8.702827146749942e-06	0.13489257442903035	203
hsa04060	Cytokine-cytokine receptor interaction	1	1.05187162855752e-148	1.05187162855752e-148	0.8640389506066377	0.12670094987773448	0.0008436750737966	0.21947417862629062	184
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	7.829555757572299e-79	7.829555757572299e-79	0.7043581584413251	0.07385481833983165	8.676404055904668e-05	0.15473539638110034	206
hsa04210	Apoptosis	1	7.384902792136834e-68	7.384902792136834e-68	0.5010690274785042	0.06116257450125466	5.294919969511161e-05	0.11787053589143175	217
hsa05168	Herpes simplex virus 1 infection	1	2.392979329816736e-77	2.392979329816736e-77	0.89385019691749	0.08440875860331705	2.8412310027813878e-05	0.17282870705172354	194
hsa04071	Sphingolipid signaling pathway	6	6.369974479612296e-28	9.028120004867832e-61	0.5811340386463366	0.06686372469311494	1.4981823919039822e-05	0.14148704142281643	210
hsa05166	Human T-cell leukemia virus 1 infection	1	1.4892557176921237e-78	1.4892557176921237e-78	0.7790917039515327	0.045027729775033144	1.1438974603415073e-05	0.1124435976061454	208
hsa05161	Hepatitis B	1	3.337092426078769e-83	3.337092426078769e-83	0.8919968202060229	0.05352806742137389	8.201116302039678e-08	0.1383064249272002	198
hsa05160	Hepatitis C	1	5.76416306814465e-46	5.76416306814465e-46	0.89385019691749	0.09187941460892755	0.0001604349074534	0.18481487306780953	187
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	4.2713829890417614e-76	4.2713829890417614e-76	0.7015647054836872	0.050538489880769366	6.031922149243079e-08	0.12853978805958727	205
hsa05169	Epstein-Barr virus infection	2	6.061302784016378e-79	6.061302784016378e-79	0.7928981445558452	0.053091724903954376	2.632851926661135e-07	0.14393493638912638	195
hsa05012	Parkinson disease	4	4.199151222199867e-25	1.950585684082761e-46	0.7833046657784437	0.05924017251319164	1.1368042106980964e-05	0.13519530864108686	235
hsa05014	Amyotrophic lateral sclerosis	2	1.5418550994586697e-43	5.4629825037276655e-48	0.8560194816661827	0.09045340635816257	0.0035303032489315	0.15876309636883523	199
hsa05226	Gastric cancer	2	3.569408163935953e-47	1.106468807012411e-78	0.89385019691749	0.060660173369800216	2.187758113445115e-06	0.131359701261053	203
hsa05415	Diabetic cardiomyopathy	2	4.204144808634628e-35	3.365839395784888e-37	0.5865979353911017	0.04627380478222065	4.559205597434762e-06	0.10262830932347136	228
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	3.858102091853023e-46	3.858102091853023e-46	0.5699903529074454	0.051898336451924924	4.3089349717518385e-08	0.12048259198068864	201
hsa05203	Viral carcinogenesis	2	1.9161318007542965e-61	9.132783395030224e-69	0.57831161455909	0.04203172742018352	3.0262152735744163e-07	0.11654879292751058	204
hsa04979	Cholesterol metabolism	1	2.4436092999412928e-70	2.4436092999412928e-70	0.908880644520742	0.4514227243414972	0.5835703543636465	0.27034452644617163	176
hsa05202	Transcriptional misregulation in cancer	1	3.786117621392158e-115	3.786117621392158e-115	0.7043581584413251	0.06793444573816607	5.363389089770566e-05	0.14697065809897777	200
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	3.3107153559596297e-62	3.3107153559596297e-62	0.799861000607755	0.090090185679713	0.0001655040560957	0.17905428302499976	204
hsa05165	Human papillomavirus infection	1	4.050846751295165e-72	4.050846751295165e-72	0.7043581584413251	0.04483487686253795	1.651443342960368e-09	0.10915558588965041	209
hsa05164	Influenza A	1	7.231307550739112e-71	7.231307550739112e-71	0.7928981445558452	0.0782001660333497	5.008945974417511e-05	0.16497184374657364	202
hsa04613	Neutrophil extracellular trap formation	1	4.2151608028098916e-46	4.2151608028098916e-46	0.945052145136519	0.06499697908120862	6.493158432908479e-07	0.15239049438884805	210
hsa05163	Human cytomegalovirus infection	1	2.3355952612524574e-60	2.3355952612524574e-60	0.652910431590019	0.059387691525146356	5.730971722434382e-07	0.1348311302212533	217
hsa04625	C-type lectin receptor signaling pathway	1	6.300905905634698e-71	6.300905905634698e-71	0.6736900022167941	0.07046396390342442	2.6123406772704232e-05	0.1468327705682604	192
hsa05020	Prion disease	7	7.826218126806749e-30	1.338495574714571e-55	0.945052145136519	0.0578564197877551	7.073241252217884e-07	0.13847026514914182	205
hsa05224	Breast cancer	1	1.0972861228528864e-66	1.0972861228528864e-66	0.8560194816661827	0.08116332880947584	5.339642190932434e-08	0.17743092303128077	190
hsa04530	Tight junction	1	2.4924014854660547e-69	2.4924014854660547e-69	0.7816708577192549	0.15379922644521776	0.03234024355828405	0.2050960465394181	188
hsa05225	Hepatocellular carcinoma	2	2.0001647480276063e-31	1.9383562983755083e-38	0.89385019691749	0.08198248735209017	0.0003439470256018	0.16383616540271348	205
hsa05017	Spinocerebellar ataxia	1	4.88887630866162e-35	4.88887630866162e-35	0.652910431590019	0.07755400840201081	0.0094028271134812	0.13951095244807593	198
hsa05010	Alzheimer disease	1	1.7407821377748618e-55	1.7407821377748618e-55	0.945052145136519	0.05375478716110336	1.1850911671166248e-05	0.12741603076943828	213
hsa05200	Pathways in cancer	1	2.1963824282547284e-101	2.1963824282547284e-101	0.6871987250202681	0.061275010845965254	2.381376904175725e-07	0.14334382658685096	206
hsa05206	MicroRNAs in cancer	1	3.7903390706213376e-127	3.7903390706213376e-127	0.8661326318575439	0.20988208518789286	0.1069904964186367	0.2299232418977929	186
hsa04927	Cortisol synthesis and secretion	1	2.595312276525824e-34	2.595312276525824e-34	0.945052145136519	0.14878773694146655	0.0606937370650065	0.18283369758485826	237
hsa05170	Human immunodeficiency virus 1 infection	1	6.13896606565261e-60	6.13896606565261e-60	0.7043581584413251	0.061772940015480435	8.702827146749942e-06	0.13489257442903035	203
hsa04060	Cytokine-cytokine receptor interaction	1	1.05187162855752e-148	1.05187162855752e-148	0.8640389506066377	0.12670094987773448	0.0008436750737966	0.21947417862629062	184
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	7.829555757572299e-79	7.829555757572299e-79	0.7043581584413251	0.07385481833983165	8.676404055904668e-05	0.15473539638110034	206
hsa04210	Apoptosis	1	7.384902792136834e-68	7.384902792136834e-68	0.5010690274785042	0.06116257450125466	5.294919969511161e-05	0.11787053589143175	217
hsa05168	Herpes simplex virus 1 infection	1	2.392979329816736e-77	2.392979329816736e-77	0.89385019691749	0.08440875860331705	2.8412310027813878e-05	0.17282870705172354	194
hsa04071	Sphingolipid signaling pathway	6	6.369974479612296e-28	9.028120004867832e-61	0.5811340386463366	0.06686372469311494	1.4981823919039822e-05	0.14148704142281643	210
hsa05166	Human T-cell leukemia virus 1 infection	1	1.4892557176921237e-78	1.4892557176921237e-78	0.7790917039515327	0.045027729775033144	1.1438974603415073e-05	0.1124435976061454	208
hsa05161	Hepatitis B	1	3.337092426078769e-83	3.337092426078769e-83	0.8919968202060229	0.05352806742137389	8.201116302039678e-08	0.1383064249272002	198
hsa05160	Hepatitis C	1	5.76416306814465e-46	5.76416306814465e-46	0.89385019691749	0.09187941460892755	0.0001604349074534	0.18481487306780953	187
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	4.2713829890417614e-76	4.2713829890417614e-76	0.7015647054836872	0.050538489880769366	6.031922149243079e-08	0.12853978805958727	205
hsa05169	Epstein-Barr virus infection	2	6.061302784016378e-79	6.061302784016378e-79	0.7928981445558452	0.053091724903954376	2.632851926661135e-07	0.14393493638912638	195
hsa05012	Parkinson disease	4	4.199151222199867e-25	1.950585684082761e-46	0.7833046657784437	0.05924017251319164	1.1368042106980964e-05	0.13519530864108686	235
hsa05014	Amyotrophic lateral sclerosis	2	1.5418550994586697e-43	5.4629825037276655e-48	0.8560194816661827	0.09045340635816257	0.0035303032489315	0.15876309636883523	199
hsa05226	Gastric cancer	2	3.569408163935953e-47	1.106468807012411e-78	0.89385019691749	0.060660173369800216	2.187758113445115e-06	0.131359701261053	203
hsa05415	Diabetic cardiomyopathy	2	4.204144808634628e-35	3.365839395784888e-37	0.5865979353911017	0.04627380478222065	4.559205597434762e-06	0.10262830932347136	228
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	3.858102091853023e-46	3.858102091853023e-46	0.5699903529074454	0.051898336451924924	4.3089349717518385e-08	0.12048259198068864	201
hsa05203	Viral carcinogenesis	2	1.9161318007542965e-61	9.132783395030224e-69	0.57831161455909	0.04203172742018352	3.0262152735744163e-07	0.11654879292751058	204
hsa04979	Cholesterol metabolism	1	2.4436092999412928e-70	2.4436092999412928e-70	0.908880644520742	0.4514227243414972	0.5835703543636465	0.27034452644617163	176
hsa05202	Transcriptional misregulation in cancer	1	3.786117621392158e-115	3.786117621392158e-115	0.7043581584413251	0.06793444573816607	5.363389089770566e-05	0.14697065809897777	200
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	3.3107153559596297e-62	3.3107153559596297e-62	0.799861000607755	0.090090185679713	0.0001655040560957	0.17905428302499976	204
hsa05165	Human papillomavirus infection	1	4.050846751295165e-72	4.050846751295165e-72	0.7043581584413251	0.04483487686253795	1.651443342960368e-09	0.10915558588965041	209
hsa05164	Influenza A	1	7.231307550739112e-71	7.231307550739112e-71	0.7928981445558452	0.0782001660333497	5.008945974417511e-05	0.16497184374657364	202
hsa04613	Neutrophil extracellular trap formation	1	4.2151608028098916e-46	4.2151608028098916e-46	0.945052145136519	0.06499697908120862	6.493158432908479e-07	0.15239049438884805	210
hsa05163	Human cytomegalovirus infection	1	2.3355952612524574e-60	2.3355952612524574e-60	0.652910431590019	0.059387691525146356	5.730971722434382e-07	0.1348311302212533	217
hsa04625	C-type lectin receptor signaling pathway	1	6.300905905634698e-71	6.300905905634698e-71	0.6736900022167941	0.07046396390342442	2.6123406772704232e-05	0.1468327705682604	192
hsa05020	Prion disease	7	7.826218126806749e-30	1.338495574714571e-55	0.945052145136519	0.0578564197877551	7.073241252217884e-07	0.13847026514914182	205
hsa05224	Breast cancer	1	1.0972861228528864e-66	1.0972861228528864e-66	0.8560194816661827	0.08116332880947584	5.339642190932434e-08	0.17743092303128077	190
hsa04530	Tight junction	1	2.4924014854660547e-69	2.4924014854660547e-69	0.7816708577192549	0.15379922644521776	0.03234024355828405	0.2050960465394181	188
hsa05225	Hepatocellular carcinoma	2	2.0001647480276063e-31	1.9383562983755083e-38	0.89385019691749	0.08198248735209017	0.0003439470256018	0.16383616540271348	205
hsa05017	Spinocerebellar ataxia	1	4.88887630866162e-35	4.88887630866162e-35	0.652910431590019	0.07755400840201081	0.0094028271134812	0.13951095244807593	198
hsa05010	Alzheimer disease	1	1.7407821377748618e-55	1.7407821377748618e-55	0.945052145136519	0.05375478716110336	1.1850911671166248e-05	0.12741603076943828	213
hsa05200	Pathways in cancer	1	2.1963824282547284e-101	2.1963824282547284e-101	0.6871987250202681	0.061275010845965254	2.381376904175725e-07	0.14334382658685096	206
hsa05206	MicroRNAs in cancer	1	3.7903390706213376e-127	3.7903390706213376e-127	0.8661326318575439	0.20988208518789286	0.1069904964186367	0.2299232418977929	186
hsa04927	Cortisol synthesis and secretion	1	2.595312276525824e-34	2.595312276525824e-34	0.945052145136519	0.14878773694146655	0.0606937370650065	0.18283369758485826	237
hsa05170	Human immunodeficiency virus 1 infection	1	6.13896606565261e-60	6.13896606565261e-60	0.7043581584413251	0.061772940015480435	8.702827146749942e-06	0.13489257442903035	203
hsa04060	Cytokine-cytokine receptor interaction	1	1.05187162855752e-148	1.05187162855752e-148	0.8640389506066377	0.12670094987773448	0.0008436750737966	0.21947417862629062	184
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	7.829555757572299e-79	7.829555757572299e-79	0.7043581584413251	0.07385481833983165	8.676404055904668e-05	0.15473539638110034	206
hsa04210	Apoptosis	1	7.384902792136834e-68	7.384902792136834e-68	0.5010690274785042	0.06116257450125466	5.294919969511161e-05	0.11787053589143175	217
hsa05168	Herpes simplex virus 1 infection	1	2.392979329816736e-77	2.392979329816736e-77	0.89385019691749	0.08440875860331705	2.8412310027813878e-05	0.17282870705172354	194
hsa04071	Sphingolipid signaling pathway	6	6.369974479612296e-28	9.028120004867832e-61	0.5811340386463366	0.06686372469311494	1.4981823919039822e-05	0.14148704142281643	210
hsa05166	Human T-cell leukemia virus 1 infection	1	1.4892557176921237e-78	1.4892557176921237e-78	0.7790917039515327	0.045027729775033144	1.1438974603415073e-05	0.1124435976061454	208
hsa05161	Hepatitis B	1	3.337092426078769e-83	3.337092426078769e-83	0.8919968202060229	0.05352806742137389	8.201116302039678e-08	0.1383064249272002	198
hsa05160	Hepatitis C	1	5.76416306814465e-46	5.76416306814465e-46	0.89385019691749	0.09187941460892755	0.0001604349074534	0.18481487306780953	187
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	4.2713829890417614e-76	4.2713829890417614e-76	0.7015647054836872	0.050538489880769366	6.031922149243079e-08	0.12853978805958727	205
hsa05169	Epstein-Barr virus infection	2	6.061302784016378e-79	6.061302784016378e-79	0.7928981445558452	0.053091724903954376	2.632851926661135e-07	0.14393493638912638	195
hsa05012	Parkinson disease	4	4.199151222199867e-25	1.950585684082761e-46	0.7833046657784437	0.05924017251319164	1.1368042106980964e-05	0.13519530864108686	235
hsa05014	Amyotrophic lateral sclerosis	2	1.5418550994586697e-43	5.4629825037276655e-48	0.8560194816661827	0.09045340635816257	0.0035303032489315	0.15876309636883523	199
hsa05226	Gastric cancer	2	3.569408163935953e-47	1.106468807012411e-78	0.89385019691749	0.060660173369800216	2.187758113445115e-06	0.131359701261053	203
hsa05415	Diabetic cardiomyopathy	2	4.204144808634628e-35	3.365839395784888e-37	0.5865979353911017	0.04627380478222065	4.559205597434762e-06	0.10262830932347136	228
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	3.858102091853023e-46	3.858102091853023e-46	0.5699903529074454	0.051898336451924924	4.3089349717518385e-08	0.12048259198068864	201
hsa05203	Viral carcinogenesis	2	1.9161318007542965e-61	9.132783395030224e-69	0.57831161455909	0.04203172742018352	3.0262152735744163e-07	0.11654879292751058	204
hsa04979	Cholesterol metabolism	1	2.4436092999412928e-70	2.4436092999412928e-70	0.908880644520742	0.4514227243414972	0.5835703543636465	0.27034452644617163	176
hsa05202	Transcriptional misregulation in cancer	1	3.786117621392158e-115	3.786117621392158e-115	0.7043581584413251	0.06793444573816607	5.363389089770566e-05	0.14697065809897777	200
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	3.3107153559596297e-62	3.3107153559596297e-62	0.799861000607755	0.090090185679713	0.0001655040560957	0.17905428302499976	204
hsa05165	Human papillomavirus infection	1	4.050846751295165e-72	4.050846751295165e-72	0.7043581584413251	0.04483487686253795	1.651443342960368e-09	0.10915558588965041	209
hsa05164	Influenza A	1	7.231307550739112e-71	7.231307550739112e-71	0.7928981445558452	0.0782001660333497	5.008945974417511e-05	0.16497184374657364	202
hsa04613	Neutrophil extracellular trap formation	1	4.2151608028098916e-46	4.2151608028098916e-46	0.945052145136519	0.06499697908120862	6.493158432908479e-07	0.15239049438884805	210
hsa05163	Human cytomegalovirus infection	1	2.3355952612524574e-60	2.3355952612524574e-60	0.652910431590019	0.059387691525146356	5.730971722434382e-07	0.1348311302212533	217
hsa04625	C-type lectin receptor signaling pathway	1	6.300905905634698e-71	6.300905905634698e-71	0.6736900022167941	0.07046396390342442	2.6123406772704232e-05	0.1468327705682604	192
hsa05020	Prion disease	7	7.826218126806749e-30	1.338495574714571e-55	0.945052145136519	0.0578564197877551	7.073241252217884e-07	0.13847026514914182	205
hsa05224	Breast cancer	1	1.0972861228528864e-66	1.0972861228528864e-66	0.8560194816661827	0.08116332880947584	5.339642190932434e-08	0.17743092303128077	190
hsa04530	Tight junction	1	2.4924014854660547e-69	2.4924014854660547e-69	0.7816708577192549	0.15379922644521776	0.03234024355828405	0.2050960465394181	188
hsa05225	Hepatocellular carcinoma	2	2.0001647480276063e-31	1.9383562983755083e-38	0.89385019691749	0.08198248735209017	0.0003439470256018	0.16383616540271348	205
hsa05017	Spinocerebellar ataxia	1	4.88887630866162e-35	4.88887630866162e-35	0.652910431590019	0.07755400840201081	0.0094028271134812	0.13951095244807593	198
hsa05010	Alzheimer disease	1	1.7407821377748618e-55	1.7407821377748618e-55	0.945052145136519	0.05375478716110336	1.1850911671166248e-05	0.12741603076943828	213
hsa05200	Pathways in cancer	1	2.1963824282547284e-101	2.1963824282547284e-101	0.6871987250202681	0.061275010845965254	2.381376904175725e-07	0.14334382658685096	206
hsa05206	MicroRNAs in cancer	1	3.7903390706213376e-127	3.7903390706213376e-127	0.8661326318575439	0.20988208518789286	0.1069904964186367	0.2299232418977929	186
hsa04927	Cortisol synthesis and secretion	1	2.595312276525824e-34	2.595312276525824e-34	0.945052145136519	0.14878773694146655	0.0606937370650065	0.18283369758485826	237
hsa05170	Human immunodeficiency virus 1 infection	1	6.13896606565261e-60	6.13896606565261e-60	0.7043581584413251	0.061772940015480435	8.702827146749942e-06	0.13489257442903035	203
hsa04060	Cytokine-cytokine receptor interaction	1	1.05187162855752e-148	1.05187162855752e-148	0.8640389506066377	0.12670094987773448	0.0008436750737966	0.21947417862629062	184
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	7.829555757572299e-79	7.829555757572299e-79	0.7043581584413251	0.07385481833983165	8.676404055904668e-05	0.15473539638110034	206
hsa04210	Apoptosis	1	7.384902792136834e-68	7.384902792136834e-68	0.5010690274785042	0.06116257450125466	5.294919969511161e-05	0.11787053589143175	217
hsa05168	Herpes simplex virus 1 infection	1	2.392979329816736e-77	2.392979329816736e-77	0.89385019691749	0.08440875860331705	2.8412310027813878e-05	0.17282870705172354	194
hsa04071	Sphingolipid signaling pathway	6	6.369974479612296e-28	9.028120004867832e-61	0.5811340386463366	0.06686372469311494	1.4981823919039822e-05	0.14148704142281643	210
hsa05166	Human T-cell leukemia virus 1 infection	1	1.4892557176921237e-78	1.4892557176921237e-78	0.7790917039515327	0.045027729775033144	1.1438974603415073e-05	0.1124435976061454	208
hsa05161	Hepatitis B	1	3.337092426078769e-83	3.337092426078769e-83	0.8919968202060229	0.05352806742137389	8.201116302039678e-08	0.1383064249272002	198
hsa05160	Hepatitis C	1	5.76416306814465e-46	5.76416306814465e-46	0.89385019691749	0.09187941460892755	0.0001604349074534	0.18481487306780953	187
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	4.2713829890417614e-76	4.2713829890417614e-76	0.7015647054836872	0.050538489880769366	6.031922149243079e-08	0.12853978805958727	205
hsa05169	Epstein-Barr virus infection	2	6.061302784016378e-79	6.061302784016378e-79	0.7928981445558452	0.053091724903954376	2.632851926661135e-07	0.14393493638912638	195
hsa05012	Parkinson disease	4	4.199151222199867e-25	1.950585684082761e-46	0.7833046657784437	0.05924017251319164	1.1368042106980964e-05	0.13519530864108686	235
hsa05014	Amyotrophic lateral sclerosis	2	1.5418550994586697e-43	5.4629825037276655e-48	0.8560194816661827	0.09045340635816257	0.0035303032489315	0.15876309636883523	199
hsa05226	Gastric cancer	2	3.569408163935953e-47	1.106468807012411e-78	0.89385019691749	0.060660173369800216	2.187758113445115e-06	0.131359701261053	203
hsa05415	Diabetic cardiomyopathy	2	4.204144808634628e-35	3.365839395784888e-37	0.5865979353911017	0.04627380478222065	4.559205597434762e-06	0.10262830932347136	228
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	3.858102091853023e-46	3.858102091853023e-46	0.5699903529074454	0.051898336451924924	4.3089349717518385e-08	0.12048259198068864	201
hsa05203	Viral carcinogenesis	2	1.9161318007542965e-61	9.132783395030224e-69	0.57831161455909	0.04203172742018352	3.0262152735744163e-07	0.11654879292751058	204
hsa04979	Cholesterol metabolism	1	2.4436092999412928e-70	2.4436092999412928e-70	0.908880644520742	0.4514227243414972	0.5835703543636465	0.27034452644617163	176
hsa05202	Transcriptional misregulation in cancer	1	3.786117621392158e-115	3.786117621392158e-115	0.7043581584413251	0.06793444573816607	5.363389089770566e-05	0.14697065809897777	200
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	3.3107153559596297e-62	3.3107153559596297e-62	0.799861000607755	0.090090185679713	0.0001655040560957	0.17905428302499976	204
hsa05165	Human papillomavirus infection	1	4.050846751295165e-72	4.050846751295165e-72	0.7043581584413251	0.04483487686253795	1.651443342960368e-09	0.10915558588965041	209
hsa05164	Influenza A	1	7.231307550739112e-71	7.231307550739112e-71	0.7928981445558452	0.0782001660333497	5.008945974417511e-05	0.16497184374657364	202
hsa04613	Neutrophil extracellular trap formation	1	4.2151608028098916e-46	4.2151608028098916e-46	0.945052145136519	0.06499697908120862	6.493158432908479e-07	0.15239049438884805	210
hsa05163	Human cytomegalovirus infection	1	2.3355952612524574e-60	2.3355952612524574e-60	0.652910431590019	0.059387691525146356	5.730971722434382e-07	0.1348311302212533	217
hsa04625	C-type lectin receptor signaling pathway	1	6.300905905634698e-71	6.300905905634698e-71	0.6736900022167941	0.07046396390342442	2.6123406772704232e-05	0.1468327705682604	192
hsa05020	Prion disease	7	7.826218126806749e-30	1.338495574714571e-55	0.945052145136519	0.0578564197877551	7.073241252217884e-07	0.13847026514914182	205
hsa05224	Breast cancer	1	1.0972861228528864e-66	1.0972861228528864e-66	0.8560194816661827	0.08116332880947584	5.339642190932434e-08	0.17743092303128077	190
hsa04530	Tight junction	1	2.4924014854660547e-69	2.4924014854660547e-69	0.7816708577192549	0.15379922644521776	0.03234024355828405	0.2050960465394181	188
hsa05225	Hepatocellular carcinoma	2	2.0001647480276063e-31	1.9383562983755083e-38	0.89385019691749	0.08198248735209017	0.0003439470256018	0.16383616540271348	205
hsa05017	Spinocerebellar ataxia	1	4.88887630866162e-35	4.88887630866162e-35	0.652910431590019	0.07755400840201081	0.0094028271134812	0.13951095244807593	198
hsa05010	Alzheimer disease	1	1.7407821377748618e-55	1.7407821377748618e-55	0.945052145136519	0.05375478716110336	1.1850911671166248e-05	0.12741603076943828	213
hsa05200	Pathways in cancer	1	2.1963824282547284e-101	2.1963824282547284e-101	0.6871987250202681	0.061275010845965254	2.381376904175725e-07	0.14334382658685096	206
hsa05206	MicroRNAs in cancer	1	3.7903390706213376e-127	3.7903390706213376e-127	0.8661326318575439	0.20988208518789286	0.1069904964186367	0.2299232418977929	186
hsa04927	Cortisol synthesis and secretion	1	2.595312276525824e-34	2.595312276525824e-34	0.945052145136519	0.14878773694146655	0.0606937370650065	0.18283369758485826	237
hsa05170	Human immunodeficiency virus 1 infection	1	6.13896606565261e-60	6.13896606565261e-60	0.7043581584413251	0.061772940015480435	8.702827146749942e-06	0.13489257442903035	203
hsa04060	Cytokine-cytokine receptor interaction	1	1.05187162855752e-148	1.05187162855752e-148	0.8640389506066377	0.12670094987773448	0.0008436750737966	0.21947417862629062	184
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	7.829555757572299e-79	7.829555757572299e-79	0.7043581584413251	0.07385481833983165	8.676404055904668e-05	0.15473539638110034	206
hsa04210	Apoptosis	1	7.384902792136834e-68	7.384902792136834e-68	0.5010690274785042	0.06116257450125466	5.294919969511161e-05	0.11787053589143175	217
hsa05168	Herpes simplex virus 1 infection	1	2.392979329816736e-77	2.392979329816736e-77	0.89385019691749	0.08440875860331705	2.8412310027813878e-05	0.17282870705172354	194
hsa04071	Sphingolipid signaling pathway	6	6.369974479612296e-28	9.028120004867832e-61	0.5811340386463366	0.06686372469311494	1.4981823919039822e-05	0.14148704142281643	210
hsa05166	Human T-cell leukemia virus 1 infection	1	1.4892557176921237e-78	1.4892557176921237e-78	0.7790917039515327	0.045027729775033144	1.1438974603415073e-05	0.1124435976061454	208
hsa05161	Hepatitis B	1	3.337092426078769e-83	3.337092426078769e-83	0.8919968202060229	0.05352806742137389	8.201116302039678e-08	0.1383064249272002	198
hsa05160	Hepatitis C	1	5.76416306814465e-46	5.76416306814465e-46	0.89385019691749	0.09187941460892755	0.0001604349074534	0.18481487306780953	187
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	4.2713829890417614e-76	4.2713829890417614e-76	0.7015647054836872	0.050538489880769366	6.031922149243079e-08	0.12853978805958727	205
hsa05169	Epstein-Barr virus infection	2	6.061302784016378e-79	6.061302784016378e-79	0.7928981445558452	0.053091724903954376	2.632851926661135e-07	0.14393493638912638	195
hsa05012	Parkinson disease	4	4.199151222199867e-25	1.950585684082761e-46	0.7833046657784437	0.05924017251319164	1.1368042106980964e-05	0.13519530864108686	235
hsa05014	Amyotrophic lateral sclerosis	2	1.5418550994586697e-43	5.4629825037276655e-48	0.8560194816661827	0.09045340635816257	0.0035303032489315	0.15876309636883523	199
hsa05226	Gastric cancer	2	3.569408163935953e-47	1.106468807012411e-78	0.89385019691749	0.060660173369800216	2.187758113445115e-06	0.131359701261053	203
hsa05415	Diabetic cardiomyopathy	2	4.204144808634628e-35	3.365839395784888e-37	0.5865979353911017	0.04627380478222065	4.559205597434762e-06	0.10262830932347136	228
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	3.858102091853023e-46	3.858102091853023e-46	0.5699903529074454	0.051898336451924924	4.3089349717518385e-08	0.12048259198068864	201
hsa05203	Viral carcinogenesis	2	1.9161318007542965e-61	9.132783395030224e-69	0.57831161455909	0.04203172742018352	3.0262152735744163e-07	0.11654879292751058	204
hsa04979	Cholesterol metabolism	1	2.4436092999412928e-70	2.4436092999412928e-70	0.908880644520742	0.4514227243414972	0.5835703543636465	0.27034452644617163	176
hsa05202	Transcriptional misregulation in cancer	1	3.786117621392158e-115	3.786117621392158e-115	0.7043581584413251	0.06793444573816607	5.363389089770566e-05	0.14697065809897777	200
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	3.3107153559596297e-62	3.3107153559596297e-62	0.799861000607755	0.090090185679713	0.0001655040560957	0.17905428302499976	204
hsa05165	Human papillomavirus infection	1	4.050846751295165e-72	4.050846751295165e-72	0.7043581584413251	0.04483487686253795	1.651443342960368e-09	0.10915558588965041	209
hsa05164	Influenza A	1	7.231307550739112e-71	7.231307550739112e-71	0.7928981445558452	0.0782001660333497	5.008945974417511e-05	0.16497184374657364	202
hsa04613	Neutrophil extracellular trap formation	1	4.2151608028098916e-46	4.2151608028098916e-46	0.945052145136519	0.06499697908120862	6.493158432908479e-07	0.15239049438884805	210
hsa05163	Human cytomegalovirus infection	1	2.3355952612524574e-60	2.3355952612524574e-60	0.652910431590019	0.059387691525146356	5.730971722434382e-07	0.1348311302212533	217
hsa04625	C-type lectin receptor signaling pathway	1	6.300905905634698e-71	6.300905905634698e-71	0.6736900022167941	0.07046396390342442	2.6123406772704232e-05	0.1468327705682604	192
hsa05020	Prion disease	7	7.826218126806749e-30	1.338495574714571e-55	0.945052145136519	0.0578564197877551	7.073241252217884e-07	0.13847026514914182	205
hsa05224	Breast cancer	1	1.0972861228528864e-66	1.0972861228528864e-66	0.8560194816661827	0.08116332880947584	5.339642190932434e-08	0.17743092303128077	190
hsa04530	Tight junction	1	2.4924014854660547e-69	2.4924014854660547e-69	0.7816708577192549	0.15379922644521776	0.03234024355828405	0.2050960465394181	188
hsa05225	Hepatocellular carcinoma	2	2.0001647480276063e-31	1.9383562983755083e-38	0.89385019691749	0.08198248735209017	0.0003439470256018	0.16383616540271348	205
hsa05017	Spinocerebellar ataxia	1	4.88887630866162e-35	4.88887630866162e-35	0.652910431590019	0.07755400840201081	0.0094028271134812	0.13951095244807593	198
hsa05010	Alzheimer disease	1	1.7407821377748618e-55	1.7407821377748618e-55	0.945052145136519	0.05375478716110336	1.1850911671166248e-05	0.12741603076943828	213
hsa05200	Pathways in cancer	1	2.1963824282547284e-101	2.1963824282547284e-101	0.6871987250202681	0.061275010845965254	2.381376904175725e-07	0.14334382658685096	206
hsa05206	MicroRNAs in cancer	1	3.7903390706213376e-127	3.7903390706213376e-127	0.8661326318575439	0.20988208518789286	0.1069904964186367	0.2299232418977929	186
hsa04927	Cortisol synthesis and secretion	1	2.595312276525824e-34	2.595312276525824e-34	0.945052145136519	0.14878773694146655	0.0606937370650065	0.18283369758485826	237
hsa05170	Human immunodeficiency virus 1 infection	1	6.13896606565261e-60	6.13896606565261e-60	0.7043581584413251	0.061772940015480435	8.702827146749942e-06	0.13489257442903035	203
hsa04060	Cytokine-cytokine receptor interaction	1	1.05187162855752e-148	1.05187162855752e-148	0.8640389506066377	0.12670094987773448	0.0008436750737966	0.21947417862629062	184
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	7.829555757572299e-79	7.829555757572299e-79	0.7043581584413251	0.07385481833983165	8.676404055904668e-05	0.15473539638110034	206
hsa04210	Apoptosis	1	7.384902792136834e-68	7.384902792136834e-68	0.5010690274785042	0.06116257450125466	5.294919969511161e-05	0.11787053589143175	217
hsa05168	Herpes simplex virus 1 infection	1	2.392979329816736e-77	2.392979329816736e-77	0.89385019691749	0.08440875860331705	2.8412310027813878e-05	0.17282870705172354	194
hsa04071	Sphingolipid signaling pathway	6	6.369974479612296e-28	9.028120004867832e-61	0.5811340386463366	0.06686372469311494	1.4981823919039822e-05	0.14148704142281643	210
hsa05166	Human T-cell leukemia virus 1 infection	1	1.4892557176921237e-78	1.4892557176921237e-78	0.7790917039515327	0.045027729775033144	1.1438974603415073e-05	0.1124435976061454	208
hsa05161	Hepatitis B	1	3.337092426078769e-83	3.337092426078769e-83	0.8919968202060229	0.05352806742137389	8.201116302039678e-08	0.1383064249272002	198
hsa05160	Hepatitis C	1	5.76416306814465e-46	5.76416306814465e-46	0.89385019691749	0.09187941460892755	0.0001604349074534	0.18481487306780953	187
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	4.2713829890417614e-76	4.2713829890417614e-76	0.7015647054836872	0.050538489880769366	6.031922149243079e-08	0.12853978805958727	205
hsa05169	Epstein-Barr virus infection	2	6.061302784016378e-79	6.061302784016378e-79	0.7928981445558452	0.053091724903954376	2.632851926661135e-07	0.14393493638912638	195
hsa05012	Parkinson disease	4	4.199151222199867e-25	1.950585684082761e-46	0.7833046657784437	0.05924017251319164	1.1368042106980964e-05	0.13519530864108686	235
hsa05014	Amyotrophic lateral sclerosis	2	1.5418550994586697e-43	5.4629825037276655e-48	0.8560194816661827	0.09045340635816257	0.0035303032489315	0.15876309636883523	199
hsa05226	Gastric cancer	2	3.569408163935953e-47	1.106468807012411e-78	0.89385019691749	0.060660173369800216	2.187758113445115e-06	0.131359701261053	203
hsa05415	Diabetic cardiomyopathy	2	4.204144808634628e-35	3.365839395784888e-37	0.5865979353911017	0.04627380478222065	4.559205597434762e-06	0.10262830932347136	228
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	3.858102091853023e-46	3.858102091853023e-46	0.5699903529074454	0.051898336451924924	4.3089349717518385e-08	0.12048259198068864	201
hsa05203	Viral carcinogenesis	2	1.9161318007542965e-61	9.132783395030224e-69	0.57831161455909	0.04203172742018352	3.0262152735744163e-07	0.11654879292751058	204
hsa04979	Cholesterol metabolism	1	2.4436092999412928e-70	2.4436092999412928e-70	0.908880644520742	0.4514227243414972	0.5835703543636465	0.27034452644617163	176
hsa05202	Transcriptional misregulation in cancer	1	3.786117621392158e-115	3.786117621392158e-115	0.7043581584413251	0.06793444573816607	5.363389089770566e-05	0.14697065809897777	200
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	3.3107153559596297e-62	3.3107153559596297e-62	0.799861000607755	0.090090185679713	0.0001655040560957	0.17905428302499976	204
hsa05165	Human papillomavirus infection	1	4.050846751295165e-72	4.050846751295165e-72	0.7043581584413251	0.04483487686253795	1.651443342960368e-09	0.10915558588965041	209
hsa05164	Influenza A	1	7.231307550739112e-71	7.231307550739112e-71	0.7928981445558452	0.0782001660333497	5.008945974417511e-05	0.16497184374657364	202
hsa04613	Neutrophil extracellular trap formation	1	4.2151608028098916e-46	4.2151608028098916e-46	0.945052145136519	0.06499697908120862	6.493158432908479e-07	0.15239049438884805	210
hsa05163	Human cytomegalovirus infection	1	2.3355952612524574e-60	2.3355952612524574e-60	0.652910431590019	0.059387691525146356	5.730971722434382e-07	0.1348311302212533	217
hsa04625	C-type lectin receptor signaling pathway	1	6.300905905634698e-71	6.300905905634698e-71	0.6736900022167941	0.07046396390342442	2.6123406772704232e-05	0.1468327705682604	192
hsa05020	Prion disease	7	7.826218126806749e-30	1.338495574714571e-55	0.945052145136519	0.0578564197877551	7.073241252217884e-07	0.13847026514914182	205
hsa05224	Breast cancer	1	1.0972861228528864e-66	1.0972861228528864e-66	0.8560194816661827	0.08116332880947584	5.339642190932434e-08	0.17743092303128077	190
hsa04530	Tight junction	1	2.4924014854660547e-69	2.4924014854660547e-69	0.7816708577192549	0.15379922644521776	0.03234024355828405	0.2050960465394181	188
hsa05225	Hepatocellular carcinoma	2	2.0001647480276063e-31	1.9383562983755083e-38	0.89385019691749	0.08198248735209017	0.0003439470256018	0.16383616540271348	205
hsa05017	Spinocerebellar ataxia	1	4.88887630866162e-35	4.88887630866162e-35	0.652910431590019	0.07755400840201081	0.0094028271134812	0.13951095244807593	198
hsa05010	Alzheimer disease	1	1.7407821377748618e-55	1.7407821377748618e-55	0.945052145136519	0.05375478716110336	1.1850911671166248e-05	0.12741603076943828	213
hsa05200	Pathways in cancer	1	2.1963824282547284e-101	2.1963824282547284e-101	0.6871987250202681	0.061275010845965254	2.381376904175725e-07	0.14334382658685096	206
hsa05206	MicroRNAs in cancer	1	3.7903390706213376e-127	3.7903390706213376e-127	0.8661326318575439	0.20988208518789286	0.1069904964186367	0.2299232418977929	186
hsa04927	Cortisol synthesis and secretion	1	2.595312276525824e-34	2.595312276525824e-34	0.945052145136519	0.14878773694146655	0.0606937370650065	0.18283369758485826	237
hsa05170	Human immunodeficiency virus 1 infection	1	6.13896606565261e-60	6.13896606565261e-60	0.7043581584413251	0.061772940015480435	8.702827146749942e-06	0.13489257442903035	203
hsa04060	Cytokine-cytokine receptor interaction	1	1.05187162855752e-148	1.05187162855752e-148	0.8640389506066377	0.12670094987773448	0.0008436750737966	0.21947417862629062	184
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	7.829555757572299e-79	7.829555757572299e-79	0.7043581584413251	0.07385481833983165	8.676404055904668e-05	0.15473539638110034	206
hsa04210	Apoptosis	1	7.384902792136834e-68	7.384902792136834e-68	0.5010690274785042	0.06116257450125466	5.294919969511161e-05	0.11787053589143175	217
hsa05168	Herpes simplex virus 1 infection	1	2.392979329816736e-77	2.392979329816736e-77	0.89385019691749	0.08440875860331705	2.8412310027813878e-05	0.17282870705172354	194
hsa04071	Sphingolipid signaling pathway	6	6.369974479612296e-28	9.028120004867832e-61	0.5811340386463366	0.06686372469311494	1.4981823919039822e-05	0.14148704142281643	210
hsa05166	Human T-cell leukemia virus 1 infection	1	1.4892557176921237e-78	1.4892557176921237e-78	0.7790917039515327	0.045027729775033144	1.1438974603415073e-05	0.1124435976061454	208
hsa05161	Hepatitis B	1	3.337092426078769e-83	3.337092426078769e-83	0.8919968202060229	0.05352806742137389	8.201116302039678e-08	0.1383064249272002	198
hsa05160	Hepatitis C	1	5.76416306814465e-46	5.76416306814465e-46	0.89385019691749	0.09187941460892755	0.0001604349074534	0.18481487306780953	187
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	4.2713829890417614e-76	4.2713829890417614e-76	0.7015647054836872	0.050538489880769366	6.031922149243079e-08	0.12853978805958727	205
hsa05169	Epstein-Barr virus infection	2	6.061302784016378e-79	6.061302784016378e-79	0.7928981445558452	0.053091724903954376	2.632851926661135e-07	0.14393493638912638	195
hsa05012	Parkinson disease	4	4.199151222199867e-25	1.950585684082761e-46	0.7833046657784437	0.05924017251319164	1.1368042106980964e-05	0.13519530864108686	235
hsa05014	Amyotrophic lateral sclerosis	2	1.5418550994586697e-43	5.4629825037276655e-48	0.8560194816661827	0.09045340635816257	0.0035303032489315	0.15876309636883523	199
hsa05226	Gastric cancer	2	3.569408163935953e-47	1.106468807012411e-78	0.89385019691749	0.060660173369800216	2.187758113445115e-06	0.131359701261053	203
hsa05415	Diabetic cardiomyopathy	2	4.204144808634628e-35	3.365839395784888e-37	0.5865979353911017	0.04627380478222065	4.559205597434762e-06	0.10262830932347136	228
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	3.858102091853023e-46	3.858102091853023e-46	0.5699903529074454	0.051898336451924924	4.3089349717518385e-08	0.12048259198068864	201
hsa05203	Viral carcinogenesis	2	1.9161318007542965e-61	9.132783395030224e-69	0.57831161455909	0.04203172742018352	3.0262152735744163e-07	0.11654879292751058	204
hsa04979	Cholesterol metabolism	1	2.4436092999412928e-70	2.4436092999412928e-70	0.908880644520742	0.4514227243414972	0.5835703543636465	0.27034452644617163	176
hsa05202	Transcriptional misregulation in cancer	1	3.786117621392158e-115	3.786117621392158e-115	0.7043581584413251	0.06793444573816607	5.363389089770566e-05	0.14697065809897777	200
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	3.3107153559596297e-62	3.3107153559596297e-62	0.799861000607755	0.090090185679713	0.0001655040560957	0.17905428302499976	204
hsa05165	Human papillomavirus infection	1	4.050846751295165e-72	4.050846751295165e-72	0.7043581584413251	0.04483487686253795	1.651443342960368e-09	0.10915558588965041	209
hsa05164	Influenza A	1	7.231307550739112e-71	7.231307550739112e-71	0.7928981445558452	0.0782001660333497	5.008945974417511e-05	0.16497184374657364	202
hsa04613	Neutrophil extracellular trap formation	1	4.2151608028098916e-46	4.2151608028098916e-46	0.945052145136519	0.06499697908120862	6.493158432908479e-07	0.15239049438884805	210
hsa05163	Human cytomegalovirus infection	1	2.3355952612524574e-60	2.3355952612524574e-60	0.652910431590019	0.059387691525146356	5.730971722434382e-07	0.1348311302212533	217
hsa04625	C-type lectin receptor signaling pathway	1	6.300905905634698e-71	6.300905905634698e-71	0.6736900022167941	0.07046396390342442	2.6123406772704232e-05	0.1468327705682604	192
hsa05020	Prion disease	7	7.826218126806749e-30	1.338495574714571e-55	0.945052145136519	0.0578564197877551	7.073241252217884e-07	0.13847026514914182	205
hsa05224	Breast cancer	1	1.0972861228528864e-66	1.0972861228528864e-66	0.8560194816661827	0.08116332880947584	5.339642190932434e-08	0.17743092303128077	190
hsa04530	Tight junction	1	2.4924014854660547e-69	2.4924014854660547e-69	0.7816708577192549	0.15379922644521776	0.03234024355828405	0.2050960465394181	188
hsa05225	Hepatocellular carcinoma	2	2.0001647480276063e-31	1.9383562983755083e-38	0.89385019691749	0.08198248735209017	0.0003439470256018	0.16383616540271348	205
hsa05017	Spinocerebellar ataxia	1	4.88887630866162e-35	4.88887630866162e-35	0.652910431590019	0.07755400840201081	0.0094028271134812	0.13951095244807593	198
hsa05010	Alzheimer disease	1	1.7407821377748618e-55	1.7407821377748618e-55	0.945052145136519	0.05375478716110336	1.1850911671166248e-05	0.12741603076943828	213
hsa05200	Pathways in cancer	1	2.1963824282547284e-101	2.1963824282547284e-101	0.6871987250202681	0.061275010845965254	2.381376904175725e-07	0.14334382658685096	206
hsa05206	MicroRNAs in cancer	1	3.7903390706213376e-127	3.7903390706213376e-127	0.8661326318575439	0.20988208518789286	0.1069904964186367	0.2299232418977929	186
hsa04927	Cortisol synthesis and secretion	1	2.595312276525824e-34	2.595312276525824e-34	0.945052145136519	0.14878773694146655	0.0606937370650065	0.18283369758485826	237
hsa05170	Human immunodeficiency virus 1 infection	1	6.13896606565261e-60	6.13896606565261e-60	0.7043581584413251	0.061772940015480435	8.702827146749942e-06	0.13489257442903035	203
hsa04060	Cytokine-cytokine receptor interaction	1	1.05187162855752e-148	1.05187162855752e-148	0.8640389506066377	0.12670094987773448	0.0008436750737966	0.21947417862629062	184
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	7.829555757572299e-79	7.829555757572299e-79	0.7043581584413251	0.07385481833983165	8.676404055904668e-05	0.15473539638110034	206
hsa04210	Apoptosis	1	7.384902792136834e-68	7.384902792136834e-68	0.5010690274785042	0.06116257450125466	5.294919969511161e-05	0.11787053589143175	217
hsa05168	Herpes simplex virus 1 infection	1	2.392979329816736e-77	2.392979329816736e-77	0.89385019691749	0.08440875860331705	2.8412310027813878e-05	0.17282870705172354	194
hsa04071	Sphingolipid signaling pathway	6	6.369974479612296e-28	9.028120004867832e-61	0.5811340386463366	0.06686372469311494	1.4981823919039822e-05	0.14148704142281643	210
hsa05166	Human T-cell leukemia virus 1 infection	1	1.4892557176921237e-78	1.4892557176921237e-78	0.7790917039515327	0.045027729775033144	1.1438974603415073e-05	0.1124435976061454	208
hsa05161	Hepatitis B	1	3.337092426078769e-83	3.337092426078769e-83	0.8919968202060229	0.05352806742137389	8.201116302039678e-08	0.1383064249272002	198
hsa05160	Hepatitis C	1	5.76416306814465e-46	5.76416306814465e-46	0.89385019691749	0.09187941460892755	0.0001604349074534	0.18481487306780953	187
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	4.2713829890417614e-76	4.2713829890417614e-76	0.7015647054836872	0.050538489880769366	6.031922149243079e-08	0.12853978805958727	205
hsa05169	Epstein-Barr virus infection	2	6.061302784016378e-79	6.061302784016378e-79	0.7928981445558452	0.053091724903954376	2.632851926661135e-07	0.14393493638912638	195
hsa05012	Parkinson disease	4	4.199151222199867e-25	1.950585684082761e-46	0.7833046657784437	0.05924017251319164	1.1368042106980964e-05	0.13519530864108686	235
hsa05014	Amyotrophic lateral sclerosis	2	1.5418550994586697e-43	5.4629825037276655e-48	0.8560194816661827	0.09045340635816257	0.0035303032489315	0.15876309636883523	199
hsa05226	Gastric cancer	2	3.569408163935953e-47	1.106468807012411e-78	0.89385019691749	0.060660173369800216	2.187758113445115e-06	0.131359701261053	203
hsa05415	Diabetic cardiomyopathy	2	4.204144808634628e-35	3.365839395784888e-37	0.5865979353911017	0.04627380478222065	4.559205597434762e-06	0.10262830932347136	228
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	3.858102091853023e-46	3.858102091853023e-46	0.5699903529074454	0.051898336451924924	4.3089349717518385e-08	0.12048259198068864	201
hsa05203	Viral carcinogenesis	2	1.9161318007542965e-61	9.132783395030224e-69	0.57831161455909	0.04203172742018352	3.0262152735744163e-07	0.11654879292751058	204
hsa04979	Cholesterol metabolism	1	2.4436092999412928e-70	2.4436092999412928e-70	0.908880644520742	0.4514227243414972	0.5835703543636465	0.27034452644617163	176
hsa05202	Transcriptional misregulation in cancer	1	3.786117621392158e-115	3.786117621392158e-115	0.7043581584413251	0.06793444573816607	5.363389089770566e-05	0.14697065809897777	200
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	3.3107153559596297e-62	3.3107153559596297e-62	0.799861000607755	0.090090185679713	0.0001655040560957	0.17905428302499976	204
hsa05165	Human papillomavirus infection	1	4.050846751295165e-72	4.050846751295165e-72	0.7043581584413251	0.04483487686253795	1.651443342960368e-09	0.10915558588965041	209
hsa05164	Influenza A	1	7.231307550739112e-71	7.231307550739112e-71	0.7928981445558452	0.0782001660333497	5.008945974417511e-05	0.16497184374657364	202
hsa04613	Neutrophil extracellular trap formation	1	4.2151608028098916e-46	4.2151608028098916e-46	0.945052145136519	0.06499697908120862	6.493158432908479e-07	0.15239049438884805	210
hsa05163	Human cytomegalovirus infection	1	2.3355952612524574e-60	2.3355952612524574e-60	0.652910431590019	0.059387691525146356	5.730971722434382e-07	0.1348311302212533	217
hsa04625	C-type lectin receptor signaling pathway	1	6.300905905634698e-71	6.300905905634698e-71	0.6736900022167941	0.07046396390342442	2.6123406772704232e-05	0.1468327705682604	192
hsa05020	Prion disease	7	7.826218126806749e-30	1.338495574714571e-55	0.945052145136519	0.0578564197877551	7.073241252217884e-07	0.13847026514914182	205
hsa05224	Breast cancer	1	1.0972861228528864e-66	1.0972861228528864e-66	0.8560194816661827	0.08116332880947584	5.339642190932434e-08	0.17743092303128077	190
hsa04530	Tight junction	1	2.4924014854660547e-69	2.4924014854660547e-69	0.7816708577192549	0.15379922644521776	0.03234024355828405	0.2050960465394181	188
hsa05225	Hepatocellular carcinoma	2	2.0001647480276063e-31	1.9383562983755083e-38	0.89385019691749	0.08198248735209017	0.0003439470256018	0.16383616540271348	205
hsa05017	Spinocerebellar ataxia	1	4.88887630866162e-35	4.88887630866162e-35	0.652910431590019	0.07755400840201081	0.0094028271134812	0.13951095244807593	198
hsa05010	Alzheimer disease	1	1.7407821377748618e-55	1.7407821377748618e-55	0.945052145136519	0.05375478716110336	1.1850911671166248e-05	0.12741603076943828	213
hsa05200	Pathways in cancer	1	2.1963824282547284e-101	2.1963824282547284e-101	0.6871987250202681	0.061275010845965254	2.381376904175725e-07	0.14334382658685096	206
hsa05206	MicroRNAs in cancer	1	3.7903390706213376e-127	3.7903390706213376e-127	0.8661326318575439	0.20988208518789286	0.1069904964186367	0.2299232418977929	186
hsa04927	Cortisol synthesis and secretion	1	2.595312276525824e-34	2.595312276525824e-34	0.945052145136519	0.14878773694146655	0.0606937370650065	0.18283369758485826	237
hsa05170	Human immunodeficiency virus 1 infection	1	6.13896606565261e-60	6.13896606565261e-60	0.7043581584413251	0.061772940015480435	8.702827146749942e-06	0.13489257442903035	203
hsa04060	Cytokine-cytokine receptor interaction	1	1.05187162855752e-148	1.05187162855752e-148	0.8640389506066377	0.12670094987773448	0.0008436750737966	0.21947417862629062	184
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	7.829555757572299e-79	7.829555757572299e-79	0.7043581584413251	0.07385481833983165	8.676404055904668e-05	0.15473539638110034	206
hsa04210	Apoptosis	1	7.384902792136834e-68	7.384902792136834e-68	0.5010690274785042	0.06116257450125466	5.294919969511161e-05	0.11787053589143175	217
hsa05168	Herpes simplex virus 1 infection	1	2.392979329816736e-77	2.392979329816736e-77	0.89385019691749	0.08440875860331705	2.8412310027813878e-05	0.17282870705172354	194
hsa04071	Sphingolipid signaling pathway	6	6.369974479612296e-28	9.028120004867832e-61	0.5811340386463366	0.06686372469311494	1.4981823919039822e-05	0.14148704142281643	210
hsa05166	Human T-cell leukemia virus 1 infection	1	1.4892557176921237e-78	1.4892557176921237e-78	0.7790917039515327	0.045027729775033144	1.1438974603415073e-05	0.1124435976061454	208
hsa05161	Hepatitis B	1	3.337092426078769e-83	3.337092426078769e-83	0.8919968202060229	0.05352806742137389	8.201116302039678e-08	0.1383064249272002	198
hsa05160	Hepatitis C	1	5.76416306814465e-46	5.76416306814465e-46	0.89385019691749	0.09187941460892755	0.0001604349074534	0.18481487306780953	187
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	4.2713829890417614e-76	4.2713829890417614e-76	0.7015647054836872	0.050538489880769366	6.031922149243079e-08	0.12853978805958727	205
hsa05169	Epstein-Barr virus infection	2	6.061302784016378e-79	6.061302784016378e-79	0.7928981445558452	0.053091724903954376	2.632851926661135e-07	0.14393493638912638	195
hsa05012	Parkinson disease	4	4.199151222199867e-25	1.950585684082761e-46	0.7833046657784437	0.05924017251319164	1.1368042106980964e-05	0.13519530864108686	235
hsa05014	Amyotrophic lateral sclerosis	2	1.5418550994586697e-43	5.4629825037276655e-48	0.8560194816661827	0.09045340635816257	0.0035303032489315	0.15876309636883523	199
hsa05226	Gastric cancer	2	3.569408163935953e-47	1.106468807012411e-78	0.89385019691749	0.060660173369800216	2.187758113445115e-06	0.131359701261053	203
hsa05415	Diabetic cardiomyopathy	2	4.204144808634628e-35	3.365839395784888e-37	0.5865979353911017	0.04627380478222065	4.559205597434762e-06	0.10262830932347136	228
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	3.858102091853023e-46	3.858102091853023e-46	0.5699903529074454	0.051898336451924924	4.3089349717518385e-08	0.12048259198068864	201
hsa05203	Viral carcinogenesis	2	1.9161318007542965e-61	9.132783395030224e-69	0.57831161455909	0.04203172742018352	3.0262152735744163e-07	0.11654879292751058	204
hsa04979	Cholesterol metabolism	1	2.4436092999412928e-70	2.4436092999412928e-70	0.908880644520742	0.4514227243414972	0.5835703543636465	0.27034452644617163	176
hsa05202	Transcriptional misregulation in cancer	1	3.786117621392158e-115	3.786117621392158e-115	0.7043581584413251	0.06793444573816607	5.363389089770566e-05	0.14697065809897777	200
